- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Volume 2012 (2012), Article ID 683729, 34 pages
Hemoglobin: A Nitric-Oxide Dioxygenase
Miami Valley Biotech, 1001 E. 2nd Street, Suite 2445, Dayton, OH 45402, USA
Received 11 September 2012; Accepted 4 October 2012
Academic Editors: Y. Furukawa and H. Iwano
Copyright © 2012 Paul R. Gardner. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Members of the hemoglobin superfamily efficiently catalyze nitric-oxide dioxygenation, and when paired with native electron donors, function as NO dioxygenases (NODs). Indeed, the NOD function has emerged as a more common and ancient function than the well-known role in O2 transport-storage. Novel hemoglobins possessing a NOD function continue to be discovered in diverse life forms. Unique hemoglobin structures evolved, in part, for catalysis with different electron donors. The mechanism of NOD catalysis by representative single domain hemoglobins and multidomain flavohemoglobin occurs through a multistep mechanism involving O2 migration to the heme pocket, O2 binding-reduction, NO migration, radical-radical coupling, O-atom rearrangement, nitrate release, and heme iron re-reduction. Unraveling the physiological functions of multiple NODs with varying expression in organisms and the complexity of NO as both a poison and signaling molecule remain grand challenges for the NO field. NOD knockout organisms and cells expressing recombinant NODs are helping to advance our understanding of NO actions in microbial infection, plant senescence, cancer, mitochondrial function, iron metabolism, and tissue O2 homeostasis. NOD inhibitors are being pursued for therapeutic applications as antibiotics and antitumor agents. Transgenic NOD-expressing plants, fish, algae, and microbes are being developed for agriculture, aquaculture, and industry.
1. Background and Introduction
Nitric-oxide dioxygenases (NODs) are enzymes that efficiently convert NO and O2 to nitrate (1). Most, if not all, NODs are hemoglobins (Hbs), and most, if not all, Hbs have the capacity to function as NODs. Hb-NODs appear to be widely distributed in nature. In fact, the NOD function appears more common and ancient than the classic O2 transport-storage function, or any other function, within the Hb superfamily . Nevertheless, textbook familiarity with the O2 transport-storage function continues to blind investigators to the enzymatic functions of various members of the Hb superfamily. For example, the genome of the nematode Caenorhabditis elegans encodes >33 candidate Hbs [2, 3], many of which are thought to store or transport O2. Multiple globins are also normally expressed in non-erythroid vertebrate cells and tissues [4, 5], and globin expression is deranged in cancer cells [6–9]. When asking the question “what are all these oxygen-binding heme proteins doing?” , investigators are now obliged to thoroughly consider enzyme functions, and in particular a NOD function
NODs are one of the most recent additions to the growing family of free radical and peroxide scavenging enzymes that includes the family of peroxidases  and peroxiredoxins (alkyl hydroperoxide reductases) , catalases , superoxide dismutases (SODs) [14, 15], superoxide reductases , and NO reductases (NORs) . There is also preliminary evidence for a NO dismutase in certain methanotrophs .
Seminal concepts within the family of peroxide and free radical scavenging enzymes can be traced to Oskar Loew’s pioneering description of “catalase”, a heme-containing enzyme with the “power of catalyzing hydrogen peroxide” [13, 19]. In 1900, Loew wrote “There seems to exist no plant and no animal which is without that enzyme [catalase]”. He also presciently wrote “One of the functions of this enzyme appears to be to prevent any accumulation of hydrogen peroxide which might be formed as a by-product in the series of energetic oxidations that characterize the cellular respiration process. Hydrogen peroxide is a poison for the living protoplasm, hence the activity of catalase is of vital importance.” Loew also made the early and important distinction between the substrate (H2O2) and enzyme in the catalytic reaction at a time when enzymes were only vaguely understood. While peroxidations had been described as early as 1855, the enzymatic nature and biological function of peroxidases would only be investigated much later [11, 20, 21]. The idea of dangerous toxic free radicals formed as by-products of an aerobic metabolism blossomed following the discovery of superoxide dismutase(s) and the demonstrations of superoxide radical actions in biological systems by Irwin Fridovich and his students [14, 15, 22]. Incalculable efforts have been expended to achieve our current understanding of the poisonous and damaging reactions, sources of the radicals and oxidants, as well as the full repertoire of detoxifying enzymes and their roles in physiology and pathophysiology. In addition, novel roles for radicals and oxidants in cell signaling and scavengers in signal modulation were appreciated by the end of the 20th century , but are still not fully comprehended.
Indeed, paradigms established by the pioneers of anti-oxidant and free radical-scavenging enzymes guided the discovery of NOD and continue to instruct investigations. Experiments have also been facilitated by a wealth of knowledge, as well as questions waiting for solution, in the areas of Hb structure, distribution, expression, functions, and evolutionary origins [24, 25]. On the other hand, the discovery of NO metabolizing enzymes followed rapidly on the heels of discoveries of the biological production and functions of NO, thus leaving much to discern and discover in a rapidly evolving field. Substantial effort is now being aimed at understanding the biological functions and enzymatic mechanisms of various NODs and the development of NOD-based technologies including research tools, recombinant plants and other organisms, and therapeutic drugs including antibiotics. Novel Hbs continue to be examined for a possible NOD function. In addition, novel non-Hb type NODs and NOD mimetics are under investigation .
2. Purpose and Scope
While several reactions of NO with erythrocyte Hb and muscle myoglobin (Mb) including the tight-binding of NO to the ferrous heme, the NO (Stickstoffoxyd, Saltpeterstoffgas)-mediated oxidation of the oxy-heme, and the formation of NO from nitrite have been under investigation for many decades [27–33], our investigations published in 1998 [34, 35] provided our first glimpse of the ~2 billion-year-old evolutionary link between NO and Hb vis-à-vis the NOD function of E. coli flavoHb. The observations offered a distinct and common enzymatic function for the primitive low-abundance Hbs first formally formulated and investigated by David Keilin around 1945 [36, 37], expanded and clarified by Austen Riggs [38, 39] and others [40–42], and pursued early on in the labs of Cyril Appleby [43, 44], Britton Chance , Hans Schlegel , Dale Webster , Jonathan and Beatrice Wittenberg , Bärbel Friedrich [48, 49], Robert Poole [50, 51], Austen Riggs [39, 52], Michiko Nakano , Robert Poyton , Daniel Goldberg [55–57], Keiji Shikama [58–61], Malcolm Potts , Robert Hill [63, 64] and many others clearing a wide path to the common NOD function. However, while appearing attractive to some, the well-known tight-binding of NO to ferrous Hbs [ = ~10 pM] made the NOD enzyme hypothesis appear rather dubious in the eyes of experts. Despite this and other challenges, data supporting a primal NOD mechanism-function for diverse members of the ancient Hb superfamily has expanded appreciably in the last 14 years. While the facts that lay obscure or dormant in the pre-1998 literature, and the findings of the first ~7 years have been dutifully and thoroughly reviewed in our 2005 and 2006 publications [65, 66] and elsewhere, my intent here is not only to describe important advances in the area of Hb/NOD research, but also to pose critical questions and discuss new concepts that will help move investigations forward and into new areas. This, of course, has demanded critiques of what I consider lingering misconceptions that continue to plague the field, stymie progress, and lead investigators off the path. It is hoped that the reader finds this paper rigorous, not trite, too pedantic, tame, or polemical. The reader is also directed to more than a dozen recent reviews presenting in-depth perspectives on various aspects of the topic [1, 67–87]. I have attempted to highlight these reviews in pertinent sections of my paper. A distillation and synthesis of the available evidence is crucial since some investigators continue to ponder upon a “common but still poorly defined function of globins” . Here, I thoroughly scrutinize the merits of a common NOD function in the light of the results of more than a decade of research.
3. Evolution and Distribution of Hbs
Several recent phylogenomic studies and reviews have catalogued the broad distribution and lineages of Hbs of various subtypes in the three life kingdoms [1, 89–94]. The amazing array of globins expressed even within individual life forms [3, 42, 74, 95] including humans [96, 97] raise myriad questions that will occupy investigators for many years. Most strikingly, the genomes of most organisms encode multiple Hbs with unknown function. Moreover, relatively few Hbs have been scrutinized for a NOD function. Which sub-types function as NODs? If a life form cannot express a Hb, how does the organism metabolize NO? Why do organisms express multiple Hbs and various Hb sub-types? What primary structure features reliably predict a NOD function and allow annotation of Hb genes? What is the significance of these structural features to function? What are all the possible functions of Hb? And the biggest question—How did Hb function evolve?
Answers to these many questions have been slow to emerge, but there are fundamental concepts guiding our understanding of Hb functions and evolution. Clearly, numerous proteins possess multiple reactivities and functions [98, 99]; a property that has been colorfully referred to as “moonlighting”  or “catalytic promiscuity” . Indeed, those reactivities serve as a framework for protein [globin] evolution. As astutely pointed out by Shikama and coworkers [61, 102], “Whatever the possible roles of such primitive or ancient globins may be [or might have been], the reversible binding of molecular oxygen to iron[II] must be the primary event to manifest their physiological functions in vivo.” The fairly unique electronic structure of the ferric heme-superoxo bond in Hbs  suggests an even more unique chemical-biological niche for the globins. Thus, while a focus on the evolution of globin structural differences suggests great functional variation [24, 25, 104, 105], a focus on the potentially limited reactivity of the conserved ferric heme-superoxo electronic structure suggests a common function.
As Max Perutz eloquently stated “Evolution is a brilliant chemist” . Proteins evolve by eliminating old traits and creating new traits from a single protein scaffold. In the case of Hbs, the old traits of flavoHb-NODs include high O2 affinities, high autooxidation rates, and internal electron transfer rates that are suited for rapid NO dioxygenation catalysis. New traits include the low O2 affinities, low autooxidation rates, external electron donors, lower NO dioxygenation rate constants , and a single globin domain that is adapted for O2 storage-transport . What is more difficult to fathom and demonstrate is a major O2-independent function for Hb that predates the ~2 billion year old, contemporary, and common NOD function . Albeit, NO reductase [69, 107] and electron transfer  functions have been proposed for flavoHb and neuroglobin (Ngb), respectively. The discoveries of an estimated 3.8 billion-year-old primordial protoglobin in a “strictly” anaerobic methanogen Methanosarcina acetivorans [109, 110] and the single domain “thermoglobin” in Aquifex aeolicus (AE000678) [52, 111] provide relic experimental systems to further explore the functional origins of the globin family.
4. FlavoHbs, Hbs, and Mbs Function as NO-Metabolizing Enzymes
Are Hbs, Mbs, trHbs, and flavoHbs simple NO scavengers or are they highly evolved enzymes? For the two domain flavoHbs, the answer has always been clear. FlavoHbs catalyze NO dioxygenation efficiently, rapidly, and with high fidelity [65, 66]. FlavoHbs belong to the oxidoreductase family utilizing NAD(P)H to incorporate two O-atoms from O2 into the substrate NO to form nitrate (2). FlavoHbs catalyzing the reaction are formally called NODs and have been designated EC 220.127.116.11 by the Enzyme Commission of the International Union of Biochemists and Molecular Biologists. Over 4,000 flavoHb protein entries are now labeled primarily as NODs at the US National Institutes of Health web site (http://www.ncbi.nlm.nih.gov/pubmed/). Many more flavoHbs are annotated for a possible NOD function. Since my last listing of flavoHb-NODs in 2005 , several flavoHbs notably expressed by human or plant pathogens have been isolated and tested directly for a NOD function. Aspergillus oryzae, A. nidulans, and A. fumigatus express 2 flavoHbs showing a NOD function [112–114]. Erwinia chrysanthemi , Giardia intestinalis , G. lamblia , and Mycobacterium tuberculosis [118, 119] flavoHbs have been also investigated. The E. chrysanthemi and Giardia flavoHbs show appreciable NOD activity in vitro
For many single domain globins (SDGs), an annotation as a NOD has always been less clear. It would appear that all single domain oxy-Hbs catalyze the NO dioxygenation reaction with reported in vitro bimolecular rate constants ranging from 106 to >109 s-1 M−1 [65, 66, 120–125]. The Arabidopsis thalania GLB1 and GLB2 (trHbs) convert NO to nitrate in vivo as evidenced by increased NO emissions and decreased tissue nitrate concentrations in globin-deficient mutants [126, 127]. But few SDGs have been shown to couple with a native redox partner for efficient enzymatic NO consumption [128–132]. Moreover, when demonstrations of weak or nonspecific redox coupling have been observed to support turnover in vitro, or in heterologous organisms, there has been an understandable reluctance to declare that sufficient evidence for a NOD function . Clearly, full proof of a NOD function requires the demonstration of catalytic -dependent NO metabolism within the native organism. Furthermore, a specific electron donor needs to be identified for demonstrations of efficient catalysis in vitro. To date, only the mammalian Cygb-NOD has been investigated both in cells [134, 135] and reconstituted with a native electron donor (ascorbate or cytochrome b5) in vitro [135, 136]. In addition, many SDGs have shown evidence of a protective enzymatic NOD function including muscle Mb , Synechococcus truncated Hb , Synechocystis cyanoglobin , and the dual function nitrate reductase-fused trHb in raphidophytes . However, one cannot declare a NOD function a priori. A NOD function requires a demonstration of enzymatic turnover. Protective effects of SDGs could also be attributed to nonenzymatic, rapid, and competing NO oxidation (dioxygenation) and nitrosylation reactions of Hbs similar to those of erythrocyte Hb and muscle Mb [31, 32, 140]. This is a small distinction, but a potentially important one.
5. Myriad NO Functions: Bioenergetic Intermediate, N Source, Toxin, and Signal Molecule
To understand the physiological functions of NODs (Hbs), knowledge of the burgeoning field of NO biology is required. NO is fairly ubiquitous and serves important roles in bioenergetic transformations, immunity, and signaling in diverse life forms. Quantitative knowledge of the sources of NO, target reactions of NO, and localized steady-state NO levels is also required to discern the competing and overlapping roles of NO. Moreover, within specific cells and tissues, these factors vary in complex ways [198, 199]. Nevertheless, instructive generalizations can be made.
In microbes, algae, and plants, NO serves as an important role as a bioenergetic intermediate and nitrogen source. The process of anaerobic or microaerobic denitrification, particularly in soil microorganisms, generates NO as an obligate intermediate in the energy-yielding reductive dissimilation of to N2 [17, 200]. Nitrate reductases generate nitrite, and nitrite reductases generate NO for reduction by proton-motive force generating membrane-bound NO reductases and N2O reductases. FlavoHb (NOD) can recycle the denitrification intermediate NO to and is required for optimal microaerobic denitrification, and presumably energy production, by fungi  and bacteria . NO is also an important intermediate in the energy-yielding pathway of microaerobic ammonia oxidation or nitrification [201, 202]. Alternatively, NO can be generated through non-specific reduction of nitrite by nitrate reductases found abundantly in plants, algae, and microbes [203–205]. Neighboring soil microorganisms and plants can assimilate N through the Hb-catalyzed dioxygenation of diffusible NO to . In addition, generated via catalytic NO dioxygenation can provide an electron sink for fermentative energy production by plants , bacteria, and fungi [52, 200].
NO is also an important intermediate in the Earth’s nitrogen cycle [207, 208]. Anthropogenic sources, such as N-fertilization, pollution, and waste generation, may contribute to excess formation of NO and the greenhouse gas N2O . Rhizobial NODs serve an important role in converting NO to in plants and in doing so avert N2O formation by rhizobia and soil microbe NO reductases . Indeed, Pseudomonas stutzeri engineered for flavoHb overproduction emit less N2O during microaerobic denitrification . Photoilluminated leaf chloroplast nitrite reductase is also an important source of atmospheric N2O presumably via the reduction of assimilated to NO , and NO to NO- followed by the combination of 2 NO− to form N2O. In this case, a chloroplast NOD (trHb) may serve as an important geochemical function by decreasing NO levels and N2O formation.
NO acts as a toxin and signal molecule throughout the biosphere. In addition to the numerous sources of NO described above, NO is produced by nitric-oxide synthases (NOSs) and various nitrite-reducing activities in many different organisms including humans . Removal of NO by catalytic NO dioxygenation can thus serve to prevent NO toxicity or attenuate NO signaling. Understanding NO toxicity and signaling in the biosphere requires an understanding of the many reactions of NO as well as its concentrations. I have listed only a few of the important biochemical reactions of NO and the relevant biological functions or consequences in Table 1. The representative list of reactions clarifies why NO is an outstanding natural antibiotic and antitumor agent and why NO metabolism by NODs or NORs provide a direct path for cellular resistance. The toxicology of NO has been discussed in greater detail in an excellent recent review by Toledo Jr. and Augusto . Not too surprisingly, many of the toxic reactions of NO have been exploited by Nature for NO signaling functions. These bifunctional toxic reactions include ferrous heme nitrosylation (e.g., soluble guanylate cyclase activation), iron-sulfur center disruption (NsrR and IRE-BP) , mononuclear iron-binding (e.g., prolyl hydroxylase, NorR and ACO), and the NO/bound reaction (e.g., DevS, DosT and FixL).
When evaluating the competitive reactions of NO in complex systems, it is very valuable to know steady-state concentrations of reactants and bimolecular rate constants. These values allow us to make some simple and powerful calculations. For example, we can determine the rate of NO removal and the maximum flux of NO going to toxic peroxynitrite formation in a cell containing and oxy-Hb. If the steady-state  = 10 pM, [NO] = 0.1 μM, and [oxy-Hb] = 0, then the rate of NO removal and peroxynitrite formation [NO]  = 7 nM NO s−1, where s−1 M−1. If oxy-Hb is also present at 1 μM, and its bimolecular rate constant () for reaction with NO s−1 M−1, then the rate of NO removal = [NO] + [NO][oxy-Hb] = 30,007 nM NO s−1. We can also see from the relationship that at any steady-state [NO] the ratio of the NO flux to and oxy-Hb equals /[oxy-Hb], or in this case 0.0023. Thus, under these physiologically relevant concentrations, only 0.23% of the NO will escape detoxification by oxy-Hb and form toxic peroxynitrite. Similar approximations can be made for other competing reactants.
6. FlavoHbs and Hbs Detoxify NO
A large number of flavoHbs and Hbs have been shown to detoxify NO, and many of these have been listed and described in my 2005 review  and in the recent Forrester and Foster review . The list of organisms that are presumed to detoxify NO using flavoHbs and Hbs has expanded profoundly with the increase in genome sequencing and in silico analysis. Not too surprisingly, far fewer experimental demonstrations of organisms utilizing flavoHbs or Hbs for their protection against NO have been reported. Recent experiments support NOD functions for flavoHbs or Hbs expressed by Bacillus subtilis [212, 213], Staphylococcus aureus [214, 215], Aspergillus oryzae [112, 216], A. nidulans , A. fumigatus , Yersinia pestis , Vibrio fischeri , Pseudoalteromonas haloplanktis , Campylobacter jejuni [220, 221], the Japanese shrub Alnus firma , Sinorhizobium meliloti , Botrytis cinerea , and Synechococcus . Expression of Mycobacterium leprae GlbO  and Synechocystis SynHb  alleviates NO toxicity in E. coli supporting a NOD function. And expression of cotton non-symbiotic Hb in Arabidopsis seedlings conferred resistance to NO . Furthermore, novel or special interest Hbs including the mammalian Cygb [134–136], and the algal raphidophyte Heterosigma akashiwo nitrate reductase fused with a trHb (NR2-2/2HbN) have been characterized as protective NO-metabolizing and NO-detoxifying enzymes . Interestingly, the Mycobacterium tuberculosis flavoHb (Rv0385) reportedly showed little NOD activity in vitro  and provided negligible nitrosative stress protection to Hmp-deficient E. coli . Similar functional uncertainty exists for the NO-inducible truncated Ctb from C. jejuni [225–227]. With the advent of rapid genome sequencing, annotation of various flavoHbs and Hbs as NODs (EC 18.104.22.168) in genome databases has become prodigious. What is needed are more reliable criteria for annotating a NOD function.
7. NOD Functions for FlavoHbs and Hbs in Microbial Pathogenesis
NO is produced as a natural antibiotic and antitumor agent in the innate immune response of animals and plants. Microbes and tumor cells have the capacity to resist NO toxicity . Microarray analyses of mRNA [152, 183, 213, 214, 220, 229–238] and in silico reconstruction of transcription networks [152, 233, 239–241] in microbes and mammalian cells have revealed myriad adaptive changes potentially protecting against NO toxicity during microbial pathogenesis and inflammation. NODs, NORs [17, 151, 242], Fe-S cluster , and DNA repair enzymes , heme biosynthetic pathways , NO-resistant metabolic pathways (e.g., glucose metabolism and respiratory oxidases) [159–161, 240, 241], nitrite metabolism , and components of iron uptake systems form important and common elements of the nitrosative stress defense. Remarkably, in plants , Vibrio fischeri , and the fungal pathogen Candida albicans , NO poisoning of respiration is apparently averted by the induction of NO-resistant alternative oxidase. Mycobacteria survive the hazardous environment of macrohages with GlbN (trHbN), GlbO (trHbO), and heat shock protein GroEL2 induction with GlbO providing greater protection than GlbN within macrophages . Some aerobic organisms do not utilize a flavoHb-NOD, but apparently utilize sole NORs for NO metabolism , but these are the exception rather than the rule.
The accumulated evidence supports the hypothesis that NO metabolism and detoxification by NODs and/or NORs form the first, and most critical, line of defense against NO toxicity in microbes. However, results reviewed in the pre-2005 literature revealed only a modest advantage of the inducible flavoHbs and Hbs for microbes in the chosen infection models . Tail vein injections of NOD-deficient Candida albicans showed limited effects on mouse survival [95, 238, 245], and those effects appeared NOS-independent . Inhalation of Cryptococcus neoformans in mice showed similar modest extensions of mouse survival times with a flavoHb deficiency . The effects of HmpX (flavoHb) deletions in Erwinia chrysanthemi infections of Saintpaulia ionantha (African violet) plants were more impressive, but interpretations were subject to potential effects of deletions of neighboring pectate lyase virulence genes [115, 247]. Nevertheless, Boccara et al. convincingly argued an important role for HmpX in the pathogenesis of E. chrysanthemi. Not only does HmpX (NOD) protect against NO toxicity, it also impacts the NO-regulated hypersensitive response required for plant immunity [115, 224, 248]. Clearly, more and better models of microbial infection are required to discover the full involvement of flavoHbs and Hbs in microbial pathogenesis, albeit the prospects appear limitless. For example, mucosal infections by C. albicans are far more common and applicable than blood stream infections. Most experimental designs also ignore the effects of the metabolic state of microbes upon subsequent infectivity . For example, naïve and metabolically depleted E. coli are more susceptible to NO toxicity and bacteriostasis than actively growing bacteria . More impressive protective roles for the flavoHb-NOD in rodent models of Salmonella typhimurium , Staphylococcus aureus , uropathogenic E. coli , Yersinia pestis , Vibrio cholerae  infections and in squid models of Vibrio fischeri symbiosis  have been subsequently reported. Interestingly, in the intestinal model of V. cholerae infection, flavoHb (Hmp) was more critical for virulence than the NO defense regulator. Stern and coworkers suggest that low constitutive levels of flavoHb protect V. cholerae from NO-dependent elimination . In the case of the plant fungal necrotroph Botrytis cinerea, flavoHb-NOD was not found to be a virulence factor .
8. Critical Roles for Hb-NODs in Preserving Bioenergetics
Hbs serve two most vital roles in the production of energy via oxidative-phosphorylation. When oxygenated, Hbs can prevent NO poisoning of the citric acid cycle enzyme aconitase, heme-copper terminal oxidases, and respiration by catalyzing NO dioxygenation [35, 163]. NO poisoning of terminal oxidases and respiration is particulary problematic during hypoxia because of the strong competition between NO and O2 [~1 : 1000] for binding the binuclear heme a3/CuB site and the noncompetitive binding of NO to the oxidized CuB site [159, 160, 164]. If sufficiently abundant, and having a low affinity for O2 binding, Hbs can also store and release O2 to sustain respiration during transient episodes of hypoxia. These two functions, or NOD activity alone, can explain the strong protection nerve Hbs afford nerve excitatory activity during episodes of anoxia/hypoxia [253, 254], muscle Mb provides the heart during hypoxia [137, 255], Cygb affords fibroblast respiration , flavoHb affords E. coli respiration , Vitreoscilla Hb affords either E. coli, plants or zebrafish (Danio rerio) engineered for biotechnological applications [78, 256–258], nonsymbiotic Hb expression has on maize ATP levels and energy charge during hypoxia [63, 74], and legume Hb affords Rhodobacter japonicum respiration  and soybean nodule bacteroid N2 fixation [125, 259]. The inducible Sinorhizobium meliloti flavoHb plays a similar role in protecting alfalfa bacteroid N2 fixation and fostering symbiosis [183, 260]. These strong dual effects on organism energetics (and survival) may have constituted the earliest, most powerful, selective force and circumstance for Hb to evolve from an efficient low-level expression NO dioxygenase to a highly expressed storage-transport protein. Ironically, the existence of Antarctic icefish lacking in Mb and Hb also supports the notion that these proteins evolved for dual functions. However, in this case, the loss O2 transport-storage and NOD functions are apparently compensated for by a NO-augmented tissue vascularization, luminal diameters of blood vessels, and mitochondrial densities .
From a different perspective, the product of the NOD reaction, nitrate, can increase glycolytic ATP production by microbes and plants during the transition from the hypoxic to anoxic state by serving as an oxidant reservoir for NADH oxidation via nitrate reductases and nitrite reductases [52, 206].
9. Beyond NO Detoxification: Signaling
The ability of Hb to consume NO in the mammalian vasculature [262, 263] and Mb to decompose NO in muscle [137, 255, 264] has been an important issue since the conception of the role of NO in controlling blood flow. Indeed, the abundance of red blood cell Hb and myocyte Mb prompted the consideration of mechanisms that would be able to preserve NO in the vasculature or muscle tissues  in the face of certain destruction. These mechanisms include NO diffusion barriers [266–268], Hb/Mb-mediated NO sequestration and release  and, more recently, Mb or Hb-mediated NO formation from NO-derived nitrite . The rapid reactions of NO with oxy and deoxy Hb and Mb also led to the early view that these reactions would impair their O2 transport-storage functions [31, 270]. However, the role of Hbs in modulating spatial and temporal NO signaling is subtle and slowly becoming apparent. In tissues, Hb, Mb, Ngb and Cygb may act as catalytic NO sinks that together with NOS dynamically and spatially determine steady-state NO levels, soluble guanylate cyclase (sGC) activation, and myriad signaling actions [198, 199, 255, 262, 271, 272] including regulating cerebral blood flow, synaptic efficiency and neurotransmitter release .
Griffiths and Garthwaite  formulated a “clamp” model for a better understanding of the consequences of NO consumption on NO steady-state levels and NO signaling functions in mammalian tissues. In this model, the sink (i.e., NOD) translates different rates of NO formation with a tissue volume into proportional steady-state NO concentrations and clamp [NO]. The NOD thus serves to “amplitude-code” NO signals. The NO inactivation rate also governs the rates of rise and fall of NO concentrations as NO sources switch on and off. In target cells, activation of sGC then causes cGMP to accumulate rapidly to levels that are graded with the prevailing NO concentration. A high NO inactivation rate endows the NO signal with temporal meaning. In addition, NO sinks add a spatial dimension for NO signals and provide additional mechanisms for regulating NO signaling such as via cellular O2 concentrations [142, 274, 275]. Furthermore, physiological inactivation mechanisms for signaling molecules generally have properties that are tuned to those of the receptors. In other words, a NOD needs to modulate NO steady-state levels at the 0.1–10 nM concentration levels that modulate sGC activity in vitro [191, 192]. Using quantitative real-time recording and modeling of neuronal NO signals via sGC activation in phosphodiesterase-deficient cells, Wood et al.  recently extended the estimates of steady-state [NO] in neuronal tissues to 0.25–3 nM with rates of NO generation estimated at 0.036 to 0.360 μM NO s−1.
Chen and Popel [277, 278] have mathematically modeled steady-state NO production rates in vascular and perivascular tissues and estimated similar values ranging from 0.017 to 1.5 μM NO s−1 that are dependent upon concentrations of the NOS isoforms and tissue O2 concentrations. Endothelial NOS (NOS3) expressed at lower concentrations (0.045 μM) produces lower NO fluxes whereas neuronal NOS (NOS1) is expressed at higher levels (0.3–0.9 μM) and produces larger NO fluxes. In these studies, estimates of NO steady-state concentrations in the perivascular tissue ranged from 0.3 to 51 nM and were O2 dependent. These values for [NO] are more than an order of magnitude lower than previous estimates. Importantly, the resulting steady-state NO concentrations are well within the range required for sGC activation (0.1–10 nM) [191, 192, 272]. The authors of these investigations made a number of simplifying assumptions including a rate of tissue NO consumption that was linearly proportional to NO and O2 concentrations as expressed by the bimolecular rate equation, rate = [NO][O2][cells], where μM−1 s−1 [cells/mL]−1 and [cells] = 108 cells mL−1 . However, the liver parenchymal cell activity used for the estimation of “” may be low since mammalian cells express NO consumption activity levels ranging from 2 to 20 nmol NO min−1107 cells−1. Using a cell concentration estimate of 108 cells mL−1, NO metabolic rates of 0.17 to 1.7 μM NO s−1 corresponding to values of to μM−1 s−1 [cells/mL]−1 are calculated. A larger NO consumption activity and value lowers the steady-state NO concentration estimates for the vascular and perivascular tissues. Moreover, contrary to the model, the activity shows normal Michaelis-Menten enzyme kinetics with (NO) and (O2) values of 0.2 μM and 17 μM, respectively , thus further complicating estimates of steady-state NO levels.
Modeling of NO levels in tissues can provide quantitative and qualitative insights into the roles of potential NO consumption pathways. For example, for superoxide radical to act as a bimolecular pathway for NO removal at rates of 0.17 to 1.7 μM NO s−1, steady-state levels of 140 pM to 1.4 nM would be required. These concentrations are well beyond the ~8 pM estimated within -generating mitochondria  and far greater than the level expected in the cytosol. On the other hand, for a Hb-NOD, like Cygb-NOD with a maximal turnover rate of ~1.2 s−1 , to act as the sole catalyst, a tissue Cygb concentration of 0.14 to 1.4 μM would be required. These concentrations are within range of the globin concentrations typically seen in nonerythroid cells [4, 280–282] and plants [74, 283]. Moreover, an O2-dependent NO consumption activity provides a feedback mechanism for controlling O2 delivery to hypoxic tissues via decreased NO consumption, [NO] elevation, sGC activation, smooth muscle relaxation, and increased capillary blood flow [142, 255, 262]. Halligan et al.  and Liu et al.  recently provided evidence and arguments supporting a role for Cygb-NOD in controlling NO levels and vasorelaxation. Similar roles for Mb expressed in smooth muscle [4, 137] and oxidase-generated  have been previously suggested. Various Hb-NODs are excellent candidates for the long sought dynamic sensor-regulator controlling tissue delivery and . The plots in Figure 1 illustrate the potential for Cygb, or other globins, to act as O2-dependent modulators of NO steady-state levels within the physiologically relevant parameters. Caution is warranted since this simple model assumes that the globin is the major catalyst. Cells may express multiple NO dioxygenation catalysts .
Cytosolic globins have the potential to influence NO signaling and cell phenotypes through NO scavenging; however, enzymatic NO scavenging by cytosolic mammalian globins has not been demonstrated in most cells to date (e.g., see ). Cygb is the exception [134, 135]. In mammals, α and/or β-chains of the red blood cell HbA0 have been detected in many different cells including hepatocytes , neurons and glial cells [287–291], macrophages , alveolar type II epithelial lung cells [282, 292], and mesangial kidney cells  suggesting additional Hb functions. Hb is enriched in pyramidal hippocampus and parietal grey matter neurons of Alzheimer’s patients . Other studies have demonstrated the expression of HbA0α- and β-chain mRNA in non-erythroid cells. Visceral metastases of breast carcinoma express elevated Hb β-chain . Cygb and Ngb are expressed in a variety of animal cells and tissues including neurons . In cancer, tumor growth is suppressed by expressing E. coli flavoHb-NOD in brain gliomas , overexpressing Cygb in head and neck squamous cell carcinomas [298, 299] or, paradoxically, by decreasing Mb in breast cancer cells . Globins, acting as NODs, may either decrease the NO signal eliciting a metastatic cell phenotype or increase NO detoxification and the resistance of tumor cell targets to endogenously generated NO (see Table 1). Removal of NO would decrease NO-elicited hypoxic tissue vascularization, mitochondrial biogenesis [300, 301], and the Hif-1α-orchestrated gene array expression important for bolstering hypoxic metabolism and the metastatic phenotype. The prolyl hydroxylase controlling Hif-1α stability and function is sensitive to inhibition by NO . NO induces and stabilizes Hif-1α and bolsters the hypoxic adaptation of cells . Moreover, Hif-1α upregulates Mb and Ngb expression [7, 9], thus providing a potential feedback loop for [NO] homeostasis. In this model, increased NO removal would decrease prolyl hydroxylase inhibition, destabilize Hif-1α, and attenuate globin expression and NO removal.
Globin-regulated NO signaling may also be important for the normal functioning of neurons. Expression of HbA0 in dopaminergic neurons is linked with pathways involved in O2 homeostasis, oxidative stress, iron metabolism, NO synthesis, and oxidative phosphorylation . Hif-1α expression was decreased in HbA0 expressing neurons and targets of Hif-1α were altered . Ngb deficiency in mouse brain exacerbates the Hif-1α-regulated response to hypoxia  further suggesting effects of the neuronal Ngb on [NO] and NO on Hif-1α stability.
There is also evidence for (flavo)Hbs modulating NO signaling pathways in fungi and bacteria. FlavoHb expression affects Dictyostelium discoideum development , and Aspergillus nidulans sexual development and mycotoxin production . NO scavenging by flavoHb attenuates the expression of the nitrosative stress response (e.g., norVW) , affects the swarming behavior of E. coli , and maintains squid-Vibrio fischeri  and Medicago truncatula-Sinorhizobium meliloti  symbioses.
R. Hill recently published an up-to-date and thorough review discussing the many known and potential roles for Hbs in modulating NO signaling processes in plants . For example, the Arabidopsis Hb, GLB1, modulates salicylate, ethylene, and jasmonic acid responses to Pseudomonas syringae and Botrytis cinerea infections . Lowering GLB1 levels and increasing NO levels elevates the defense against pathogens via multiple hormones. GLB1 expression also decreases ethylene-induced upward leaf movements in response to root hypoxia (hyponasty) .
10. Regulation of Globin Expression and NOD Function
A variety of mechanisms exist for controlling the expression of flavoHbs and Hbs in different organisms. Numerous organisms are now known to regulate globin expression in response to NO and hypoxia [65, 80] via specific NO and O2-responsive transcription factors as part of NO and hypoxic stress responses [67, 80]. Other inducing signals emanate from the inhibition of the electron transport chain , iron deficiency, oxidative stress, osmotic stress, cold stress, or hormones. A complex interplay of NO, O2, temperature [237, 308], iron availability, nitrate, nitrite, and oxidative stress can control Hb-NOD expression in various organisms. Moreover, it is impossible to deduce a NO detoxification function of a protein/gene solely from inducing signals since many NO-inducible proteins/genes are accessory  and not all NO detoxifying enzyme (NOD) genes are responsive to NO [95, 128, 142, 309, 310]. Nevertheless, given the common capacity of Hbs to function as NODs, the induction of a Hb by NO should be considered strong evidence for a NO metabolic function. It is also important to remember that NO can be produced from media nitrate and/or nitrite and that high levels of apparently constitutive (flavo)Hb expression [95, 138, 310] may be due to endogenous NO formation.
An impressive literature has amassed describing NO-responsive regulation of globin expression in various life forms since the writing of my 2005 review . At that time, a role for the NO-sensitive regulator NorR in the context of the transcriptional regulation of norVW in E. coli [151, 194, 311] and norBC in Ralstonia eutropha  was known. The mechanism of NO-sensing by NorR was subsequently elucidated by D’Autréaux et al. . Roles for the ferric uptake regulator (Fur), methionine repressor (MetR), superoxide response regulator (SoxRS), fumarate nitrate reductase regulator (Fnr) in E. coli, or Salmonella hmp (flavoHb) transcription had also been investigated and reported [69, 314–316], but those regulators did not satisfactorily explain NO induction [229, 317–319]. The advent of genomics and systematic and comparative operon analyses  greatly accelerated the identification NO-sensing regulators and the characterization of globin regulation in various bacteria. Stephen Spiro recently reviewed the literature on NO sensor regulators in the larger context of gas sensors in bacterial nitrogen metabolism . Efforts to identify NO-sensing regulators in representative yeast and fungi have progressed more slowly. Upregulation of globin expression in plants, algae, and animals in response to NO and hypoxia have also been described and is consistent with a NOD function. Here, I briefly review the NO and hypoxia sensing regulators of globin expression in the context of the putative NOD function.
NO-regulated NORs and NODs cooperate in the NO defense in bacteria. However, within any single organism, NOD and NOR appear, for the most part, to be under the control of different NO sensor regulators. On the other hand, homologous regulators control either NOR or NOD in different organisms. For example, the sigma-54 dependent transcription activator NorR regulates NOR expression in Ralstonia eutropha  and E. coli [151, 194, 311] in response to nanomolar NO, but NorR regulates NOD (hmp) expression in Vibrio cholera [239, 252]. Similarly, in Pseudomonas aeruginosa, rpoN, a sigma-54 homologue, and FhpR, a NorR homologue, regulate fhp (flavoHb) in response to NO . Through a veritable tour de force, S. Spiro and coworkers demonstrated that NorR utilizes an EPR-detectable mononuclear iron center embedded in a PAS-GAF domain to bind and sense NO and to activate transcription of norVW in E. coli . It is this iron center that can also react with peroxide to impair the NO response .
In Salmonella , E. coli [80, 322], B. subtilis [213, 323] and many other bacteria, the transcription repressor NsrR senses NO via a labile [4Fe-4S] center containing a solvent-exposed NO-reactive iron atom [195, 322]. The NO sensing mechanism appears similar to the mechanism of iron-sulfur dehydratase inactivation by NO, or iron chelators [143, 144, 324]. Curiously, early investigators reported E. coli flavoHb upregulation following exposure to the -generating redox-cycling agent paraquat  and the ferrous iron-chelator dipyridyl , effects presumably mediated via NsrR Fe-S center destruction . In Campylobacter, NssR, a Crp-Fnr superfamily member, controls expression of the Cgb-NOD and trHb Ctb, presumably through NO interactions with its iron-sulfur center [220, 227]. N2-fixing Sinorhizobium utilizes NnrR and FixLJ to sense NO  and upregulates transcription of >100 genes including hmp. FixL contains heme and can potentially sense NO via nitrosylation and dioxygenation reactions and upregulates NOD (hmp) . NnrR is also a Crp-Fnr superfamily member and upregulates NOR in Sinorhizobium , and nitrite reduction in the ammonia-oxidizing NO-generating lithoautotroph Nitrosomonas europaea [201, 325]. Discoveries of additional NO sensor-regulators in bacteria are anticipated.
Many bacteria have long been known to upregulate (flavo)Hb expression in response to hypoxia [46, 50, 53, 326]. The common regulator appears to be Fnr, and the signal is O2, not NO . Induction of a NOD in response to hypoxia makes sense since O2 is a cosubstrate for the NOD reaction and since NO is more toxic to respiration at a low pO2.
Progress has also been made in understanding NO regulation of flavoHbs in fungi and yeast. In Saccharomyces cerevisiae, the Fzf1p regulator is required for NO induction of YHB transcription . In Candida albicans, CTA4 a zinc-finger protein is required for induction of YHB1 transcription , and Cwt1p acts as a repressor of a nitrosative stress regulon that includes YHB1 . NO upregulates flavoHb (NOD) expression by Aspergillus oryzae , the plant pathogen Botrytis cinerea  and other fungi  presumably via similar mechanisms. The full details of NO sensing and transcription activation remain to be elucidated.
One of the more interesting discoveries has been that the Fusarium graminearum virus-DK21 downregulates flavoHb mRNA and protein expression by the pathogenic plant fungus Fusarium graminearum along with virulence . A role for the flavoHb in virulence is suggested.
10.3. Photosynthetic Organisms
Numerous examples of NO and hypoxia upregulating Hbs in plants have been described and reviewed [74, 81, 82, 328]. The fused nitrate reductase-trHb (NR2-2/2HbN) is induced by NO in the microalgal species Heterosigma akashiwo . Arabidopsis class 1 nsHb is induced during growth with nitrate . Two nonsymbiotic trHb genes are strongly induced by nitrate, nitrite, and NO in cultured rice cells . Cotton and wheat nsHbs are induced by NO  or NO donors . Only one of the five Hb genes, LjHb1 encoding a nsHb, is induced by NO and hypoxia in Lotus japonicum [308, 332]. Another nsHb (LjHb2) is induced by sucrose, abscisic acid, and osmotic stress. Clearly, not every Hb with a capacity for a NOD function is induced by NO or hypoxia. For example, the cyanobacterium Synechococcus sp. GlbN provides resistance to NO, but is apparently not inducible by NO, nitrate, or nitrite .
The protective Giardia lamblia flavoHb-NOD is induced by nitrite, nitrosoglutathione, and NO donors .
Numerous animal Hbs are reportedly induced by hypoxia, but apparently none by NO. The Hb β-chain is induced in macrophages by interferon and lipopolysaccharide  which also elicit NO synthesis. However, the induced Hb β-chain failed to increase NO consumption by macrophages . HbA0 chains are expressed in rat ischaemic rat neurons  and are upregulated in response to hemorrhage , hemin, erythropoeitin , and oxygen-glucose deprivation . The chains are not always coordinately regulated; oxygen-glucose deprivation increases rat neuronal α-chain mRNA 1.9-fold, but decreases Hb β-chain mRNA 3-fold . HbA0 is also reportedly present in hippocampal and parietal grey matter neurons of Alzheimer’s patients , a hypoxic and inflammatory condition that may induce globin expression. Hb α- and β-chains are also expressed in alveolar type II lung epithelial cells in response to hypoxia [282, 292] and Hif-2α or Hif-1α control transcription . Ngb is induced by hypoxia  and is under control of the master transcriptional regulator of the hypoxic response, Hif-1α [336–338]. Hypoxia also induces fish Mb in nonmuscle cells including liver, gill, and brain . Numerous other studies have shown elevated expression of mRNAs for Hb α- and β-chains, Mb, Cygb, and Ngb in non-erythroid cells and especially hypoxic tumors [7, 9]. What remains unclear is whether these animal globins have a significant capacity for NO dioxygenation and modulation of NO functions and how this relates to pathophysiology. For example, Ngb-deficiency in mice leads to changes in Hif-1α-regulated pathways in response to hypoxia . Is this due to deficient NO metabolism and NO stabilization of Hif-1αvia prolyl hydroxylase inhibition? Is NO, like O2, a signal that normally controls Hif-1α?
While knowledge of the many factors and mechanisms controlling transcription or translation of globins in various life forms is revealing and often supportive of a NOD function, a quantitative knowledge of the NO and O2 concentration dependencies of the responses is critical for understanding Hb function in NO homeostasis control, detoxification, and/or signal modulation. The overriding question is: What level of NO is normal and how do cells maintain and respond to changes in the concentration of NO via globin synthesis regulation?
11. Hb Structure(s) and the NOD Mechanism
The molecular, atomic, and electronic details of the NO dioxygenation reaction form the heart of our understanding of Hb structure-function and evolution. Proposals of a common, intrinsic, and ancient NOD function require a thorough understanding of the reaction and the chemical properties of Hbs or flavoHbs that make them either good or poor catalysts. There are several recognized basic requirements for a NOD function that Hbs must possess. These include(1)a high O2 affinity, (2)a mechanism for decreasing NO binding to heme,(3)a superoxide radical-like character of the bound O2,(4)a protected pocket for the peroxynitrite intermediate,(5)an O-atom isomerization mechanism, (6)a mechanism for nitrate egress,(7)a mechanism for univalent reduction. Here, I will focus on new knowledge, key concepts, and current questions about Hb chemistry that are directly related to the NO dioxygenation reaction, NOD catalysis, and a NOD function. New investigators of Hb-NODs should consult the seminal literature [34, 49, 52, 339–341] and prior reviews describing (flavo)Hb structure-function-evolution [1, 65–67, 71, 72, 102, 342] for background and additional information. Mowat et al. provide an excellent recent overview of the flavoHb-NOD structure-function .
11.1. High O2 Affinity
By definition, all Hbs bind O2 reversibly (3). However, Hb affinities for O2 vary greatly with equilibrium dissociation constants ( values) ranging from low nM to greater than 20 μM O2. On- and off-rates for O2 determine O2 affinities, and these are influenced by structure as described in an excellent recent review by Marti et al. . A high O2 affinity is critical for limiting NO inhibition during catalytic NO dioxygenation. Mutations increasing the O2 off rate of flavoHb increase NO inhibition . O2 must be able to outcompete NO for binding the ferrous heme for a Hb to function as a NOD. Hbs with lower O2 affinities (e.g., Cygb) function as effective NODs but only at a low [NO] relative to [O2] .
11.2. Mechanisms for Decreasing NO Binding to Heme
Competition between NO and O2 for binding the ferrous heme, as predicted from transient kinetic measurements, should prohibit a NOD function for most (flavo)Hbs [65, 344]. For many Hbs, the (NO) value determined by laser photolysis and stopped-flow is ~10 pM. Yet, steady-state assays of NOD activity reveal much weaker inhibition by NO [52, 135, 341, 344] thus suggesting the existence of mechanisms for decreasing NO binding during catalysis (4)
The most attractive explanation for this phenomenon is the allosteric modulation of an NO tunnel or gate by O2 binding. In the M. tuberculosis trHbN, O2 and NO access the ferrous heme through two different gated tunnels . O2 binding opens a long tunnel for NO and increases NO access [346–348]. Tunnel switching occurs on the picosecond to nanosecond time scale and is compatible with a role in NOD catalysis . A novel role for PheE15 in gating O2 and NO migration through channels has been suggested in which the distal H-bonding TyrB10 and GlnE11 act as the triggers [348, 350, 351]. Similar tunnels or gates may control NO access in other Hbs. Bis-histidyl ligation and structural plasticity may serve a similar role in controlling ligand access in the NOD function of plant nsHb [84, 352].
Other explanations for diminished NO inhibition include NO reduction by the flavoHbs , yet, rates of NO reduction by some flavoHbs appear too low . Interestingly, Liu et al. were able to mathematically model the Cygb-NOD activity with the available transient kinetic rate constants for NO and O2 binding and NO dioxygenation  suggesting the absence of mechanisms for decreasing NO binding in some Hbs.
11.3. Superoxide Radical-Like Character of the Bound O2
The ferric iron forms unique bonding interactions with the bound important for NOD function. The heme-Fe3+ () unpaired electron interacts with the unpaired electron through strong antiferromagnetic coupling in a unique end-on orientation . In the NO dioxygenation reaction, the unpaired NO electron associated with the N-atom couples with the unpaired electron. One electron is formally transferred from NO to the half-filled () orbital (reduction of superoxo), but not to the metal; thus the strong O2 bond is broken and the Fe-O bond is strengthened. The reaction is analogous to the diffusion-limited reaction of NO and in solution  except that the strong anti-ferromagnetic coupling of an end-on has the capacity to preferentially localize the unpaired electron density to the O-atom proximal to the iron and to direct the NO reaction (vide infra).
The anti-ferromagnetic coupling is eliminated with the return of the electron from the bound to Fe3+ permitting O2 dissociation. However, many Hbs that function as NODs (e.g., E. coli flavoHb) show relatively high autooxidation rates and release. Toxic release is more problematic at high oxy-Hb concentrations and is slow for abundant Hbs and Mbs functioning in O2 transport-storage [356–358]. In contrast, the less abundant neuronal Ngb shows high autooxidation rates in vitro . Curiously, this has led some investigators to discount a NOD function . However, high autooxidation rates can be an artefact of in vitro conditions and should not be the sole basis for conclusions about function. For example, autooxidation of the Candida norvigensis flavoHb-NOD oxy-complex is very slow, but increases when the reductase domain cofactor FAD is absent or when the reductase domain is separated from the Hb domain [61, 102].
11.4. Protected Pocket for the Peroxynitrite Intermediate
The half-life of the fleeting peroxynitrite intermediate is expected to be in the microsecond range due to facile iron-catalyzed isomerization to ferric-nitrato, whereas the ferric-nitrato species has a measured half-life of milliseconds [361, 362]. The putative HbFe3+(ONOO−) intermediate detected in reactions of oxy-Mb, -Ngb and -GlbO in the millisecond time range [122, 123, 363–365] must now be assigned to the ferric-nitrato species. Oxy-globin model compounds, Fe(Por)(NH3)(O2), also react with NO at 80–100 K forming only the low-spin ferric-nitrato complexes, thus implying that peroxynitrite intermediates, if formed, also undergo very facile isomerization . In contrast, NO reacts with oxy-coboglobin model compounds, Co(Por)(NH3)(O2), forming a detectable peroxynitrite intermediate and nitrato species at low temperature . More recently, Navati and Friedman  reported preliminary evidence for Fe3+(ONOO−) formation during the reaction of NO with oxy-Mb and oxy-Hb in a special “dry” glassy matrix.
The ferric-peroxynitrite would form in the distal pocket of Hb-NODs which is well isolated from nucleophiles and solvent. Hb pockets are typically lined with a large number of hydrophobic residues with histidine, glutamine, and/or tyrosine residues forming hydrogen bonds to the ligand. A protected pocket may explain how Hb functions as a high-fidelity catalyst of NO dioxygenation whereas the indoleamine dioxygenase-like oxy Turbo Mb cannot .
11.5. O-Atom Isomerization or Rearrangement Mechanism
Two mechanisms for formation of nitrate from the reaction of NO and HbFe3+() (7) have been previously discussed . Both provide a pathway for O–O bond breaking and O-atom isomerization or rearrangement in the peroxynitrite intermediate. The first that we envisioned was an iron-catalyzed mechanism in which ferric iron, acting as a Lewis acid, facilitates O-atom rearrangement . We wrote “The heme-Fe3+ may facilitate an oxygen bond rearrangement by participating in a iron-mediated oxygen bond shift analogous to the proton-mediated shift suggested for the nonenzymic mechanism for HOONO decomposition to .” The mechanism was never fully rationalized, developed, or argued in the literature, but it was assumed that the mechanism would bear similarity to the mechanism of peroxynitrite isomerization accelerated by acidic pH (pH < 2) [368, 369]. The second, a ferryl mechanism involving peroxynitrite, O–O bond homolysis, and ferryl O-atom transfer was strongly supported by theory, overwhelmingly favored, and thoroughly argued and investigated [65, 66, 342, 364]. However, both the doubt cast by recent [121, 362] and earlier  investigations and the paucity of strong experimental support for the ferryl mechanism have demanded new insights and the scrutiny of alternative O-atom rearrangement mechanisms.
In 1954, Anbar and Taube  suggested a concerted internal O-atom rearrangement mechanism for the isomerization of peroxynitrous acid to nitrate to explain O-atom retention, and a similar mechanism, as already mentioned, was suggested as a possibility for the Hb reaction, albeit remaining poorly defined (see above) [65, 66]. Tsai et al.  had argued against an internal rearrangement mechanism for peroxynitrite/peroxynitrous acid in 1996 “because contracting of the O–O–N bond angle produces a strong repulsion between the terminal peroxide oxygen and the two oxygens bound to nitrogen.” Discussions with Henry Taube and recent descriptions of the unique bonding in Hbs  provided new insights for a novel concerted internal O-atom rearrangement mechanism (see below). The new mechanism casts doubt on the relevance and validity of mechanistic inferences drawn from experiments demonstrating peroxynitrite isomerization catalyzed by ferric Mb [372–375] or metalloporphyrins [26, 66, 376]. Models of heme-peroxynitrite adducts envision the negatively charged terminal O-atom bonded to iron [376, 377].
The two possible O-atom rearrangement mechanisms are illustrated in Figure 2. In the new reaction scheme (1), NO attacks and bonds the O-atom proximal to the iron atom breaking the strong π O2 bond and strengthening the Fe–O bond, the terminal O-atom attacks the nitrogen, and the O–O peroxide bond heterolytically breaks to form Fe3+. As envisioned, another electron pair donor (e.g., NO, HCN or I−) should be able to intercept the terminal O-atom to form and an oxygenated product (e.g., NO2, CNO− or IO−). The role of the ferric iron is purely that of a Lewis acid, as we first imagined , and the Hb pocket shields reactive intermediates. Ferric iron forms an ionic or coordinate bond with ONOO-, withdraws electrons from the terminal peroxide O-atom, and increases terminal O-atom reactivity with N. In contrast, in the ferryl mechanism (2), NO attacks the O-atom distal to the iron atom to form Fe3+(ONOO−), the O–O bond weakens and homolytically breaks to form the “caged” Fe4+ = O (O−) and NO2 pair which rapidly combine to form Fe3+().
The support for a ferryl mechanism was previously reviewed [65, 66, 364] and recently critiqued [121, 362, 375, 378]. From atomistic simulations of the truncated group I HbN, Mishra and Meuwly  concluded that the O–O bond scission energy barrier was too high and homolysis too slow thus suggesting an internal rearrangement mechanism. Su and Groves  have concluded that NO2 is an unavoidable product of the ferryl mechanism, yet, there is no evidence for NO2 formation or ferryl O-atom scrambling with water during (flavo)Hb-catalyzed NO dioxygenation . One would expect NO2-mediated nitration damage to the B10 tyrosine residue in the distal pocket of flavoHb-NOD and a loss of NOD activity similar to the nitrations of more distant tyrosines observed in Mb and Hb [66, 373, 374, 379–383]. The release of reactive toxic intermediates during NO oxidation by oxy-Hb is the antithesis of a NOD function, and the evidence for that is meager . What then are the arguments and evidence suggesting a concerted Lewis acid mechanism (Figure 2, (1))? First, the reaction mechanism demands the application of density functional theory and further scrutiny. Past theoretical investigations of peroxynitrous acid isomerization  have not considered the effects of hydrogen ion interactions with peroxynitrous acid O-atoms. Nor has O-atom retention during peroxynitrous acid isomerization [370, 385] been investigated as a function of pH. Clearly, hydrogen ions increase the rate of the reaction [368, 369] well beyond the peroxynitrous acid pKa of 6.5–7 , but this phenomenon has never been clarified. A proton, or Lewis acid, interacting with the peroxide O-atom proximal to N would decrease the strong repulsion between the terminal peroxide oxygen and the two oxygens bound to nitrogen. In an analogous reaction, hydrogen ions catalyze O-atom transfer from H2O2 to I- and other two-electron donors [387–390]. The only apparent catalytic mechanism is through O-atom protonation, which withdraws electrons from the proximal O-atom, increases O or OH+ reactivity with I- and which causes peroxide bond heterolysis forming water and IO− or IOH . A Lewis acid (e.g., Fe3+) would be expected to be able to catalyze a similar O-atom transfer. There are also reasons why a mechanism involving NO attack of the O-atom proximal to iron in Hbs is attractive. The proximal O-atom is more accessible to NO. Moreover, it is the most probable location for the anti-ferromagnetically coupled unpaired Fe3+() electron  that couples with the unpaired NO electron. Hughes and Nicklin had suggested a heterolytic mechanism for peroxynitrous acid isomerization in 1968 , but the potential role of hydronium or hydrogen ions in catalyzing the reaction was not considered.
11.6. Mechanisms for Nitrate Egress
Martí et al. simulated nitrate release from Mycobacterium tuberculosis trHbN . The molecular dynamic simulations suggest that formation of the ferric-nitrato species causes a structural distortion of the pocket cavity walls forming pores for water entry. Water hydration weakens the bond between the heme iron atom and nitrate exits in ~5 ns via a unique pathway differing from O2 and NO tunnels. A role for ThrE2 in assisting nitrate egress was proposed. The role of plant nsHb pocket plasticity in nitrate removal has also been discussed . The Mycobacterium leprae GlbO ferric-nitrato intermediate showed a 10–100-fold longer half-life than other globins  suggesting a slow nitrate egress mechanism.
11.7. Mechanisms for Univalent Reduction
Each NO dioxygenation reaction consumes a single electron that must be supplied by an electron donor for catalytic turnover. The ferric heme is reduced by an electron (8a) for the O2 binding reaction (3). Importantly, Hbs require mechanisms to prevent the transfer of a second electron to the higher potential ferric superoxo complex. A second electron would generate ferric-peroxide (8b), and a third electron would generate ferryl. Reduction of the putative ferric-peroxynitrite intermediate could release peroxynitrite or generate hydroxyl radical (8c). These reactive species would be expected to cause damage to the heme and/or protein.
Native electron donors are known for only a handful of Hb-NODs, but distinct patterns are emerging. The ultimate electron donors for the flavoHb-NOD  and dual function raphidophyte trHb-nitrate reductase  are flavin-containing reductases linked by a multidomain structure. The C-terminal flavoHb reductase domain [39, 49] and C-terminal trHb-nitrate reductase domain structures belong to the FNR superfamily which includes NAD[P]H:ferredoxin oxidoreductase and NADH:cytochrome b5 oxidoreductase. The truncated cyanoglobin (GlbN) and ferredoxin reductase genes are also linked in a bi-cistronic operon controlled by the NO sensor-regulator NsrR in Legionella pneumophila . Together, the data suggest a common role for ferredoxin reductases and other FNR-like proteins as electron donors for trHbs and SDGs either linked in multi-domain structures or as separate proteins. The role of the of pre-A sequence for truncated HbN-NOD activity in Mycobacteria may be to facilitate interactions with a specific ferredoxin reductase . Ferredoxin:NADP+ oxidoreductase from E. coli was systematically tested for its capacity to support NOD activity of various Hbs in vitro , however, in those reactions, “NOD activity” is impossible to discern from reactions of . High concentrations of SOD are required to prevent reactions of NO with the invariably released by reductases . Red blood cell Hb is reduced by cytochrome b5, and cytochrome b5 can support the Cygb-NOD activity in vitro . Ascorbate also supports the Cygb-NOD activity at concentrations found within Cygb expressing fibroblasts and neurons [135, 136], and a putative binding site for ascorbate has been identified . An accessory role for NADPH:cytochrome P450 oxidoreductase in CygbFe3+ reduction has also been suggested . The barley nsHb can be reduced by an ascorbate-dependent monodehydroascorbate reductase . A mass spectrometry approach has been utilized to identify the Ngb and Mb interactome . The method may also reveal novel electron donor candidates.
Hb structures suggest two mechanisms for controlling univalent electron transfer. Bis-histidyl ligation in hexa-coordinate nsHbs, Cygb, and Ngb provides structural plasticity  and a mechanism for controlling electron donor binding and electron transfer. For example, movements of the E-helix and ArgE10 with changes in binding may modulate ascorbate binding and electron transfer in Cygb . In this case, bis-histidyl ligation to the ferric iron would be expected to induce an ascorbate binding-site, and bis-histidyl ligation to Fe3+() to decrease ascorbate binding. A rotating water bridge may also provide a mechanism for controlling univalent electron transfer from reduced flavins. The flavoHb and SDG structures [49, 65] and electron pathway analyses  suggest an important role for water molecules bridging the FAD and heme in mediating electron transfer. In the E. coli flavoHb-NOD structure , the bridging water molecule hydrogen-bonded and anchored by LysF7 ammonium group has the capacity to rotate to ON and OFF orientations (Figure 3). Strengthening of a short, strong hydrogen bond between water and the heme propionate, with O2 binding and a pKa shift of the heme propionate, provides a mechanism for controlling the bridging water orientation and regulating univalent electron transfer in Hb-NODs. The oxygen core repels electrons in the OFF orientation and would block electron tunneling. In support of the hypothesis, mutation of LysF7 dysregulates univalent electron transfer, oxidatively destroys the heme, and incapacitates the NOD function .
The many adaptations of the Hbs for the NOD function show that Mother Nature is indeed a brilliant chemist!
12. The FlavoHb Denitrosylase (O2 Nitrosylase) Concept
Following the report of NO metabolism by the NO-inducible E. coli flavoHb and kinetic investigations supporting a NOD mechanism [34, 52, 341], Hausladen et al. argued for a major revision by suggesting a denitrosylase mechanism for NO conversion to nitrate [396, 397]. NO binding to the ferrous heme, and Fe2+ reducing NO to Fe3+() and N2O was reported, and evidence for a reaction of O2 with Fe3+() to form nitrate (9) under more relevant physiological O2 and NO concentrations was argued. The rationale for the denitrosylase hypothesis was largely motivated by transient kinetic measurements showing a 1500-fold greater affinity of the ferrous heme for NO than O2 [52, 341] coupled with the observation of flavoHb-catalyzed NO metabolic activity at an exceptionally high ~1 : 6 NO : O2 ratio . Hausladen et al. concluded that the NO and O2 affinities necessarily indicated an unfeasible competition of O2 for the flavoHb heme under physiologically relevant conditions. Thus, the high NO affinity supposedly negated any possibility of a NOD mechanism at physiological O2 and NO levels. The argument epitomized the dogmatic belief that NO binding to any ferrous hemoglobin would prevent O2 binding and thus a catalytic NO metabolic activity that was dependent upon O2 binding. NO competition, or the lack thereof, remains relevant in investigations and assignments of a NOD function-mechanism for various hemoglobins (see above) [133, 135, 136, 344], but it does not prohibit the mechanism
Despite a dearth of either experimental or theoretical support for the flavoHb denitrosylase mechanism after more than 10 years, a handful of investigators persistently assign merit to the mechanism [67, 69, 70, 215, 250, 399] or equate the two mechanisms [87, 400] and in so doing obscure the true function of (flavo)Hbs and impede general progress. Moreover, proponents of the denitrosylase mechanism continue to reject the dioxygenase mechanism and nomenclature, but have received only a partial scientific rebuttal [65, 344, 397, 401]. Hence, a refutation of the denitrosylase mechanism is demanded.
The following is a list of reasons why a denitrosylase mechanism is theoretically unfeasible and weakly supported by experiment. (1) NO reduction ( V)[189, 402] to the nitroxyl () intermediate has a large energy barrier. values for NO reduction by flavoHb are >2000–fold lower than the values for NO dioxygenation ; (2) the reaction of Fe3+() with O2 is not kinetically favored [123, 403]; (3) O2 would be more rate-limiting for a denitrosylation at low physiological O2 concentrations than it would for the NOD mechanism; (4) the mechanism requires O2 to react with the N-atom liganded to the iron which does not provide an obvious reaction path for O-atom rearrangement; (5) O2 binding and NO scavenging are affected by the flavoHb distal pocket structure (TyrB10), but NO binding is not ; (6) CO competitively inhibits NO metabolism with respect to O2, not NO, throughout the physiological [O2] range [52, 344]; (7) the NO metabolic activity of flavoHb is saturable by O2 [52, 341, 344] with no evidence of an activity increase at low O2 as suggested and reported [396, 398]; (8) NO inhibits the NO metabolic activity of flavoHb at NO:O2 ratios >1 : 100 and not as potently as predicted from NO affinity measurements [52, 341, 344]; (9) flavoHb-NOD activity is induced by NO providing an effective escape from the otherwise problematic NO inhibition at low [O2] [151, 404]; (10) NO reductases are also expressed at low O2 concentrations thus substituting for lost flavoHb function due to NO inhibition [151, 404]; (11) the denitrosylase proposal assumes that micromolar NO concentrations are required for NO toxicity and thus the NO detoxification function of flavoHb. Presumably, under these high NO levels, a dioxygenase mechanism would be impossible. But, even a “tiny” 50 nM NO is toxic to aerobic E. coli  and flavoHb protects against this toxicity [35, 151, 404]. Thus, flavoHb-NOD can detoxify NO without significant NO inhibition even at 5 μM O2. Furthermore, NOD turnover under normoxia (~400 NO s−1 heme−1) far exceeds the activity expected from the denitrosylase mechanism. NO reduction by flavoHb, a step in the denitrosylase mechanism, has never exceeded 0.2 NO s−1 heme−1 [65, 107]. For the two mechanisms to be comparable in rate, the NOD mechanism would need to be inhibited by 99.95%. At 50 nM NO, the available [O2] would need to be <5 nM for 99.95% NOD inhibition for a remotely plausible and equivalent NO scavenging function. (12) Finally, the initially troubling observation of flavoHb metabolizing NO and NADH at an NO : O2 ratio of >1 : 6  can be explained by the fact that unusually high levels of flavoHb (0.5–1 μM) were present in the reactions such that the added NO (35 μM) was so rapidly consumed as not ever to achieve >5 μM NO! (see Figure 1(a), ). Moreover, the substantial NADH oxidase activity of flavoHb can account for NADH oxidation observed at these high concentrations of flavoHb (see Figure 1(d), ). These unfavorable conditions for NOD catalysis may also explain the relatively high yield of nitrite formation and would even compromise the deduced O2 : NO : NADH reaction stoichiometry . The concentrations of flavoHb protein used in steady-state kinetic analyses are typically 5,000-fold lower and involve high turnover numbers [52, 341, 344].
Unresolved issues nevertheless remain. For example, why is the affinity of flavoHb for NO ~15-fold greater when determined by the flash photolysis-rebinding method than when estimated from steady-state kinetic analysis? NO removal by the flavoHb NO reductase activity during catalysis is one possibility , but the activity may be insufficient to account for NO resistance. Similar questions arise for all other globins including the mammalian Cygb. The Cygb NO : O2 affinity ratio of ~125,000 : 1 immediately suggests a much greater inhibition by NO than that observed at NO : O2 ratios of >1 : 500 . Liu et al.  have recently used modeling simulations to argue that the steady-state kinetics measured for the Cygb-NOD activity are allowed by the high NO affinity ( pM), but the model required assumptions including NO affinity decreases with temperature. Less consideration has been given to structural dynamics and changes in NO access [346, 348] as a common mechanism for limiting NO binding and inhibition of catalysis (see above).
13. Why So Many Different Hb-Type NODs?
While there is certain danger of a fallacy of composition in suggesting a NOD function for all Hbs, the literature now shows that many different Hb structures in many different forms of life function as NODs. This realization raises important questions. If various Hbs function as NODs, why the structural diversity and the multiplicity of Hbs within organisms?
Cursory answers to these questions can be readily gleaned from the anti-oxidant and radical scavenging enzyme systems. For example, in order to scavenge H2O2, organisms express catalase, glutathione peroxidases (8 isoforms in humans), cytochrome c peroxidase, ascorbate peroxidase, and peroxiredoxins (6 isoforms in mammals) . And, for removal, multiple SOD isoforms are expressed (7 isoforms in Arabidopsis) [11, 15, 405]. These enzyme isoforms show differential localization in subcellular compartments, expression during development and stresses, electron sources, catalytic requirements, posttranslational regulation, and subtle differences in physiological functions.
The analogy implies a similar ubiquity and richness of NO- and Hb-related functions in nature. Moreover, examples are emerging to support this rubric. Aspergillus flavoHb-NODs are differentially distributed to the cytosol and mitochondria because FHb2 bears a mitochondrial N-terminal signal sequence [112, 216]. A class I truncated Hb localizes along chloroplasts thylakoid membranes in algae . Other examples of Hbs with membrane localization signals or affinities include the M. tuberculosis HbO [407, 408], VHb [409, 410], the myristoylated Crab globin , and the myristoylated or palmitoylated fish GlbX . Membrane association may also facilitate reduction by membrane-bound reductases. Saccharomyces cerevisiae flavoHb localizes to mitochondria and cytosol without an apparent signal sequence . The wheat nsHb interacts with, and apparently cofunctions with, photosystem I and II . Many Hbs show tissue-specific and developmental regulation of expression [82, 116, 222, 296, 304, 336, 413]. Some Hb-NODs are induced by NO stress, and others are not [95, 116, 216, 310]. Some flavoHb-NODs prefer NADH while others prefer NADPH [52, 114, 216], and expression appears to correlate with the availability of the electron source. The Cygb-NOD utilizes ascorbate as an electron donor in vitro [135, 136] and is expressed in ascorbate-rich fibroblasts and neurons . Transcript network analysis strongly suggests a role for ferredoxin: NADP+ oxidoreductase as the electron donor for cyanoglobin (GlbN) in Legionella pneumophila , and GlbN would be required to interact specifically with the reductase. Some globins are suited for NOD catalysis at relatively high micromolar NO concentrations and fluxes (e.g., flavoHbs) [52, 341] whereas others show lower turnover rates and are more susceptible to NO inhibition (e.g., Cygb and Ngb) . This is reasonable since some globins serve primary NO detoxification functions while others subserve NO signaling functions. Some Hbs may function better at low or high temperatures [111, 219] while others may function under dehydrating osmotic stresses . Potential mechanisms for post-translational regulation are also emerging. Reeder et al. have reported that lipid binding to Cygb alters heme coordination and suggest that this provides a mechanism for lipids to alter or regulate Cygb function . Protein phosphorylation and thiol-disulfide interchange have been suggested as mechanisms regulating Ngb function [415–417]. In addition, some globins (e.g., muscle Mb and legume Hb) may be suited to serve dual functions in transport-storage and NO metabolism [125, 137, 255, 262]. These many differences are achieved by many unique Hb structures while intrinsic binding and NO dioxygenation activity appear to be preserved in all Hbs.
14. Are Hemoglobins Unique O2-Dependent Catalysts for NO Metabolism?
The simple rapid bimolecular reaction between NO and to generate peroxynitrite ( M−1 s−1) [189, 355], and ultimately yield ~70% nitrate, initially suggested only minimal requirements for efficient O2-dependent NO metabolism in biological systems . While attractive, the very serious consequences of peroxynitrite toxicity [189, 190] were often overlooked. It is now clear that many organisms metabolize NO to nitrate via Hb-type NODs. What is not clear is whether Hb is the only protein family capable of catalyzing significant O2-dependent NO decomposition in cells. Other O2-binding heme or copper catalysts yield peroxynitrite reaction products [26, 418] or scramble the O-atoms with water  suggesting a unique capacity of Hbs for high-fidelity NO dioxygenation. On the other hand, an oxygenated Rhodobacter spaeroides cytochrome apparently dioxygenates NO in vitro, forms a complex with an electron-carrying b-type cytochrome and may function as a novel NOD .
In many cases, the catalysts of O2-dependent NO metabolism in microbes, plants, brain tissue [199, 271, 274, 420, 421], lung tissue , liver parenchymal cells , various cultured cell lines [142, 423], endothelial cells , macrophages , and the aortic wall [426, 427] remain to be defined. Besides the Hbs, cytochrome c oxidase , succinate-cytochrome c reductase , dihydrolipoamide dehydrogenase , and cytochrome P450s  join a growing list of cellular NO removal catalysts put forward for consideration.
15. Other Enzymatic Functions for Hemoglobins?
In addition to NO dioxygenation, several specialized enzymatic activities and functions have been proposed for various Hbs. Discerning a meaningful biological function from myriad fortuitous in vitro activities of Hbs  continues to be an important challenge. In all cases, investigators must always ask whether (1) other enzymes coexist in cells that could better serve the proposed function, (2) the structure evolved for the proposed function, and (3) the reaction is beneficial for long-term survival of an organism. In evaluating proposed functions of Hbs, it is also important to consider the fundamental argument of Shikama and coworkers [61, 102] that (4) “the reversible binding of molecular oxygen to iron(II) must be the primary event to manifest their physiological functions in vivo.” Of the following recently proposed enzymatic functions, surprisingly, only the heme oxygenase activity meets the last and most basic of these criteria.
15.1. NO Reductase
Anaerobic NO reduction was first suggested to be an important biological function for the E. coli flavoHb by Kim et al. . The reaction (10) served to explain the anaerobic induction of flavoHb by NOx  and the anaerobic growth protection flavoHb provided against nitrosothiols .
However, the proposed function has critical weaknesses. For example, other microbial flavoHbs show much lower , or negligible , NO reductase activity. The maximal turnover rate for NO reduction is >2000-fold lower than that measured for NOD activity, and is unstable (unpublished results). Furthermore, the flavoHb shows no NO reductase activity within anaerobic E. coli . Moreover, there are more efficient NO reductases in organisms expressing flavoHb or other Hbs [17, 151], and flavoHbs are capable of reducing nitrosothiols directly , thus explaining the protection observed. Yet, uncertainty, and confusion, over a NO reductase function clearly persists in the field of nitrosative and oxidative stress research .
15.2. Peroxynitrite Isomerase
The commonly accepted NOD mechanism includes the efficient isomerization of a ferric heme-bound peroxynitrite intermediate to nitrate (7). Given the formation of toxic peroxynitrite in cells from the rapid reaction of NO and , Herold and others have suggested that various Hbs and Mb may also function as scavengers of peroxynitrite [125, 138, 432]. However, large rate constants (>106 s−1 M−1) for peroxynitrite isomerization were only measured for distal E7 histidine mutants  suggesting that entry, binding or isomerization of the ONOO- anion in the heme pocket is normally hindered by E7 histidine. Exposure of Mb or Hb to exogenous peroxynitrite also nitrates and damages the protein [373, 374, 379–383]. Hence, these Hb structures do not appear adapted for a peroxynitrite isomerase function. Secondly, peroxynitrite reacts with a variety of abundant biomolecules (e.g., CO2 and glutathione) , and these biomolecules would compete with ferric Hb or Mb. Moreover, proposals of a peroxynitrite isomerase function ignore (1) the important function of SODs and NODs in preventing toxic peroxynitrite formation within cells and (2) reactions with the predominantly oxy Hb within cells [382, 383].
15.3. Nitrite Reductase
As early as 2003, Mark Gladwin and others began pursuing possible NO-generating nitrite reductase functions for the mammalian red blood cell Hb [433, 434] and muscle Mb [269, 435, 436]. The reaction (11) produces NO from nitrite under aerobic and hypoxic conditions in vitro and in vivo and is stimulated by acidic conditions that occur in tissue ischaemia
A vital role for the reaction in the hypoxic vasodilation of capillaries and homeostatic control of tissue O2 delivery was proposed. In addition, the reputed nitrite reductase function has been extended to other members of the Hb superfamily. For example, dithionite-reduced Ngb catalyzes NO production from millimolar nitrite under anaerobic conditions with rate constants estimated at 0.12 to 5 s−1 M−1 [416, 437]. Furthermore, Gladwin and co-workers have reported effects of distal histidine interactions, disulfide bond formation, and protein phosphorylation on the rate of the deoxy Ngb-nitrite reaction [415, 416]. The reaction rate constant increased to physiologically relevant values (~50 s−1 M−1) with the elimination or weakening of the distal histidine-heme interaction. Li et al. reported similar low levels of nitrite reducing activity (0.14 s−1 M−1) for Cygb and demonstrated a significant role for the activity in soluble guanylate cyclase activation in cultured aortic smooth muscle cells with 10 μM nitrite . This is remarkable since the theoretical maximum rate of NO generation under these conditions with an upper [deoxy-Cygb] estimate of 1 μM is 1.4 pM s−1. Neighboring endothelial cells normally generate and release NO at a far higher rate of 17 to 1500 nM s−1 [277, 278]. As pointed out by Sturms et al., “the modest (low micromolar) levels of nitrite typically found in mammalian tissues diminish the likelihood that nitrite reductase activity is a major function of these proteins” . Rather, Sturms and Hargrove suggest that plant hexacoordinate Hbs may be more suited to nitrite reduction since nitrite levels are higher in plant tissues. They have demonstrated anaerobic nitrite reduction by deoxy forms of rice Hb and Synechocystis Hb with respective bimolecular rate constants of 166 and 130 s−1 M−1 , but these Hbs are of relatively low abundance. Tiso et al. subsequently reported comparable bimolecular rate constants of 5 and 20 s−1 M−1 for the Arabidopsis thaliana nonsymbiotic Hbs .
It is important to note, however, that the reaction of nitrite with globins nitrosylates ferrous heme and cysteine sulfhydryls  and that the reaction of nitrite with globins in the presence of H2O2 nitrates proteins [441, 442]. Moreover, high nitrite concentrations under mildly acidic aerobic conditions form nitriheme, a damaged heme . Thus, the anoxic reduction reaction is likely a non-specific and damaging reaction of Hbs. Furthermore, the NO-generating reactions of Hbs must always be evaluated with other enzyme systems that also act as non-specific nitrite reductases  including the plant nitrate reductase  and mitochondria .
15.4. Hydroxylamine Reductase
Sturms et al. have suggested an additional role for plant and cyanobacterial deoxyHbs in reducing hydroxylamine (12), an intermediate in nitrite reduction, under anaerobic conditions . The proposed role presumes a failure of the nitrite reductase to adequately fulfill the function
15.5. Alkylhydroperoxide Reductase
Bonamore et al. have reported an anaerobic alkyl hydroperoxide reductase activity for E. coli flavoHb with turnover rates of ~1 s−1 [71, 446]. Given the high affinity of the flavoHb distal pocket for hydrophobic lipids, the authors have suggested a function for flavoHbs and related single domain Hbs in protecting cells from lipid-related oxidative stress. However, the benefit of flavoHb for protecting cells against peroxide stress is questionable given the exquisite sensitivity of the heme to destruction by peroxide(s) .
Numerous peroxidative activities of Hbs have been demonstrated in vitro suggesting potential peroxidase functions. Recent suggestions and investigations of Hbs functioning as peroxidases include the Synechocccus GlbN (a class 1 trHb) , Cygb [448–451], Ngb [450, 452], and several Arabidopsis Hbs . As pointed out by Paul , when evaluating a peroxidase function, one needs to determine overall turnover rate, rates of elementary steps, and specificity for electron donors and compare them with those reported for genuine peroxidases. A peroxidase function must also be demonstrated within the living organism in the normal background of peroxidases and catalase. Only in the case of the peroxidative dehalogenation of phenols by the polychaete Amphitite ornate Hb  has a peroxidase function been convincingly demonstrated.
15.7. Lactate Dehydrogenase
Gupta et al.  have recently reported the failure of Mycobacterium tuberculosis flavoHb [Rv0385] to meet the qualifications of a NOD. The protein is hexa-coordinate and shows very low NOD activity  and little ability to protect against nitrosative stress imposed by acidified nitrite when expressed in E. coli or M. smegmatis . A function as a D-lactate specific dehydrogenase was suggested. The proposed mechanism is similar to that of the L-lactate oxidizing flavocytochrome b2  where lactate transfers electrons to the flavin, and the flavin transfers electrons to the heme. A rather low in vitro turnover number for D-lactate oxidation of 0.026 s−1 is estimated from the published data . The possibility of post-translational modifications influencing activity was not considered. Interestingly, the putative M. tuberculosis flavoHb (Rv3571) was previously suggested to function in NO detoxification , but the work has not been confirmed or extended.
15.8. Electron Carrier
Other electron transfer functions, absent a role for O2, have been suggested for Hbs. Brittain et al. have suggested that the hexa-coordinate Ngb transfers electrons to the mitochondrial cytochrome c to prevent apoptosis , and additional roles in reductive stabilization of Hif-1α and Nrf2 during hypoxia have recently been argued . However, Ngb-deficient mouse models do not support a role for Ngb in preventing apoptosis during hypoxia . The reported changes in the Hif-1α-regulated transcription response in Ngb-deficiency  may be explained by impaired NO metabolism and NO inhibition of the Hif-1α destabilizing prolyl 4-hydroxylase [170, 171].
15.9. Heme Oxygenase
The flavoHb heme is readily destroyed and iron is released upon exposure to H2O2 . FlavoHbs, and presumably other Hbs, thus have the capacity to act as heme oxygenases. Moreover, multielectron reduction of the heme-bound O2 to H2O2 and/or ferryl by the reductase domain of a flavoHb (8b) generates the necessary intermediates for initiating the heme oxygenase-like mechanism . When the distal TyrB10 and His E7 residues are mutated in the C. jejuni truncated Ctb, Ctb can act as a heme oxygenase .
15.10. Anaerobic CO Metabolism
The 3.8–4.1-billion-year-old Methanosarcina acetivorans protoglobin [MaPgb] binds CO tightly and is thought to function in anaerobic CO fixation possibly through CO interactions . An O2-dependent NOD function appears to have been discounted because the organism is “strictly” anaerobic. However, the authors ignore the fact that many strict anaerobes tolerate brief O2 exposures in their natural habitats. Indeed, the genome of Methanosarcina acetivorans contains genes for the O2 defensive enzymes Cu,Zn-SOD (sodC) and catalase/peroxidase (katG). Moreover, assumptions of an origin of O2-generating reactions with increasing atmospheric O2 concentrations (~2.45 billion years ago) ignore uncertain O2 utilization rates and potential pockets of O2 generation on the Archaean Earth .
16. DNA-Binding and Other Regulatory Functions of Hb Domains
There are numerous examples of the Hb scaffold being used by Nature as part of multi-domain DNA-binding transcription regulators and enzymes including kinases, guanylate cyclases, and phosphodiesterases . These ‘globin-coupled sensors’ were outlined and discussed by Maqsudul Alam and his colleagues in their 2005 review . Not surprisingly, the Hb domains in these proteins are generally thought to bind and sense O2. They regulate important physiologic functions such as biofilm formation by Salmonella . Several of the >33 C. elegans globins are fused within multi-domain proteins and likely possess O2-sensing regulatory functions [2, 3]. Whether SDGs function in a similar capacity, but in non-covalent association with enzymes, is an important consideration when evaluating the function of Hbs. For example, oxidized ferric Ngb has been found act as a heterotrimeric Gα-protein guanine nucleotide dissociation inhibitor and has been proposed to regulate Gα-protein signaling [461, 462].
Importantly, the facile NO dioxygenation reaction may also be relevant to the biological function of some multi-domain sensor-regulators. For example, the O2 binding Azotobacter vinelandii AvGReg, a globin-coupled sensor, reacts rapidly with NO and is thought to serve a NO detoxification  or NO sensing function. In the case of the Mycobacterium tuberculosis PAS domain sensors DevS and DosT, NO rapidly reacts with the oxy forms to generate nitrate and the ferric heme form . The putative NO dioxygenation reaction triggers the dormancy program through subsequent formation of the kinase activating ferrous-NO form. The results are intriguing and may explain the ability of NO to induce and maintain the antibiotic-resistant dormant state of the bacterium in tuberculosis [464, 465]. A similar NO dioxygenation reaction of the FixL regulator may explain a major part of the NO transcriptional response of Sinorhizobium meliloti .
17. Hb-NOD Technologies
Progress in understanding the NO-scavenging NOD function and mechanism of various (flavo)Hbs continues to inspire medical, agricultural, and industrial inventions and is helping to unravel the complex biology of NO in a variety of organisms.
For example, human red blood cell Hb has been modified and is being tested for use as an injectable long-lived NO and oxidant scavenger for treatment of septic shock . Future designs that incorporate a catalytic Hb-NOD activity are anticipated. Alternatively, small molecule NOD mimetics  may find therapeutic applications once shielding of reactive intermediates in the NO dioxygenation reaction can be achieved.
Mechanistic inhibitors of NODs are being investigated for therapeutic use against microbial infections, hypertension, and malignant tumors [467–469]. Imidazoles bearing bulky hydrophobic groups such as the antifungal agent miconazole are particularly effective inhibitors of the flavoHbs . X-ray crystal structures of miconazole and other imidazoles with R. eutropha flavoHb reveal key interactions with hydrophobic residues (e.g., Ile25) in the distal heme pocket . These interactions suggest strategies for the rational design of therapeutic inhibitors such as the addition of specific hydrophobic groups to the miconazole nucleus. Imidazoles may also be especially effective towards S. aureus and other microbes. Miconazole increases /H2O2 generation by flavoHb in S. aureus in addition to blocking the NOD function .
In agriculture, Monsanto Corp. is engineering corn, soybean, and other crop plants expressing E. coli, Erwinia chrysanthemi and yeast flavoHb-NODs for increased resistance to stresses generating NO, increased capacity for soil nitrogen (NO) sequestration in the form of nitrate, and improved growth and fruit production characteristics . Using the patented technology, projected growth and fruit yields increase by ~20% and ~5%, respectively. Many others have engineered transgenic plants to express the Vitreoscilla Hb, or other SDGs with the capacity for catalytic NO dioxygenation [75, 129, 256]. The potential beneficial effects for growth, resistance to hypoxia, nitrosative stress, and so forth as well as potential detrimental effects have been recently reviewed . In aquaculture, hypoxia resistant fish are being created through uniform expression of the Vitreoscilla Hb directed by the carp actin promoter .
Vitreoscilla Hb is now being frequently exploited to increase the industrial production of proteins and other molecules by bacteria and yeasts under hypoxic reactor conditions [473–481], and the primary benefit appears to be increased microaerobic respiration vis-à-vis the NOD function [256, 258]. Another potential application is the use of the recently discovered dual function algal raphidophyte NOD-nitrate reductase  in bioremediation reactors to scavenge NO produced in fossil fuel combustion and to supply algae with nitrate for increased production of biofuels .
More recently, the flavoHb-NOD has been touted as a molecular tool for determining the role of NO in biological processes . As stressed by Forrester et al. , the strategy has clear advantages over pharmacological methods employing NOS inhibitors or gene knock-outs. Indeed, flavoHb and SDGs have already been used to discover and dissect the role of NO in glioma growth and cancer , fungal development and mycotoxin production , the plant hypersensitive response [115, 224, 484], symbiosis and nodule development [87, 260], N2 fixation [183, 184], and plant senescence .
18. Summary and Outlook
In all fields, we find change and permanence in thinking  and a maturation of obscure phenomena to fundamental theories and advances through the scientific process, as lucidly stated by Werner Heisenberg (1901–1976).
“For an understanding of the phenomena, the first condition is the introduction of adequate concepts; only with the help of the correct concepts can we really know what has been observed. When we enter a new field, very often new concepts are needed, and these new concepts usually come up in a rather unclear and undeveloped form. Later they are modified, sometimes they are almost completely abandoned and are replaced by better concepts which then, finally are clear and well-defined.”
Only through the introduction of “correct concepts”, controlled experiments, exacting scrutiny, careful retrospection, and the revision or refutation of faulty concepts can basic truths be established from obscure phenomena. This has been aptly illustrated by our progress in understanding the biology of Hb and NO. Sir Humphry Davy’s investigations of the “respiration” of Stickstoffoxyd (NO/NO2) by blood and tissues in 1800 produced the first relevant, yet unclear, phenomena including the remarkable oxidation of the red pigment of blood by the gas . Since then, the red-pigmented proteins Hb/Mb have been shown to carry O2 in multicellular organisms, while the NO-metabolizing activity of Hb is more ancient, widespread and only beginning to become clear. An understanding of O2 binding remains important for both functions, but the discovery of the NO dioxygenase function has introduced numerous new questions including some that challenge dogma and traditional views of Hb structure-function. In addition to continuing to ask which Hbs function as NODs, greater knowledge of enzyme mechanism and biological function are needed to understand the diverse Hb structures and their evolution. A better understanding of the structures governing the confounding competitive binding of O2 and NO to the ferrous heme during catalysis, or rather lack thereof, is requisite. Catalysis also needs to be understood in terms of the relevant in vivo concentrations of NO and O2. Also, much remains to be discovered in the area of electron donors and electron transfer.
Knowledge of the NOD activity and function of various Hbs and flavoHbs is being applied to the development of NOD inhibitors for use as therapeutic antibiotics, antitumor agents, and vasomodulators. FlavoHbs are being widely used as tools to assess the involvement of NO in the physiology and pathophysiology of plants, animals, fungi, and bacteria. Plants are being genetically modified for (flavo)Hb expression for increased NO resistance, nitrogen assimilation, growth, and crop yields. Hbs and flavoHbs are also being used to increase the productivity of bacteria, yeasts, and algae in biotechnological and environmental remediation applications. It is hoped that success in any of these or other applications provides tangible rewards for past and current efforts aimed at understanding the NOD function of Hbs.
Finally, I end with a tribute to the spirit of the discoverer of the “Sauerstoffsaugung” (Hb’s O2-absorbing function) and pioneer of molecular biology, Friedrich Hünefeld , by echoing his motto 172 years later.
Whatever is still hidden reveals ages in the light!
|SDG:||Single domain globin|
|sGC:||Soluble guanylate cyclase|
|IRE-BP:||Iron responsive element binding protein.|
Many colleagues contributed to the evolution of the ideas and knowledge presented in this paper. If the author was remiss in citation, it was due to the rapid expansion of the literature and breadth of the field. The author is especially thankful to Dr. Anne Gardner for many thoughtful discussions and experimental contributions. The author thanks his students, assistants, and collaborators listed on many of the publications for their contributions. The author gratefully acknowledges discussions with the late Professor Henry Taube that led him to formulate the internal O-atom rearrangement mechanism presented herein. This work was initiated with support from the American Heart Association Scientist Development Grant (9730193N), the Cincinnati Children’s Hospital Trustee Grant, and the National Institutes of Health Grant (R01 GM65090).
- S. N. Vinogradov and L. Moens, “Diversity of globin function: enzymatic, transport, storage, and sensing,” The Journal of Biological Chemistry, vol. 283, no. 14, pp. 8773–8777, 2008.
- D. Hoogewijs, S. de Henau, S. Dewilde et al., “The Caenorhabditis globin gene family reveals extensive nematode-specific radiation and diversification,” BMC Evolutionary Biology, vol. 8, no. 1, article 279, 2008.
- D. Hoogewijs, E. Geuens, S. Dewilde et al., “Wide diversity in structure and expression profiles among members of the Caenorhabditis elegans globin protein family,” BMC Genomics, vol. 8, article 356, 2007.
- Y. Qiu, L. Sutton, and A. F. Riggs, “Identification of myoglobin in human smooth muscle,” The Journal of Biological Chemistry, vol. 273, no. 36, pp. 23426–23432, 1998.
- J. Fraser, L. V. de Mello, D. Ward et al., “Hypoxia-inducible myoglobin expression in nonmuscle tissues,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 8, pp. 2977–2981, 2006.
- T. A. Gorr, D. Wichmann, C. Pilarsky et al., “Old proteins-new locations: myoglobin, haemoglobin, neuroglobin and cytoglobin in solid tumors and cancer cells,” Acta Physiologica, vol. 202, no. 3, pp. 563–581, 2010.
- G. Kristiansen, J. Hu, D. Wichmann et al., “Endogenous myoglobin in breast cancer is hypoxia-inducible by alternative transcription and functions to impair mitochondrial activity. A role in tumor suppression,” The Journal of Biological Chemistry, vol. 286, no. 50, pp. 43417–43428, 2011.
- G. Xinarianos, F. E. McRonald, J. M. Risk et al., “Frequent genetic and epigenetic abnormalities contribute to the deregulation of cytoglobin in non-small cell lung cancer,” Human Molecular Genetics, vol. 15, no. 13, pp. 2038–2044, 2006.
- U. Oleksiewicz, N. Daskoulidou, T. Liloglou et al., “Neuroglobin and myoglobin in non-small cell lung cancer: expression, regulation and prognosis,” Lung Cancer, vol. 74, no. 3, pp. 411–418, 2011.
- A. F. Riggs and T. A. Gorr, “A globin in every cell?” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 8, pp. 2469–2470, 2006.
- T. Gaspar, C. Penel, T. Thorpe, and H. Greppin, Peroxidases 1970–1980: A Survey of Their Biochemical and Physiological Roles in Higher Plants, Université de Genéve, Geneva, Switzerland, 1982.
- S. G. Rhee, H. Z. Chae, and K. Kim, “Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling,” Free Radical Biology and Medicine, vol. 38, no. 12, pp. 1543–1552, 2005.
- O. Loew, “A new enzyme of general occurrence in organisms. A preliminary note,” Science, vol. 11, pp. 701–702, 1900.
- J. M. McCord and I. Fridovich, “Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein),” The Journal of Biological Chemistry, vol. 244, no. 22, pp. 6049–6055, 1969.
- I. Fridovich, “Superoxide radical and superoxide dismutases,” Annual Review of Biochemistry, vol. 64, pp. 97–112, 1995.
- F. Bonnot, T. Molle, S. Menage et al., “Control of the evolution of iron peroxide intermediate in superoxide reductase from Desulfoarculus baarsii. Involvement of lysine 48 in protonation,” Journal of the American Chemical Society, vol. 134, no. 11, pp. 5120–5130, 2012.
- W. G. Zumft, “Nitric oxide reductases of prokaryotes with emphasis on the respiratory, heme-copper oxidase type,” Journal of Inorganic Biochemistry, vol. 99, no. 1, pp. 194–215, 2005.
- K. F. Ettwig, M. K. Butler, D. Le Paslier et al., “Nitrite-driven anaerobic methane oxidation by oxygenic bacteria,” Nature, vol. 464, no. 7288, pp. 543–548, 2010.
- R. E. Oesper, “Oscar Loew,” Journal of Chemical Education, vol. 7, no. 2, pp. 314–315, 1930.
- P. Nicholls, “The oxygenase-peroxidase theory of Bach and Chodat and its modern equivalents: change and permanence in scientific thinking as shown by our understanding of the roles of water, peroxide, and oxygen in the functioning of redox enzymes,” Biochemistry, vol. 72, no. 10, pp. 1039–1046, 2007.
- A. N. Bach and R. Chodat, “Untersuchungen über die Rolle der Peroxyde in der lebenden Zelle, IV Über Peroxydase,” Berichte der Deutschen Chemischcn Gesellschaft, vol. 35, pp. 2466–2470, 1902.
- I. Fridovich and P. Handler, “Detection of free radicals generated during enzymic oxidations by the initiation of sulfite oxidation,” The Journal of Biological Chemistry, vol. 236, pp. 1836–1840, 1961.
- S. J. Neill, R. Desikan, A. Clarke, R. D. Hurst, and J. T. Hancock, “Hydrogen peroxide and nitric oxide as signalling molecules in plants,” Journal of Experimental Botany, vol. 53, no. 372, pp. 1237–1247, 2002.
- J. B. Wittenberg and B. A. Wittenberg, “Mechanisms of cytoplasmic hemoglobin and myoglobin function,” Annual Review of Biophysics and Biophysical Chemistry, vol. 19, pp. 217–241, 1990.
- R. E. Weber and S. N. Vinogradov, “Nonvertebrate hemoglobins: functions and molecular adaptations,” Physiological Reviews, vol. 81, no. 2, pp. 569–628, 2001.
- M. P. Schopfer, B. Mondal, D. H. Lee, A. A. N. Sarjeant, and K. D. Karlin, “Heme/O2/∙NO nitric oxide dioxygenase (NOD) reactivity: phenolic nitration via a putative heme-peroxynitrite intermediate,” Journal of the American Chemical Society, vol. 131, no. 32, pp. 11304–11305, 2009.
- L. Hermann, “Ueber die Wirkung des Stickstoffoxydgases auf das Blut,” Archiv für Anatomie, Physiologie und Wissenschaftliche Medicin, pp. 469–481, 1865.
- D. Keilin and E. F. Hartree, “Reaction of nitric oxide with hæmoglobin and methæmoglobin,” Nature, vol. 139, no. 3517, article 548, 1937.
- H. Davy, Researches Chemical and Philisophical, Chiefly Concerning Nitrous Oxide or Dephlogisticated Nitrous Air, and Its Respiration, J. Johnson, London, UK, 1800.
- H. Davy, Humphry Davy's physiologische-chemische Untersuchungen über das Athmen, besonders über das Athmen von oxydirtem Stickgas, vol. 2, Menerschen Buchhandlung, Lemgo, Germany, 1814.
- M. P. Doyle and J. W. Hoekstra, “Oxidation of nitrogen oxides by bound dioxygen in hemoproteins,” Journal of Inorganic Biochemistry, vol. 14, no. 4, pp. 351–358, 1981.
- R. F. Eich, T. Li, D. D. Lemon et al., “Mechanism of NO-induced oxidation of myoglobin and hemoglobin,” Biochemistry, vol. 35, no. 22, pp. 6976–6983, 1996.
- R. S. Wade and C. E. Castro, “Reactions of oxymyoglobin with NO, NO2, and NO2- under argon and in air,” Chemical Research in Toxicology, vol. 9, no. 8, pp. 1382–1390, 1996.
- P. R. Gardner, A. M. Gardner, L. A. Martin, and A. L. Salzman, “Nitric oxide dioxygenase: an enzymic function for flavohemoglobin,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 18, pp. 10378–10383, 1998.
- P. R. Gardner, G. Costantino, and A. L. Salzman, “Constitutive and adaptive detoxification of nitric oxide in Escherichia coli. Role of nitric-oxide dioxygenase in the protection of aconitase,” The Journal of Biological Chemistry, vol. 273, no. 41, pp. 26528–26533, 1998.
- D. Keilin and Y. L. Wang, “Haemoglobin in the root nodules of leguminous plants,” Nature, vol. 155, no. 3930, pp. 227–229, 1945.
- D. Keilin, “Haemoglobin in fungi: occurrence of haemoglobin in yeast and the supposed stabilization of the oxygenated cytochrome oxidase,” Nature, vol. 172, no. 4374, pp. 390–393, 1953.
- A. F. Riggs, “Aspects of the origin and evolution of non-vertebrate hemoglobins,” Integrative and Comparative Biology, vol. 31, no. 3, pp. 535–545, 1991.
- H. Zhu and A. F. Riggs, “Yeast flavohemoglobin is an ancient protein related to globins and a reductase family,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 11, pp. 5015–5019, 1992.
- T. Suzuki and K. Imai, “Evolution of myoglobin,” Cellular and Molecular Life Sciences, vol. 54, no. 9, pp. 979–1004, 1998.
- L. Moens, J. Vanfleteren, Y. van de Peer et al., “Globins in nonvertebrate species: dispersal by horizontal gene transfer and evolution of the structure-function relationships,” Molecular Biology and Evolution, vol. 13, no. 2, pp. 324–333, 1996.
- R. C. Hardison, “A brief history of hemoglobins: plant, animal, protist, and bacteria,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 12, pp. 5675–5679, 1996.
- C. A. Appleby, “Electron transport systems of Rhizobium japonicum. II. Rhizobium haemoglobin, cytochromes and oxidases in free-living (cultured) cells,” Biochimica et Biophysica Acta, vol. 172, no. 1, pp. 88–105, 1969.
- C. A. Appleby, J. D. Tjepkema, and M. J. Trinick, “Hemoglobin in a nonleguminous plant, parasponia: possible genetic origin and function in nitrogen fixation,” Science, vol. 220, no. 4600, pp. 951–953, 1983.
- R. Oshino, N. Oshino, and B. Chance, “Studies on yeast hemoglobin. The properties of yeast hemoglobin and its physiological function in the cell,” European Journal of Biochemistry, vol. 35, no. 1, pp. 23–33, 1973.
- I. Probst, G. Wolf, and H. G. Schlegel, “An oxygen-binding flavohemoprotein from Alcaligenes eutrophus,” Biochimica et Biophysica Acta, vol. 576, no. 2, pp. 471–478, 1979.
- R. P. Dikshit, K. L. Dikshit, Y. Liu, and D. A. Webster, “The bacterial hemoglobin from Vitreoscilla can support the aerobic growth of Escherichia coli lacking terminal oxidases,” Archives of Biochemistry and Biophysics, vol. 293, no. 2, pp. 241–245, 1992.
- R. Cramm, R. A. Siddiqui, and B. Friedrich, “Primary sequence and evidence for a physiological function of the flavohemoprotein of Alcaligenes eutrophus,” The Journal of Biological Chemistry, vol. 269, no. 10, pp. 7349–7354, 1994.
- U. Ermler, R. A. Siddiqui, R. Cramm, and B. Friedrich, “Crystal structure of the flavohemoglobin from Alcaligenes eutrophus at 1.75 Å resolution,” EMBO Journal, vol. 14, no. 24, pp. 6067–6077, 1995.
- R. K. Poole, M. F. Anjum, J. Membrillo-Hernández, S. O. Kim, M. N. Hughes, and V. Stewart, “Nitric oxide, nitrite, and Fnr regulation of hmp (flavohemoglobin) gene expression in Escherichia coli K-12,” Journal of Bacteriology, vol. 178, no. 18, pp. 5487–5492, 1996.
- M. F. Anjum, N. Ioannidis, and R. K. Poole, “Response of the NAD(P)H-oxidising flavohaemoglobin (Hmp) to prolonged oxidative stress and implications for its physiological role in Escherichia coli,” FEMS Microbiology Letters, vol. 166, no. 2, pp. 219–223, 1998.
- P. R. Gardner, A. M. Gardner, L. A. Martin et al., “Nitric-oxide dioxygenase activity and function of flavohemoglobins. Sensitivity to nitric oxide and carbon monoxide inhibition,” The Journal of Biological Chemistry, vol. 275, no. 41, pp. 31581–31587, 2000.
- M. Lacelle, M. Kumano, K. Kurita, K. Yamane, P. Zuber, and M. M. Nakano, “Oxygen-controlled regulation of the flavohemoglobin gene in Bacillus subtilis,” Journal of Bacteriology, vol. 178, no. 13, pp. 3803–3808, 1996.
- X. J. Zhao, D. Raitt, P. V. Burke, A. S. Clewell, K. E. Kwast, and R. O. Poyton, “Function and expression of flavohemoglobin in Saccharomyces cerevisiae. Evidence for a role in the oxidative stress response,” The Journal of Biological Chemistry, vol. 271, no. 41, pp. 25131–25138, 1996.
- M. J. Crawford and D. E. Goldberg, “Role for the Salmonella flavohemoglobin in protection from nitric oxide,” The Journal of Biological Chemistry, vol. 273, no. 20, pp. 12543–12547, 1998.
- M. J. Crawford, D. R. Sherman, and D. E. Goldberg, “Regulation of Saccharomyces cerevisiae flavohemoglobin gene expression,” The Journal of Biological Chemistry, vol. 270, no. 12, pp. 6991–6996, 1995.
- D. R. Sherman, B. Guinn, M. M. Perdok, and D. E. Goldberg, “Components of sterol biosynthesis assembled on the oxygen-avid hemoglobin of Ascaris,” Science, vol. 258, no. 5090, pp. 1930–1932, 1992.
- H. Iwaasa, T. Takagi, and K. Shikama, “Amino acid sequence of yeast hemoglobin a two-domain structure,” Journal of Molecular Biology, vol. 227, no. 3, pp. 948–954, 1992.
- H. Iwaasa, T. Takagi, and K. Shikama, “Protozoan myoglobin from Paramecium caudatum. Its unusual amino acid sequence,” Journal of Molecular Biology, vol. 208, no. 2, pp. 355–358, 1989.
- H. Iwaasa, T. Takagi, and K. Shikama, “Protozoan hemoglobin from Tetrahymena pyriformis. Isolation, characterization, and amino acid sequence,” The Journal of Biological Chemistry, vol. 265, no. 15, pp. 8603–8609, 1990.
- G. Kobayashi, T. Nakamura, H. Ohmachi, A. Matsuoka, T. Ochiai, and K. Shikama, “Yeast flavohemoglobin from Candida norvegensis: its structural, spectral, and stability properties,” The Journal of Biological Chemistry, vol. 277, no. 45, pp. 42540–42548, 2002.
- D. R. Hill, T. J. Belbin, M. V. Thorsteinsson et al., “GlbN (cyanoglobin) is a peripheral membrane protein that is restricted to certain Nostoc spp.,” Journal of Bacteriology, vol. 178, no. 22, pp. 6587–6598, 1996.
- A. W. Sowa, S. M. G. Duff, P. A. Guy, and R. D. Hill, “Altering hemoglobin levels changes energy status in maize cells under hypoxia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 17, pp. 10317–10321, 1998.
- R. D. Hill, “What are hemoglobins doing in plants?” Canadian Journal of Botany, vol. 76, no. 5, pp. 707–712, 1998.
- P. R. Gardner, “Nitric oxide dioxygenase function and mechanism of flavohemoglobin, hemoglobin, myoglobin and their associated reductases,” Journal of Inorganic Biochemistry, vol. 99, no. 1, pp. 247–266, 2005.
- P. R. Gardner, A. M. Gardner, W. T. Brashear et al., “Hemoglobins dioxygenate nitric oxide with high fidelity,” Journal of Inorganic Biochemistry, vol. 100, no. 4, pp. 542–550, 2006.
- M. T. Forrester and M. W. Foster, “Protection from nitrosative stress: a central role for microbial flavohemoglobin,” Free Radical Biology and Medicine, vol. 52, no. 9, pp. 1620–1633, 2012.
- L. A. Bowman, S. McLean, R. K. Poole, and J. M. Fukuto, “The diversity of microbial responses to nitric oxide and agents of nitrosative stress close cousins but not identical twins,” Advances in Microbial Physiology, vol. 59, pp. 135–219, 2011.
- R. K. Poole, “Nitric oxide and nitrosative stress tolerance in bacteria,” Biochemical Society Transactions, vol. 33, no. 1, pp. 176–180, 2005.
- M. Angelo, A. Hausladen, D. J. Singel, and J. S. Stamler, “Interactions of NO with hemoglobin: from microbes to man,” Methods in Enzymology, vol. 436, pp. 131–168, 2008.
- A. Bonamore and A. Boffi, “Flavohemoglobin: structure and reactivity,” IUBMB Life, vol. 60, no. 1, pp. 19–28, 2008.
- C. G. Mowat, B. Gazur, L. P. Campbell, and S. K. Chapman, “Flavin-containing heme enzymes,” Archives of Biochemistry and Biophysics, vol. 493, no. 1, pp. 37–52, 2010.
- A. Tillmann, N. A. R. Gow, and A. J. P. Brown, “Nitric oxide and nitrosative stress tolerance in yeast,” Biochemical Society Transactions, vol. 39, no. 1, pp. 219–223, 2011.
- K. H. Hebelstrup, A. U. Igamberdiev, and R. D. Hill, “Metabolic effects of hemoglobin gene expression in plants,” Gene, vol. 398, no. 1-2, pp. 86–93, 2007.
- S. Jokipii-Lukkari, A. D. Frey, P. T. Kallio, and H. Häggman, “Intrinsic non-symbiotic and truncated haemoglobins and heterologous Vitreoscilla haemoglobin expression in plants,” Journal of Experimental Botany, vol. 60, no. 2, pp. 409–422, 2009.
- K. J. Gupta, K. H. Hebelstrup, L. A. Mur, and A. U. Igamberdiev, “Plant hemoglobins: important players at the crossroads between oxygen and nitric oxide,” FEBS Letters, vol. 585, no. 24, pp. 3843–3849, 2011.
- A. U. Igamberdiev, N. V. Bykova, and R. D. Hill, “Structural and functional properties of class 1 plant hemoglobins,” IUBMB Life, vol. 63, no. 3, pp. 146–152, 2011.
- A. D. Frey, M. Shepherd, S. Jokipii-Lukkari, H. Häggman, and P. T. Kallio, “The single-domain globin of Vitreoscilla. Augmentation of aerobic metabolism for biotechnological applications,” Advances in Microbial Physiology, vol. 58, pp. 82–139, 2011.
- P. T. Kallio, C. J. T. Bollinger, T. Koskenkorva, and A. D. Frey, “Assessment of biotechnologically relevant characteristics of heterologous hemoglobins in E. coli,” Methods in Enzymology, vol. 436, pp. 255–272, 2008.
- S. Spiro, “Nitrous oxide production and consumption: regulation of gene expression by gas-sensitive transcription factors,” Philosophical Transactions of the Royal Society B, vol. 367, no. 1593, pp. 1213–1225, 2012.
- V. Garrocho-Villegas, S. K. Gopalasubramaniam, and R. Arredondo-Peter, “Plant hemoglobins: what we know six decades after their discovery,” Gene, vol. 398, no. 1-2, pp. 78–85, 2007.
- R. D. Hill, “Non-symbiotic haemoglobins—what's happening beyond nitric oxide scavenging?” AoB Plants, vol. 2012, Article ID pls004, 13 pages, 2012.
- P. Ascenzi and P. Visca, “Scavenging of reactive nitrogen species by mycobacterial truncated hemoglobins,” Methods in Enzymology, vol. 436, pp. 317–337, 2008.
- F. Spyrakis, F. J. Luque, and C. Viappiani, “Structural analysis in nonsymbiotic hemoglobins: what can we learn from inner cavities?” Plant Science, vol. 181, no. 1, pp. 8–13, 2011.
- U. Oleksiewicz, T. Liloglou, J. K. Field, and G. Xinarianos, “Cytoglobin: biochemical, functional and clinical perspective of the newest member of the globin family,” Cellular and Molecular Life Sciences, vol. 68, no. 23, pp. 3869–3883, 2011.
- M. A. Marti, L. Capece, A. Bidon-Chanal et al., “Nitric oxide reactivity with globins as investigated through computer simulation,” Methods in Enzymology, vol. 437, pp. 477–498, 2008.
- C. Sánchez, J. J. Cabrera, A. J. Gates, E. J. Bedmar, D. J. Richardson, and M. J. Delgado, “Nitric oxide detoxification in the rhizobia-legume symbiosis,” Biochemical Society Transactions, vol. 39, no. 1, pp. 184–188, 2011.
- M. Blank, J. Wollberg, F. Gerlach et al., “A membrane-bound vertebrate globin,” PLoS ONE, vol. 6, no. 9, Article ID e25292, 2011.
- S. N. Vinogradov, D. Hoogewijs, X. Bailly et al., “A phylogenomic profile of globins,” BMC Evolutionary Biology, vol. 6, article 31, 2006.
- D. Hoogewijs, S. Dewilde, A. Vierstraete, L. Moens, and S. N. Vinogradov, “A phylogenetic analysis of the globins in fungi,” PLoS ONE, vol. 7, no. 2, Article ID e31856, 2012.
- S. N. Vinogradov, “Tracing globin phylogeny using PSIBLAST searches based on groups of sequences,” Methods in Enzymology, vol. 436, pp. 571–583, 2008.
- S. N. Vinogradov, D. Hoogewijs, X. Bailly et al., “A model of globin evolution,” Gene, vol. 398, no. 1-2, pp. 132–142, 2007.
- S. N. Vinogradov, D. Hoogewijis, and R. Arredondo-Peter, “What are the origins and phylogeny of plant hemoglobins,” Communicative and Integrative Biology, vol. 4, no. 4, pp. 443–445, 2011.
- D. A. Vuletich and J. T. Lecomte, “A phylogenetic and structural analysis of truncated hemoglobins,” Journal of Molecular Evolution, vol. 62, no. 2, pp. 196–210, 2006.
- B. D. Ullmann, H. Myers, W. Chiranand et al., “Inducible defense mechanism against nitric oxide in Candida albicans,” Eukaryotic Cell, vol. 3, no. 3, pp. 715–723, 2004.
- T. Burmester, M. Haberkamp, S. Mitz et al., “Neuroglobin and cytoglobin: genes, proteins and evolution,” IUBMB Life, vol. 56, no. 11-12, pp. 703–707, 2004.
- D. Hoogewijs, B. Ebner, F. Germani et al., “Androglobin: a chimeric globin in metazoans that is preferentially expressed in Mammalian testes,” Molecular Biology and Evolution, vol. 29, no. 4, pp. 1105–1114, 2012.
- K. Kirschner and H. Bisswanger, “Multifunctional proteins,” Annual Review of Biochemistry, vol. 45, pp. 143–166, 1976.
- T. Ramasarma, “One protein-many functions,” Current Science, vol. 67, pp. 24–29, 1994.
- C. J. Jeffery, “Moonlighting proteins,” Trends in Biochemical Sciences, vol. 24, no. 1, pp. 8–11, 1999.
- P. J. O'Brien and D. Herschlag, “Catalytic promiscuity and the evolution of new enzymatic activities,” Chemistry and Biology, vol. 6, no. 4, pp. R91–R105, 1999.
- K. Shikama and A. Matsuoka, “Structure-function relationships in unusual nonvertebrate globins,” Critical Reviews in Biochemistry and Molecular Biology, vol. 39, no. 4, pp. 217–259, 2004.
- L. W. Chung, X. Li, H. Hirao, and K. Morokuma, “Comparative reactivity of ferric-superoxo and ferryl-oxo species in heme and non-heme complexes,” Journal of the American Chemical Society, vol. 133, no. 50, pp. 20076–120079, 2011.
- J. T. J. Lecomte, D. A. Vuletich, and A. M. Lesk, “Structural divergence and distant relationships in proteins: evolution of the globins,” Current Opinion in Structural Biology, vol. 15, no. 3, pp. 290–301, 2005.
- J. B. Wittenberg, M. Bolognesi, B. A. Wittenberg, and M. Guertin, “Truncated hemoglobins: a new family of hemoglobins widely distributed in bacteria, unicellular eukaryotes, and plants,” The Journal of Biological Chemistry, vol. 277, no. 2, pp. 871–874, 2002.
- M. F. Perutz, “Mechanisms regulating the reactions of human hemoglobin with oxygen and carbon monoxide,” Annual Review of Physiology, vol. 52, pp. 1–25, 1990.
- S. O. Kim, Y. Orii, D. Lloyd, M. N. Hughes, and R. K. Poole, “Anoxic function for the Escherichia coli flavohaemoglobin (Hmp): reversible binding of nitric oxide and reduction to nitrous oxide,” FEBS Letters, vol. 445, no. 2-3, pp. 389–394, 1999.
- A. Fago, A. J. Mathews, L. Moens, S. Dewilde, and T. Brittain, “The reaction of neuroglobin with potential redox protein partners cytochrome b5 and cytochrome c,” FEBS Letters, vol. 580, no. 20, pp. 4884–4888, 2006.
- T. A. K. Freitas, S. Hou, E. M. Dioum et al., “Ancestral hemoglobins in Archaea,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 17, pp. 6675–6680, 2004.
- S. Abbruzzetti, L. Tillman, S. Bruno et al., “Ligation tunes protein reactivity in an ancient haemoglobin: kinetic evidence for an allosteric mechanism in Metanosarcina acetivorans protoglobin,” PLoS ONE, vol. 7, Article ID e33614, 2012.
- J. J. L. Miranda, D. H. Maillett, J. Soman, and J. S. Olson, “Thermoglobin, oxygen-avid hemoglobin in a bacterial hyperthermophile,” The Journal of Biological Chemistry, vol. 280, no. 44, pp. 36754–36761, 2005.
- S. Zhou, S. Fushinobu, Y. Nakanishi, S. W. Kim, T. Wakagi, and H. Shoun, “Cloning and characterization of two flavohemoglobins from Aspergillus oryzae,” Biochemical and Biophysical Research Communications, vol. 381, no. 1, pp. 7–11, 2009.
- S. Zhou, T. Narukami, M. Nameki et al., “Heme-biosynthetic porphobilinogen deaminase protects Aspergillus nidulans from nitrosative stress,” Applied and Environmental Microbiology, vol. 78, no. 1, pp. 103–109, 2012.
- A. N. Hvitved, NO dioxygenation in mammalian myoglobins and microbial flavohemoglobins [Ph.D. thesis], Rice University, Houston, Tex, USA, 2008.
- M. Boccara, C. E. Mills, J. Zeier et al., “Flavohaemoglobin HmpX from Erwinia chrysanthemi confers nitrosative stress tolerance and affects the plant hypersensitive reaction by intercepting nitric oxide produced by the host,” Plant Journal, vol. 43, no. 2, pp. 226–237, 2005.
- D. Mastronicola, F. Testa, E. Forte et al., “Flavohemoglobin and nitric oxide detoxification in the human protozoan parasite Giardia intestinalis,” Biochemical and Biophysical Research Communications, vol. 399, no. 4, pp. 654–658, 2010.
- S. Rafferty, B. Luu, R. E. March, and J. Yee, “Giardia lamblia encodes a functional flavohemoglobin,” Biochemical and Biophysical Research Communications, vol. 399, no. 3, pp. 347–351, 2010.
- S. Gupta, S. Pawaria, C. Lu et al., “An unconventional hexacoordinated flavohemoglobin from Mycobacterium tuberculosis,” The Journal of Biological Chemistry, vol. 287, no. 20, pp. 16435–16446, 2012.
- S. Gupta, S. Pawaria, C. Lu, S. R. Yeh, and K. L. Dikshit, “Novel flavohemoglobins of mycobacteria,” IUBMB Life, vol. 63, no. 5, pp. 337–345, 2011.
- J. Igarashi, K. Kobayashi, and A. Matsuoka, “A hydrogen-bonding network formed by the B10-E7-E11 residues of a truncated hemoglobin from Tetrahymena pyriformis is critical for stability of bound oxygen and nitric oxide detoxification,” Journal of Biological Inorganic Chemistry, vol. 16, no. 4, pp. 599–609, 2011.
- S. Mishra and M. Meuwly, “Atomistic simulation of NO dioxygenation in group I truncated hemoglobin,” Journal of the American Chemical Society, vol. 132, no. 9, pp. 2968–2982, 2010.
- P. Ascenzi, A. Bocedi, M. Bolognesi, G. Fabozzi, M. Milani, and P. Visca, “Nitric oxide scavenging by Mycobacterium leprae GlbO involves the formation of the ferric heme-bound peroxynitrite intermediate,” Biochemical and Biophysical Research Communications, vol. 339, no. 1, pp. 450–456, 2006.
- M. Brunori, A. Giuffrè, K. Nienhaus, G. U. Nienhaus, F. M. Scandurra, and B. Vallone, “Neuroglobin, nitric oxide, and oxygen: functional pathways and conformational changes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 24, pp. 8483–8488, 2005.
- H. Ouellet, L. Juszczak, D. Dantsker et al., “Reactions of Mycobacterium tuberculosis truncated hemoglobin O with ligands reveal a novel ligand-inclusive hydrogen bond network,” Biochemistry, vol. 42, no. 19, pp. 5764–5774, 2003.
- S. Herold and A. Puppo, “Oxyleghemoglobin scavenges nitrogen monoxide and peroxynitrite: a possible role in functioning nodules?” Journal of Biological Inorganic Chemistry, vol. 10, no. 8, pp. 935–945, 2005.
- K. H. Hebelstrup, M. van Zanten, J. Mandon et al., “Haemoglobin modulates NO emission and hyponasty under hypoxia-related stress in Arabidopsis thaliana,” Journal of Experimental Botany, vol. 63, no. 15, pp. 5581–5591, 2012.
- M. Perazzolli, P. Dominici, M. C. Romero-Puertas et al., “Arabidopsis nonsymbiotic hemoglobin AHb1 modulates nitric oxide bioactivity,” Plant Cell, vol. 16, no. 10, pp. 2785–2794, 2004.
- H. Ouellet, Y. Ouellet, C. Richard et al., “Truncated hemoglobin HbN protects Mycobacterium bovis from nitric oxide,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 9, pp. 5902–5907, 2002.
- R. Pathania, N. K. Navani, A. M. Gardner, P. R. Gardner, and K. L. Dikshit, “Nitric oxide scavenging and detoxification by the Mycobacterium tuberculosis haemoglobin, HbN in Escherichia coli,” Molecular Microbiology, vol. 45, no. 5, pp. 1303–1314, 2002.
- A. Lama, S. Pawaria, and K. L. Dikshit, “Oxygen binding and NO scavenging properties of truncated hemoglobin, HbN, of Mycobacterium smegmatis,” FEBS Letters, vol. 580, no. 17, pp. 4031–4041, 2006.
- A. U. Igamberdiev, C. Seregélyes, N. Manac'h, and R. D. Hill, “NADH-dependent metabolism of nitric oxide in alfalfa root cultures expressing barley hemoglobin,” Planta, vol. 219, no. 1, pp. 95–102, 2004.
- A. U. Igamberdiev, N. V. Bykova, and R. D. Hill, “Nitric oxide scavenging by barley hemoglobin is facilitated by a monodehydroascorbate reductase-mediated ascorbate reduction of methemoglobin,” Planta, vol. 223, no. 5, pp. 1033–1040, 2006.
- B. J. Smagghe, J. T. Trent III, and M. S. Hargrove, “NO dioxygenase activity in hemoglobins is ubiquitous in vitro, but limited by reduction in vivo,” PLoS ONE, vol. 3, no. 4, Article ID e2039, 2008.
- K. E. Halligan, F. L. Jourd'heuil, and D. Jourd'heuil, “Cytoglobin is expressed in the vasculature and regulates cell respiration and proliferation nitric oxide dioxygenation,” The Journal of Biological Chemistry, vol. 284, no. 13, pp. 8539–8547, 2009.
- A. M. Gardner, M. R. Cook, and P. R. Gardner, “Nitric-oxide dioxygenase function of human cytoglobin with cellular reductants and in rat hepatocytes,” The Journal of Biological Chemistry, vol. 285, no. 31, pp. 23850–23857, 2010.
- X. Liu, D. Follmer, J. R. Zweier et al., “Characterization of the function of cytoglobin as an oxygen-dependent regulator of nitric-oxide concentration,” Biochemistry, vol. 51, no. 25, pp. 5072–5082, 2012.
- U. Flögel, M. W. Merx, A. Gödecke, U. K. M. Decking, and J. Schrader, “Myoglobin: a scavenger of bioactive NO,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 2, pp. 735–740, 2001.
- N. L. Scott, Y. Xu, G. Shen et al., “Functional and structural characterization of the 2/2 hemoglobin from Synechococcus sp. PCC 7002,” Biochemistry, vol. 49, no. 33, pp. 7000–7011, 2010.
- J. J. Stewart and K. J. Coyne, “Analysis of raphidophyte assimilatory nitrate reductase reveals unique domain architecture incorporating a 2/2 hemoglobin,” Plant Molecular Biology, vol. 77, no. 6, pp. 565–575, 2011.
- P. K. Witting, D. J. Douglas, and A. G. Mauk, “Reaction of human myoglobin and nitric oxide. Heme iron or protein sulfhydryl (s) nitrosation dependence on the absence or presence of oxygen,” The Journal of Biological Chemistry, vol. 276, no. 6, pp. 3991–3998, 2001.
- K. J. Gupta, J. K. Shah, Y. Brotman et al., “Inhibition of aconitase by nitric oxide leads to induction of the alternative oxidase and to a shift of metabolism towards biosynthesis of amino acids,” Journal of Experimental Botany, vol. 63, no. 4, pp. 1773–1784, 2012.
- P. R. Gardner, L. A. Martin, D. Hall, and A. M. Gardner, “Dioxygen-dependent metabolism of nitric oxide in mammalian cells,” Free Radical Biology and Medicine, vol. 31, no. 2, pp. 191–204, 2001.
- M. C. Kennedy, W. E. Antholine, and H. Beinert, “An EPR investigation of the products of the reaction of cytosolic and mitochondrial aconitases with nitric oxide,” The Journal of Biological Chemistry, vol. 272, no. 33, pp. 20340–30347, 1997.
- P. R. Gardner, G. Costantino, C. Szabó, and A. L. Salzman, “Nitric oxide sensitivity of the aconitases,” The Journal of Biological Chemistry, vol. 272, no. 40, pp. 25071–25076, 1997.
- J. C. Drapier and J. B. Hibbs Jr., “Aconitases: a class of metalloproteins highly sensitive to nitric oxide synthesis,” Methods in Enzymology, vol. 269, pp. 26–36, 1996.
- G. M. Pieper, N. L. N. Halligan, G. Hilton et al., “Non-heme iron protein: a potential target of nitric oxide in acute cardiac allograft rejection,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 6, pp. 3125–3130, 2003.
- D. A. Navarre, D. Wendehenne, J. Durner, R. Noad, and D. F. Klessig, “Nitric oxide modulates the activity of tobacco aconitase,” Plant Physiology, vol. 122, no. 2, pp. 573–582, 2000.
- C. Bouton, M. Raveau, and J. C. Drapier, “Modulation of iron regulatory protein functions: further insights into the role of nitrogen- and oxygen-derived reactive species,” The Journal of Biological Chemistry, vol. 271, no. 4, pp. 2300–2306, 1996.
- G. Weiss, B. Goossen, W. Doppler et al., “Translational regulation via iron-responsive elements by the nitric oxide/NO-synthase pathway,” EMBO Journal, vol. 12, no. 9, pp. 3651–3657, 1993.
- J. C. Drapier, H. Hirling, J. Wietzerbin, P. Kaldy, and L. C. Kuhn, “Biosynthesis of nitric oxide activates iron regulatory factor in macrophages,” EMBO Journal, vol. 12, no. 9, pp. 3643–3649, 1993.
- A. M. Gardner, R. A. Helmick, and P. R. Gardner, “Flavorubredoxin, an inducible catalyst for nitric oxide reduction and detoxification in Escherichia coli,” The Journal of Biological Chemistry, vol. 277, no. 10, pp. 8172–8177, 2002.
- D. R. Hyduke, L. R. Jarboe, L. M. Tran, K. J. Y. Chou, and J. C. Liao, “Integrated network analysis identifies nitric oxide response networks and dihydroxyacid dehydratase as a crucial target in Escherichia coli,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 20, pp. 8484–8489, 2007.
- B. Ren, N. Zhang, J. Yang, and H. Ding, “Nitric oxide-induced bacteriostasis and modification of iron-sulphur proteins in Escherichia coli,” Molecular Microbiology, vol. 70, no. 4, pp. 953–964, 2008.
- X. Duan, J. Yang, B. Ren, G. Tan, and H. Ding, “Reactivity of nitric oxide with the [4Fe-4S] cluster of dihydroxyacid dehydratase from Escherichia coli,” Biochemical Journal, vol. 417, no. 3, pp. 783–789, 2009.
- A. F. Vanin and Y. V. Varich, “Formation of nitrozyl complexes of non haem iron (2.03 complexes) in animal tissues in vivo,” Biofizika, vol. 24, no. 4, pp. 666–670, 1979.
- J. R. Lancaster Jr. and J. B. Hibbs Jr., “EPR demonstration of iron-nitrosyl complex formation by cytotoxic activated macrophages,” Proceedings of the National Academy of Sciences of the United States of America, vol. 87, no. 3, pp. 1223–1227, 1990.
- Y. M. Kim, H. T. Chung, R. L. Simmons, and T. R. Billiar, “Cellular non-heme iron content is a determinant of nitric oxide-mediated apoptosis, necrosis, and caspase inhibition,” The Journal of Biological Chemistry, vol. 275, no. 15, pp. 10954–10961, 2000.
- A. P. Landry, X. Duan, H. Huang, and H. Ding, “Iron-sulfur proteins are the major source of protein-bound dinitrosyl iron complexes formed in Escherichia coli cells under nitric oxide stress,” Free Radical Biology and Medicine, vol. 50, no. 11, pp. 1582–1590, 2011.
- A. Giuffre, V. B. Borisov, D. Mastronicola, P. Sarti, and E. Forte, “Cytochrome bd oxidase and nitric oxide: from reaction mechanisms to bacterial physiology,” FEBS Letters, vol. 586, no. 5, pp. 622–629, 2012.
- V. B. Borisov, E. Forte, A. Giuffrè, A. Konstantinov, and P. Sarti, “Reaction of nitric oxide with the oxidized di-heme and heme-copper oxygen-reducing centers of terminal oxidases: different reaction pathways and end-products,” Journal of Inorganic Biochemistry, vol. 103, no. 8, pp. 1185–1187, 2009.
- M. G. Mason, M. Shepherd, P. Nicholls et al., “Cytochrome bd confers nitric oxide resistance to Escherichia coli,” Nature Chemical Biology, vol. 5, no. 2, pp. 94–96, 2009.
- A. K. Dunn, E. A. Karr, Y. Wang, A. R. Batton, E. G. Ruby, and E. V. Stabb, “The alternative oxidase (AOX) gene in Vibrio fischeri is controlled by NsrR and upregulated in response to nitric oxide,” Molecular Microbiology, vol. 77, no. 1, pp. 44–55, 2010.
- T. M. Stevanin, N. Ioannidis, C. E. Mills, S. O. Kim, M. N. Hughes, and R. K. Poole, “Flavohemoglobin Hmp affords inducible protection for Escherichia coli respiration, catalyzed by cytochromes bo' or bd, from nitric oxide,” The Journal of Biological Chemistry, vol. 275, no. 46, pp. 35868–35875, 2000.
- M. G. Mason, P. Nicholls, M. T. Wilson, and C. E. Cooper, “Nitric oxide inhibition of respiration involves both competitive (heme) and noncompetitive (copper) binding to cytochrome c oxidase,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 3, pp. 708–713, 2006.
- G. C. Brown, “Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidase,” FEBS Letters, vol. 356, no. 2-3, pp. 295–298, 1994.
- P. Sarti, A. Giuffrè, M. C. Barone, E. Forte, D. Mastronicola, and M. Brunori, “Nitric oxide and cytochrome oxidase: reaction mechanisms from the enzyme to the cell,” Free Radical Biology and Medicine, vol. 34, no. 5, pp. 509–520, 2003.
- G. C. Brown, “Reversible binding and inhibition of catalase by nitric oxide,” European Journal of Biochemistry, vol. 232, no. 1, pp. 188–191, 1995.
- N. Purwar, J. M. McGarry, J. Kostera, A. A. Pacheco, and M. Schmidt, “Interaction of nitric oxide with catalase: structural and kinetic analysis,” Biochemistry, vol. 50, no. 21, pp. 4491–4503, 2011.
- D. Clark, J. Durner, D. A. Navarre, and D. F. Klessig, “Nitric oxide inhibition of tobacco catalase and ascorbate peroxidase,” Molecular Plant-Microbe Interactions, vol. 13, no. 12, pp. 1380–1384, 2000.
- E. Metzen, J. Zhou, W. Jelkmann, J. Fandrey, and B. Brüne, “Nitric oxide impairs normoxic degradation of HIF-1α by inhibition of prolyl hydroxylases,” Molecular Biology of the Cell, vol. 14, no. 8, pp. 3470–3481, 2003.
- M. Cao, A. Westerhausen-Larson, C. Niyibizi et al., “Nitric oxide inhibits the synthesis of type-II collagen without altering Col2A1 mRNA abundance: prolyl hydroxylase as a possible target,” Biochemical Journal, vol. 324, no. 1, pp. 305–310, 1997.
- Y. M. Kim, H. A. Bergonia, C. Müller, B. R. Pitt, W. D. Watkins, and J. R. Lancaster Jr., “Loss and degradation of enzyme-bound heme induced by cellular nitric oxide synthesis,” The Journal of Biological Chemistry, vol. 270, no. 11, pp. 5710–5713, 1995.
- M. P. López-García, “Endogenous nitric oxide is responsible for the early loss of P450 in cultured rat hepatocytes,” FEBS Letters, vol. 438, no. 3, pp. 145–149, 1998.
- Y. Minamiyama, S. Takemura, S. Imaoka, Y. Funae, Y. Tanimoto, and M. Inoue, “Irreversible inhibition of cytochrome P450 by nitric oxide,” Journal of Pharmacology and Experimental Therapeutics, vol. 283, no. 3, pp. 1479–1485, 1997.
- M. Lepoivre, F. Fieschi, J. Coves, L. Thelander, and M. Fontecave, “Inactivation of ribonucleotide reductase by nitric oxide,” Biochemical and Biophysical Research Communications, vol. 179, no. 1, pp. 442–448, 1991.
- O. Guittet, B. Ducastel, J. S. Salem et al., “Differential sensitivity of the tyrosyl radical of mouse ribonucleotide reductase to nitric oxide and peroxynitrite,” The Journal of Biological Chemistry, vol. 273, no. 34, pp. 22136–22144, 1998.
- C. J. Haskin, N. Ravi, J. B. Lynch, E. Münck, and L. Que Jr., “Reaction of NO with the reduced R2 protein of ribonucleotide reductase from Escherichia coli,” Biochemistry, vol. 34, no. 35, pp. 11090–11098, 1995.
- B. Roy, O. Guittet, C. Beuneu, G. Lemaire, and M. Lepoivre, “Depletion of deoxyribonucleoside triphosphate pools in tumor cells by nitric oxide,” Free Radical Biology and Medicine, vol. 36, no. 4, pp. 507–516, 2004.
- M. Juckett, Y. Zheng, H. Yuan et al., “Heme and the endothelium. Effects of nitric oxide on catalytic iron and heme degradation by heme oxygenase,” The Journal of Biological Chemistry, vol. 273, no. 36, pp. 23388–23397, 1998.
- J. Wang, S. Lu, P. Moënne-Loccoz, and P. R. Ortiz de Montellano, “Interaction of nitric oxide with human heme oxygenase-1,” The Journal of Biological Chemistry, vol. 278, pp. 2341–2347, 2003.
- V. A. Szalai and G. W. Brudvig, “Reversible binding of nitric oxide to tyrosyl radicals in photosystem II. Nitric oxide quenches formation of the S3 EPR signal species in acetate-inhibited photosystem II,” Biochemistry, vol. 35, no. 47, pp. 15080–15087, 1996.
- F. Sasakura, T. Uchiumi, Y. Shimoda et al., “A class 1 hemoglobin gene from Alnus firma functions in symbiotic and nonsymbiotic tissues to detoxify nitric oxide,” Molecular Plant-Microbe Interactions, vol. 19, no. 4, pp. 441–450, 2006.
- E. Meilhoc, Y. Cam, A. Skapski, and C. Bruand, “The response to nitric oxide of the nitrogen-fixing symbiont Sinorhizobium meliloti,” Molecular Plant-Microbe Interactions, vol. 23, no. 6, pp. 748–759, 2010.
- Y. Shimoda, F. Shimoda-Sasakura, K. I. Kucho et al., “Overexpression of class 1 plant hemoglobin genes enhances symbiotic nitrogen fixation activity between Mesorhizobium loti and Lotus japonicus,” Plant Journal, vol. 57, no. 2, pp. 254–263, 2009.
- J. C. Trinchant and J. Rigaud, “Nitrite and nitric oxide as inhibitors of nitrogenase from soybean bacteroids,” Applied and Environmental Microbiology, vol. 44, no. 6, pp. 1385–1388, 1982.
- K. Kato, K. Kanahama, and Y. Kanayama, “Involvement of nitric oxide in the inhibition of nitrogenase activity by nitrate in Lotus root nodules,” Journal of Plant Physiology, vol. 167, no. 3, pp. 238–241, 2010.
- M. R. Hyman, L. C. Seefeldt, T. V. Morgan, D. J. Arp, and L. E. Mortenson, “Kinetic and spectroscopic analysis of the inactivating effects of nitric oxide on the individual components of Azotobacter vinelandii nitrogenase,” Biochemistry, vol. 31, no. 11, pp. 2947–2955, 1992.
- K. H. Tibelius and R. Knowles, “Hydrogenase activity in Azospirillum brasilense is inhibited by nitrite, nitric oxide, carbon monoxide, and acetylene,” Journal of Bacteriology, vol. 160, no. 1, pp. 103–106, 1984.
- J. C. Toledo Jr. and O. Augusto, “Connecting the chemical and biological properties of nitric oxide,” Chemical Research in Toxicology, vol. 25, no. 5, pp. 975–989, 2012.
- J. S. Beckman and W. H. Koppenol, “Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly,” American Journal of Physiology, vol. 271, no. 5, pp. C1424–C1437, 1996.
- B. Roy and J. Garthwaite, “Nitric oxide activation of guanylyl cyclase in cells revisited,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 32, pp. 12185–12190, 2006.
- E. Mo, H. Amin, I. H. Bianco, and J. Garthwaite, “Kinetics of a cellular nitric oxide/cGMP/phosphodiesterase-5 pathway,” The Journal of Biological Chemistry, vol. 279, no. 25, pp. 26149–26158, 2004.
- J. C. Crack, J. Green, M. I. Hutchings, A. J. Thomas, and N. E. Le Brun, “Bacterial iron-sulfur regulatory proteins as biological sensor-switches,” Antioxidants and Redox Signaling, vol. 17, no. 9, pp. 1215–1231, 2012.
- A. M. Gardner, C. R. Gessner, and P. R. Gardner, “Regulation of the nitric oxide reduction operon (norRVW) in Escherichia coli. Role of NorR and σ54 in the nitric oxide stress response,” The Journal of Biological Chemistry, vol. 278, no. 12, pp. 10081–10086, 2003.
- E. T. Yukl, M. A. Elbaz, M. M. Nakano, and P. Moènne-Loccoz, “Transcription factor NsrR from Bacillus subtilis senses nitric oxide with a 4Fe-4S cluster,” Biochemistry, vol. 47, no. 49, pp. 13084–13092, 2008.
- E. T. Yukl, A. Ioanoviciu, S. Sivaramakrishnan, M. M. Nakano, P. R. Ortiz de Montellano, and P. Moënne-Loccoz, “Nitric oxide dioxygenation reaction in DevS and the initial response to nitric oxide in Mycobacterium tuberculosis,” Biochemistry, vol. 50, no. 6, pp. 1023–1028, 2011.
- N. Manac'h-Little, A. U. Igamberdiev, and R. D. Hill, “Hemoglobin expression affects ethylene production in maize cell cultures,” Plant Physiology and Biochemistry, vol. 43, no. 5, pp. 485–489, 2005.
- A. Ledo, J. Frade, R. M. Barbosa, and J. Laranjinha, “Nitric oxide in brain: diffusion, targets and concentration dynamics in hippocampal subregions,” Molecular Aspects of Medicine, vol. 25, no. 1-2, pp. 75–89, 2004.
- R. M. Santos, C. F. Lourenço, A. Ledo, R. M. Barbosa, and J. Laranjinha, “Nitric oxide inactivation mechanisms in the brain: role in bioenergetics and neurodegeneration,” International Journal of Cell Biology, vol. 2012, Article ID 391914, 13 pages, 2012.
- S. W. Kim, S. Fushinobu, S. Zhou, T. Wakagi, and H. Shoun, “The possible involvement of copper-containing nitrite reductase (NirK) and flavohemoglobin in denitrification by the fungus Cylindrocarpon tonkinense,” Bioscience, Biotechnology and Biochemistry, vol. 74, no. 7, pp. 1403–1407, 2010.
- I. C. Anderson, M. Poth, J. Homstead, and D. Burdige, “A comparison of NO and N2O production by the autotrophic nitrifier Nitrosomonas europaea and the heterotrophic nitrifier Alcaligenes faecalis,” Applied and Environmental Microbiology, vol. 59, no. 11, pp. 3525–3533, 1993.
- H. J. E. Beaumont, B. van Schooten, S. I. Lens, H. V. Westerhoff, and R. J. M. van Spanning, “Nitrosomonas europaea expresses a nitric oxide reductase during nitrification,” Journal of Bacteriology, vol. 186, no. 13, pp. 4417–4421, 2004.
- H. Yamasaki and Y. Sakihama, “Simultaneous production of nitric oxide and peroxynitrite by plant nitrate reductase: in vitro evidence for the NR-dependent formation of active nitrogen species,” FEBS Letters, vol. 468, no. 1, pp. 89–92, 2000.
- Y. Sakihama, S. Nakamura, and H. Yamasaki, “Nitric oxide production mediated by nitrate reductase in the green alga Chlamydomonas reinhardtii: an alternative NO production pathway in photosynthetic organisms,” Plant and Cell Physiology, vol. 43, no. 3, pp. 290–297, 2002.
- N. J. Gilberthorpe and R. K. Poole, “Nitric oxide homeostasis in Salmonella typhimurium: roles of respiratory nitrate reductase and flavohemoglobin,” The Journal of Biological Chemistry, vol. 283, no. 17, pp. 11146–11154, 2008.
- A. U. Igamberdiev and R. D. Hill, “Nitrate, NO and haemoglobin in plant adaptation to hypoxia: an alternative to classic fermentation pathways,” Journal of Experimental Botany, vol. 55, no. 408, pp. 2473–2482, 2004.
- N. Gruber and J. N. Galloway, “An Earth-system perspective of the global nitrogen cycle,” Nature, vol. 451, no. 7176, pp. 293–296, 2008.
- V. Smil, “Global population and the nitrogen cycle,” Scientific American, pp. 76–81, 1997.
- N. Takaya and H. Shoun, “Genetic engineering using fungal flavohemoglobin for constructing Pseudomonas stutzeri strain emitting less nitrous oxide,” Journal of Bioscience and Bioengineering, vol. 94, no. 3, pp. 282–284, 2002.
- D. R. Smart and A. J. Bloom, “Wheat leaves emit nitrous oxide during nitrate assimilation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 14, pp. 7875–7878, 2001.
- J. L. Zweier, H. Li, A. Samouilov, and X. Liu, “Mechanisms of nitrite reduction to nitric oxide in the heart and vessel wall,” Nitric Oxide, vol. 22, no. 2, pp. 83–90, 2010.
- M. M. Nakano, “Essential role of flavohemoglobin in long-term anaerobic survival of Bacillus subtilis,” Journal of Bacteriology, vol. 188, no. 17, pp. 6415–6418, 2006.
- A. Rogstam, J. T. Larsson, P. Kjelgaard, and C. von Wachenfeldt, “Mechanisms of adaptation to nitrosative stress in Bacillus subtilis,” Journal of Bacteriology, vol. 189, no. 8, pp. 3063–3071, 2007.
- A. R. Richardson, P. M. Dunman, and F. C. Fang, “The nitrosative stress response of Staphylococcus aureus is required for resistance to innate immunity,” Molecular Microbiology, vol. 61, no. 4, pp. 927–939, 2006.
- V. L. Gonçalves, L. S. Nobre, J. B. Vicente, M. Teixeira, and L. M. Saraiva, “Flavohemoglobin requires microaerophilic conditions for nitrosative protection of Staphylococcus aureus,” FEBS Letters, vol. 580, no. 7, pp. 1817–1821, 2006.
- S. Zhou, S. Fushinobu, S. W. Kim et al., “Functional analysis and subcellular location of two flavohemoglobins from Aspergillus oryzae,” Fungal Genetics and Biology, vol. 48, no. 2, pp. 200–207, 2011.
- F. Sebbane, N. Lemaître, D. E. Sturdevant et al., “Adaptive response of Yersinia pestis to extracellular effectors of innate immunity during bubonic plague,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 31, pp. 11766–11771, 2006.
- Y. Wang, A. K. Dunn, J. Wilneff, M. J. McFall-Ngai, S. Spiro, and E. G. Ruby, “Vibrio fischeri flavohaemoglobin protects against nitric oxide during initiation of the squid-Vibrio symbiosis,” Molecular Microbiology, vol. 78, no. 4, pp. 903–915, 2010.
- E. Parrilli, M. Giuliani, G. Marino, and M. L. Tutino, “Influence of production process design on inclusion bodies protein: the case of an Antarctic flavohemoglobin,” Microbial Cell Factories, vol. 9, article 19, 2010.
- K. T. Elvers, S. M. Turner, L. M. Wainwright et al., “NssR, a member of the Crp-Fnr superfamily from Campylobacter jejuni, regulates a nitrosative stress-responsive regulon that includes both a single-domain and a truncated haemoglobin,” Molecular Microbiology, vol. 57, no. 3, pp. 735–750, 2005.
- M. S. Pittman, K. T. Elvers, L. Lee et al., “Growth of Campylobacter jejuni on nitrate and nitrite: electron transport to NapA and NrfA via NrfH and distinct roles for NrfA and the globin Cgb in protection against nitrosative stress,” Molecular Microbiology, vol. 63, no. 2, pp. 575–590, 2007.
- J. L. Turrion-Gomez, A. P. Eslava, and E. P. Benito, “The flavohemoglobin BCFHG1 is the main NO detoxification system and confers protection against nitrosative conditions but is not a virulence factor in the fungal necrotroph Botrytis cinerea,” Fungal Genetics and Biology, vol. 47, no. 5, pp. 484–496, 2010.
- G. Fabozzi, P. Ascenzi, S. D. Renzi, and P. Visca, “Truncated hemoglobin GlbO from Mycobacterium leprae alleviates nitric oxide toxicity,” Microbial Pathogenesis, vol. 40, no. 5, pp. 211–220, 2006.
- Z. L. Qu, N. Q. Zhong, H. Y. Wang, A. P. Chen, G. L. Jian, and G. X. Xia, “Ectopic expression of the cotton non-symbiotic hemoglobin gene GhHbd1 triggers defense responses and increases disease tolerance in Arabidopsis,” Plant and Cell Physiology, vol. 47, no. 8, pp. 1058–1068, 2006.
- K. T. Elvers, G. Wu, N. J. Gilberthorpe, R. K. Poole, and S. F. Park, “Role of an inducible single-domain hemoglobin in mediating resistance to nitric oxide and nitrosative stress in Campylobacter jejuni and Campylobacter coli,” Journal of Bacteriology, vol. 186, no. 16, pp. 5332–5341, 2004.
- C. Lu, T. Egawa, L. M. Wainwright, R. K. Poole, and S. R. Yeh, “Structural and functional properties of a truncated hemoglobin from a food-borne pathogen Campylobacter jejuni,” The Journal of Biological Chemistry, vol. 282, no. 18, pp. 13627–13636, 2007.
- H. K. Smith, M. Shepherd, C. Monk, J. Green, and R. K. Poole, “The NO-responsive hemoglobins of Campylobacter jejuni: concerted responses of two globins to NO and evidence in vitro for globin regulation by the transcription factor NssR,” Nitric Oxide, vol. 25, no. 2, pp. 234–241, 2011.
- F. C. Fang, “Antimicrobial reactive oxygen and nitrogen species: concepts and controversies,” Nature Reviews Microbiology, vol. 2, no. 10, pp. 820–832, 2004.
- P. Mukhopadhyay, M. Zheng, L. A. Bedzyk, R. A. LaRossa, and G. Storz, “Prominent roles of the NorR and Fur regulators in the Escherichia coli transcriptional response to reactive nitrogen species,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 3, pp. 745–750, 2004.
- D. Schnappinger, S. Ehrt, M. I. Voskuil et al., “Transcriptional adaptation of Mycobacterium tuberculosis within macrophages: insights into the phagosomal environment,” Journal of Experimental Medicine, vol. 198, no. 5, pp. 693–704, 2003.
- M. C. Justino, J. B. Vicente, M. Teixeira, and L. M. Saraiva, “New genes implicated in the protection of anaerobically grown Escherichia coli against nitric oxide,” The Journal of Biological Chemistry, vol. 280, no. 4, pp. 2636–2643, 2005.
- M. P. Nittler, D. Hocking-Murray, C. K. Foo, and A. Sil, “Identification of Histoplasma capsulatum transcripts induced in response to reactive nitrogen species,” Molecular Biology of the Cell, vol. 16, no. 10, pp. 4792–4813, 2005.
- J. E. Karlinsey, I. S. Bang, L. A. Becker et al., “The NsrR regulon in nitrosative stress resistance of Salmonella enterica serovar Typhimurium,” Molecular Microbiology, vol. 85, no. 6, pp. 1179–1193, 2012.
- C. M. Moore, M. M. Nakano, T. Wang, R. W. Ye, and J. D. Helmann, “Response of Bacillus subtilis to nitric oxide and the nitrosating agent sodium nitroprusside,” Journal of Bacteriology, vol. 186, no. 14, pp. 4655–4664, 2004.
- J. Hemish, N. Nakaya, V. Mittal, and G. Enikolopov, “Nitric oxide activates diverse signaling pathways to regulate gene expression,” The Journal of Biological Chemistry, vol. 278, no. 43, pp. 42321–42329, 2003.
- A. Sarver and J. DeRisi, “Fzf1p regulates an inducible response to nitrosative stress in Saccharomyces cerevisiae,” Molecular Biology of the Cell, vol. 16, no. 10, pp. 4781–4791, 2005.
- E. D. Chow, O. W. Liu, S. O'Brien, and H. D. Madhani, “Exploration of whole-genome responses of the human AIDS-associated yeast pathogen Cryptococcus neoformans var grubii: nitric oxide stress and body temperature,” Current Genetics, vol. 52, no. 3-4, pp. 137–148, 2007.
- B. S. Hromatka, S. M. Noble, and A. D. Johnson, “Transcriptional response of Candida albicans to nitric oxide and the role of the YHB1 gene in nitrosative stress and virulence,” Molecular Biology of the Cell, vol. 16, no. 10, pp. 4814–4826, 2005.
- D. A. Rodionov, I. L. Dubchak, A. P. Arkin, E. J. Alm, and M. S. Gelfand, “Dissimilatory metabolism of nitrogen oxides in bacteria: comparative reconstruction of transcriptional networks,” PLoS Computational Biology, vol. 1, no. 5, article e55, 2005.
- J. Zhu, A. Jambhekar, A. Sraver, and J. DeRisi, “A Bayesian network driven approach to model the transcriptional response to nitric oxide in Saccharomyces cerevisiae,” PLoS ONE, vol. 1, no. 1, article e94, 2006.
- A. Sellam, F. Tebbji, M. Whiteway, and A. Nantel, “A novel role for the transcription factor Cwt1p as a negative regulator of nitrosative stress in Candida albicans,” PLoS ONE, vol. 7, no. 8, Article ID e43956, 2012.
- A. Daiber, H. Shoun, and V. Ullrich, “Nitric oxide reductase (P450nor) from Fusarium oxysporum,” Journal of Inorganic Biochemistry, vol. 99, no. 1, pp. 185–193, 2005.
- M. C. Justino, C. C. Almeida, M. Teixeira, and L. M. Saraiva, “Escherichia coli di-iron YtfE protein is necessary for the repair of stress-damaged iron-sulfur clusters,” The Journal of Biological Chemistry, vol. 282, no. 14, pp. 10352–10359, 2007.
- S. V. Joseph, G. K. Madhavilatha, R. A. Kumar, and S. Mundayoor, “Comparative analysis of mycobacterial truncated hemoglobin promoters and the groEL2 promoter in free-living and intracellular Mycobacteria,” Applied and Environmental Microbiology, vol. 78, no. 18, pp. 6499–6506, 2012.
- W. Chiranand, I. McLeod, H. Zhou et al., “CTA4 transcription factor mediates induction of nitrosative stress response in Candida albicans,” Eukaryotic Cell, vol. 7, no. 2, pp. 268–278, 2008.
- M. de Jesús-Berríos, L. Liu, J. C. Nussbaum, G. M. Cox, J. S. Stamler, and J. Heitman, “Enzymes that counteract nitrosative stress promote fungal virulence,” Current Biology, vol. 13, no. 22, pp. 1963–1968, 2003.
- S. Favey, G. Labesse, V. Vouille, and M. Boccara, “Flavohaemoglobin HmpX: a new pathogenicity determinant in Erwinia chrysanthemi strain 3937,” Microbiology, vol. 141, no. 4, pp. 863–871, 1995.
- C. Seregélyes, A. U. Igamberdiev, A. Maassen, J. Hennig, D. Dudits, and R. D. Hill, “NO-degradation by alfalfa class 1 hemoglobin (Mhb1): a possible link to PR-1a gene expression in Mhb1-overproducing tobacco plants,” FEBS Letters, vol. 571, no. 1–3, pp. 61–66, 2004.
- A. Vazquez-Torres, T. Stevanin, J. Jones-Carson, M. Castor, R. C. Read, and F. C. Fang, “Analysis of nitric oxide-dependent antimicrobial actions in macrophages and mice,” Methods in Enzymology, vol. 437, pp. 521–538, 2008.
- I. S. Bang, L. Liu, A. Vazquez-Torres, M. L. Crouch, J. S. Stamler, and F. C. Fang, “Maintenance of nitric oxide and redox homeostasis by the Salmonella flavohemoglobin Hmp,” The Journal of Biological Chemistry, vol. 281, no. 38, pp. 28039–28047, 2006.
- L. Svensson, M. Poljakovic, S. Säve et al., “Role of flavohemoglobin in combating nitrosative stress in uropathogenic Escherichia coli—implications for urinary tract infection,” Microbial Pathogenesis, vol. 49, no. 3, pp. 59–66, 2010.
- A. M. Stern, A. J. Hay, Z. Liu et al., “The NorR regulon is critical for Vibrio cholerae resistance to nitric oxide and sustained colonization of the intestines,” MBio, vol. 3, no. 2, pp. e00013–e00012, 2012.
- D. W. Kraus and J. M. Colacino, “Extended oxygen delivery from the nerve hemoglobin of Tellina alternata (Bivalvia),” Science, vol. 232, no. 4746, pp. 90–92, 1986.
- C. Hundahl, A. Fago, S. Dewilde et al., “Oxygen binding properties of non-mammalian nerve globins,” FEBS Journal, vol. 273, no. 6, pp. 1323–1329, 2006.
- J. B. Wittenberg and B. A. Wittenberg, “Myoglobin function reassessed,” Journal of Experimental Biology, vol. 206, no. 12, pp. 2011–2020, 2003.
- A. D. Frey and P. T. Kallio, “Nitric oxide detoxification—a new era for bacterial globins in biotechnology?” Trends in Biotechnology, vol. 23, no. 2, pp. 69–73, 2005.
- B. Guan, H. Ma, Y. Wang et al., “Vitreoscilla hemoglobin (VHb) overexpression increases hypoxia tolerance in zebrafish (Danio rerio),” Marine Biotechnology, vol. 13, no. 2, pp. 336–344, 2011.
- B. C. Stark, K. L. Dikshit, and K. R. Pagilla, “Recent advances in understanding the structure, function, and biotechnological usefulness of the hemoglobin from the bacterium Vitreoscilla,” Biotechnology Letters, vol. 33, no. 9, pp. 1705–1714, 2011.
- J. Rigaud and A. Puppo, “Effect of nitrite upon leghemoglobin and interaction with nitrogen fixation,” Biochimica et Biophysica Acta, vol. 497, no. 3, pp. 702–706, 1977.
- J. del Giudice, Y. Cam, I. Damiani et al., “Nitric oxide is required for an optimal establishment of the Medicago truncatula-Sinorhizobium meliloti symbiosis,” New Phytologist, vol. 191, no. 2, pp. 405–417, 2011.
- B. D. Sidell and K. M. O'Brien, “When bad things happen to good fish: the loss of hemoglobin and myoglobin expression in Antarctic icefishes,” Journal of Experimental Biology, vol. 209, no. 10, pp. 1791–1802, 2006.
- A. Gödecke, “On the impact of NO-globin interactions in the cardiovascular system,” Cardiovascular Research, vol. 69, no. 2, pp. 309–317, 2006.
- Å. Wennmalm, G. Benthin, and A. S. Peterssen, “Dependence of the metabolism of nitric oxide (NO) in healthy human whole blood on the oxygenation of its red cell haemoglobin,” British Journal of Pharmacology, vol. 106, no. 3, pp. 507–508, 1992.
- M. Brunori, “Nitric oxide moves myoglobin centre stage,” Trends in Biochemical Sciences, vol. 26, no. 4, pp. 209–210, 2001.
- T. Ishibashi, M. Hamaguchi, K. Kato et al., “Relationship between myoglobin contents and increases in cyclic GMP produced by glyceryl trinitrate and nitric oxide in rabbit aorta, right atrium and papillary muscle,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 347, no. 5, pp. 553–561, 1993.
- X. Liu, M. J. S. Miller, M. S. Joshi, H. Sadowska-Krowicka, D. A. Clark, and J. R. Lancaster Jr., “Diffusion-limited reaction of free nitric oxide with erythrocytes,” The Journal of Biological Chemistry, vol. 273, no. 30, pp. 18709–18713, 1998.
- M. S. Joshi, T. B. Ferguson Jr., T. H. Han et al., “Nitric oxide is consumed, rather than conserved, by reaction with oxyhemoglobin under physiological conditions,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 16, pp. 10341–10346, 2002.
- M. W. Vaughn, K. T. Huang, L. Kuo, and J. C. Liao, “Erythrocytes possess an intrinsic barrier to nitric oxide consumption,” The Journal of Biological Chemistry, vol. 275, no. 4, pp. 2342–2348, 2000.
- E. Tiravanti, A. Samouilov, and J. L. Zweier, “Nitrosyl-heme complexes are formed in the ischemic heart: evidence of nitrite-derived nitric oxide formation, storage, and signaling in post-ischemic tissues,” The Journal of Biological Chemistry, vol. 279, no. 12, pp. 11065–11073, 2004.
- H. Chiodi and J. G. Mohler, “Effects of exposure of blood hemoglobin to nitric oxide,” Environmental Research, vol. 37, no. 2, pp. 355–363, 1985.
- C. Griffiths and J. Gartwaite, “The shaping of nitric oxide signals by a cellular sink,” Journal of Physiology, vol. 536, no. 3, pp. 855–862, 2001.
- C. N. Hall and J. Garthwaite, “What is the real physiological NO concentration in vivo?” Nitric Oxide, vol. 21, no. 2, pp. 92–103, 2009.
- G. M. Edelman and J. A. Gally, “Nitric oxide: linking space and time in the brain,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 24, pp. 11651–11652, 1992.
- C. Griffiths, B. Yamini, C. Hall, and J. Garthwaite, “Nitric oxide inactivation in brain by a novel O2-dependent mechanism resulting in the formation of nitrate ions,” Biochemical Journal, vol. 362, no. 2, pp. 459–464, 2002.
- D. D. Thomas, X. Liu, S. P. Kantrow, and J. R. Lancaster Jr., “The biological lifetime of nitric oxide: implications for the perivascular dynamics of NO and O2,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 1, pp. 355–360, 2001.
- K. C. Wood, A. M. Batchelor, K. Bartus et al., “Picomolar nitric oxide signals from central neurons recorded using ultrasensitive detector cells,” The Journal of Biological Chemistry, vol. 286, no. 50, pp. 43172–43181, 2011.
- K. Chen and A. S. Popel, “Theoretical analysis of biochemical pathways of nitric oxide release from vascular endothelial cells,” Free Radical Biology and Medicine, vol. 41, no. 4, pp. 668–680, 2006.
- K. Chen and A. S. Popel, “Vascular and perivascular nitric oxide release and transport: biochemical pathways of neuronal nitric oxide synthase (NOS1) and endothelial nitric oxide synthase (NOS3),” Free Radical Biology and Medicine, vol. 42, no. 6, pp. 811–822, 2007.
- D. D. Tyler, “Polarographic assay and intracellular distribution of superoxide dismutase in rat liver,” Biochemical Journal, vol. 147, no. 3, pp. 493–504, 1975.
- T. Burmester, B. Welch, S. Reinhardt, and T. Hankeln, “A vertebrate globin expressed in the brain,” Nature, vol. 407, no. 6803, pp. 520–523, 2000.
- T. Burmester and T. Hankeln, “Commentary what is the function of neuroglobin?” Journal of Experimental Biology, vol. 212, no. 10, pp. 1423–1428, 2009.
- D. A. Newton, K. M. K. Rao, R. A. Dluhy, and J. E. Baatz, “Hemoglobin is expressed by alveolar epithelial cells,” The Journal of Biological Chemistry, vol. 281, no. 9, pp. 5668–5676, 2006.
- S. M. G. Duff, P. A. Guy, X. Nie, D. C. Durnin, and R. D. Hill, “Haemoglobin expression in germinating barley,” Seed Science Research, vol. 8, no. 4, pp. 431–436, 1998.
- I. T. Demchenko, T. D. Oury, J. D. Crapo, and C. A. Piantadosi, “Regulation of the brain's vascular responses to oxygen,” Circulation Research, vol. 91, no. 11, pp. 1031–1037, 2002.
- L. Liu, M. Zeng, and J. S. Stamler, “Hemoglobin induction in mouse macrophages,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 12, pp. 6643–6647, 1999.
- R. E. Pearce, C. J. McIntyre, A. Madan et al., “Effects of freezing, thawing, and storing human liver microsomes on cytochrome P450 activity,” Archives of Biochemistry and Biophysics, vol. 331, no. 2, pp. 145–169, 1996.
- M. Biagioli, M. Pinto, D. Cesselli et al., “Unexpected expression of α- and β-globin in mesencephalic dopaminergic neurons and glial cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 36, pp. 15454–15459, 2009.
- Y. Ohyagi, T. Yamada, and I. Goto, “Hemoglobin as a novel protein developmentally regulated in neurons,” Brain Research, vol. 635, no. 1-2, pp. 323–327, 1994.
- D. W. Schelshorn, A. Schneider, W. Kuschinsky et al., “Expression of hemoglobin in rodent neurons,” Journal of Cerebral Blood Flow and Metabolism, vol. 29, no. 3, pp. 585–595, 2009.
- M. de Leon, A. A. Welcher, U. Suter, and E. M. Shooter, “Identification of transcriptionally regulated genes after sciatic nerve injury,” Journal of Neuroscience Research, vol. 29, no. 4, pp. 437–448, 1991.
- Y. He, Y. Hua, J. Y. Lee et al., “Brain alpha- and beta-globin expression after intracerebral hemorrhage,” Translational Stroke Research, vol. 1, no. 1, pp. 48–56, 2010.
- M. Bhaskaran, H. Chen, Z. Chen, and L. Liu, “Hemoglobin is expressed in alveolar epithelial type II cells,” Biochemical and Biophysical Research Communications, vol. 333, no. 4, pp. 1348–1352, 2005.
- H. Nishi, R. Inagi, H. Kato et al., “Hemoglobin is expressed by mesangial cells and reduces oxidant stress,” Journal of the American Society of Nephrology, vol. 19, no. 8, pp. 1500–1508, 2008.
- C. W. Wu, P. C. Liao, L. Yu et al., “Hemoglobin promotes Aβ oligomer formation and localizes in neurons and amyloid deposits,” Neurobiology of Disease, vol. 17, no. 3, pp. 367–377, 2004.
- M. Capulli, A. Angelucci, K. Driouch et al., “Increased expression of a set of genes enriched in oxygen binding function discloses a predisposition of breast cancer bone metastases to generate metastasis spread in multiple organs,” Journal of Bone and Mineral Research, vol. 27, no. 11, pp. 2387–2398, 2012.
- T. Hankeln, S. Wystub, T. Laufs et al., “The cellular and subcellular localization of neuroglobin and cytoglobin–a clue to their function?” IUBMB Life, vol. 56, no. 11-12, pp. 671–679, 2004.
- C. E. Eyler, Q. Wu, K. Yan et al., “Glioma stem cell proliferation and tumor growth are promoted by nitric oxide synthase-2,” Cell, vol. 146, no. 1, pp. 53–66, 2011.
- R. J. Shaw, M. M. Omar, S. Rokadiya et al., “Cytoglobin is upregulated by tumour hypoxia and silenced by promoter hypermethylation in head and neck cancer,” British Journal of Cancer, vol. 101, no. 1, pp. 139–144, 2009.
- N. Shivapurkar, V. Stastny, N. Okumura et al., “Cytoglobin, the newest member of the globin family, functions as a tumor suppressor gene,” Cancer Research, vol. 68, no. 18, pp. 7448–7456, 2008.
- I. Momken, D. Fortin, B. Serrurier, X. Bigard, R. Ventura-Clapier, and V. Veksler, “Endothelial nitric oxide synthase (NOS) deficiency affects energy metabolism pattern in murine oxidative skeletal muscle,” Biochemical Journal, vol. 368, no. 1, pp. 341–347, 2002.
- E. Nisoli, S. Falcone, C. Tonello et al., “Mitochondrial biogenesis by NO yields functionally active mitochondria in mammals,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 47, pp. 16507–16512, 2004.
- D. D. Thomas, M. G. Espey, L. A. Ridnour et al., “Hypoxic inducible factor 1α, extracellular signal-regulated kinase, and p53 are regulated by distinct threshold concentrations of nitric oxide,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 24, pp. 8894–8899, 2004.
- C. A. Hundahl, H. Luuk, S. Ilmjärv et al., “Neuroglobin-deficiency exacerbates Hif1A and c-FOS response, but does not affect neuronal survival during severe hypoxia in vivo,” PLoS ONE, vol. 6, no. 12, Article ID e28160, 2011.
- M. Iijima, H. Shimizu, Y. Tanaka, and H. Urushihara, “Identification and characterization of two flavohemoglobin genes in Dictyostelium discoideum,” Cell Structure and Function, vol. 25, no. 1, pp. 47–55, 2000.
- S. Baidya, J. W. Cary, W. S. Grayburn, and A. M. Calvo, “Role of nitric oxide and flavohemoglobin homolog genes in Aspergillus nidulans sexual development and mycotoxin production,” Applied and Environmental Microbiology, vol. 77, no. 15, pp. 5524–5528, 2011.
- T. M. Stevanin, R. C. Read, and R. K. Poole, “The hmp gene encoding the NO-inducible flavohaemoglobin in Escherichia coli confers a protective advantage in resisting killing within macrophages, but not in vitro: Links with swarming motility,” Gene, vol. 398, no. 1-2, pp. 62–68, 2007.
- L. A. Mur, A. Sivakumaran, J. Mandon, S. M. Cristescu, F. J. Harren, and K. H. Hebelstrup, “Haemoglobin modulates salicylate and jasmonate/ethylene-mediated resistance mechanisms against pathogens,” Journal of Experimental Botany, vol. 63, no. 12, pp. 4375–4387, 2012.
- Y. Shimoda, M. Nagata, A. Suzuki et al., “Symbiotic rhizobium and nitric oxide induce gene expression of non-symbiotic hemoglobin in Lotus japonicus,” Plant and Cell Physiology, vol. 46, no. 1, pp. 99–107, 2005.
- A. D. Frey, T. Koskenkorva, and P. T. Kallio, “Vitreoscilla hemoglobin promoter is not responsive to nitrosative and oxidative stress in Escherichia coli,” FEMS Microbiology Letters, vol. 224, no. 1, pp. 127–132, 2003.
- Y. Sasaki, N. Takaya, A. Nakamura, and H. Shoun, “Isolation of flavohemoglobin from the actinomycete Streptomyces antibioticus grown without external nitric oxide stress,” Bioscience, Biotechnology and Biochemistry, vol. 68, no. 5, pp. 1106–1112, 2004.
- M. I. Hutchings, N. Mandhana, and S. Spiro, “The NorR protein of Escherichia coli activates expression of the flavorubredoxin gene NorV in response to reactive nitrogen species,” Journal of Bacteriology, vol. 184, no. 16, pp. 4640–4643, 2002.
- A. Pohlmann, R. Cramm, K. Schmelz, and B. Friedrich, “A novel NO-responding regulator controls the reduction of nitric oxide in Ralstonia eutropha,” Molecular Microbiology, vol. 38, no. 3, pp. 626–638, 2000.
- B. D'Autréaux, N. P. Tucker, R. Dixon, and S. Spiro, “A non-heme iron centre in the transcription factor NorR senses nitric oxide,” Nature, vol. 437, no. 7059, pp. 769–772, 2005.
- H. Cruz-Ramos, J. Crack, G. Wu et al., “NO sensing by FNR: regulation of the Escherichia coli NO-detoxifying flavohaemoglobin, Hmp,” EMBO Journal, vol. 21, no. 13, pp. 3235–3244, 2002.
- B. D'Autréaux, D. Touati, B. Bersch, J. M. Latour, and I. Michaud-Soret, “Direct inhibition by nitric oxide of the transcriptional ferric uptake regulation protein via nitrosylation of the iron,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 26, pp. 16619–16624, 2002.
- M. J. Crawford and D. E. Goldberg, “Regulation of the Salmonella typhimurium flavohemoglobin gene: a new pathway for bacterial gene expression in response to nitric oxide,” The Journal of Biological Chemistry, vol. 273, no. 51, pp. 34028–34032, 1998.
- J. Membrillo-Hernández, S. O. Kim, G. M. Cook, and R. K. Poole, “Paraquat regulation of hmp (flavohemoglobin) gene expression in Escherichia coli K-12 is SoxRS independent but modulated by σ(s),” Journal of Bacteriology, vol. 179, no. 10, pp. 3164–3170, 1997.
- J. Membrillo-Hernández, M. D. Coopamah, A. Channa, M. N. Hughes, and R. K. Poole, “A novel mechanism for upregulation of the Escherichia coli K-12 hmp (flavohaemoglobin) gene by the “NO releaser”, S-nitrosoglutathione: nitrosation of homocysteine and modulation of MetR binding to the glyA-hmp intergenic region,” Molecular Microbiology, vol. 29, no. 4, pp. 1101–1112, 1998.
- S. Spiro, “Regulators of bacterial responses to nitric oxide,” FEMS Microbiology Reviews, vol. 31, no. 2, pp. 193–211, 2007.
- H. Arai, M. Hayashi, A. Kuroi, M. Ishii, and Y. Igarashi, “Transcriptional regulation of the flavohemoglobin gene for aerobic nitric oxide detoxification by the second nitric oxide-responsive regulator of Pseudomonas aeruginosa,” Journal of Bacteriology, vol. 187, no. 12, pp. 3960–3968, 2005.
- J. M. Baptista, M. C. Justino, A. M. P. Melo, M. Teixeira, and L. M. Saraiva, “Oxidative stress modulates the nitric oxide defense promoted by Escherichia coli flavorubredoxin,” Journal of Bacteriology, vol. 194, no. 14, pp. 3611–3617, 2012.
- D. M. Bodenmiller and S. Spiro, “The yjeB (nsrR) gene of Escherichia coli encodes a nitric oxide-sensitive transcriptional regulator,” Journal of Bacteriology, vol. 188, no. 3, pp. 874–881, 2006.
- S. Kommineni, A. Lama, B. Popescu, and M. M. Nakano, “Global transcriptional control by NsrR in Bacillus subtilis,” Journal of Bacteriology, vol. 194, no. 7, pp. 1679–1688, 2012.
- P. R. Gardner, “Aconitase: sensitive target and measure of superoxide,” Methods in Enzymology, vol. 349, pp. 9–23, 2002.
- H. J. E. Beaumont, S. I. Lens, W. N. M. Reijnders, H. V. Westerhoff, and R. J. M. van Spanning, “Expression of nitrite reductase in Nitrosomonas europaea involves NsrR, a novel nitrite-sensitive transcription repressor,” Molecular Microbiology, vol. 54, no. 1, pp. 148–158, 2004.
- K. L. Dikshit, R. P. Dikshit, and D. A. Webster, “Study of Vitreoscilla globin (vgb) gene expression and promoter activity in E. coli through transcriptional fusion,” Nucleic Acids Research, vol. 18, no. 14, pp. 4149–4155, 1990.
- S. J. Kwon, S. Y. Cho, K. M. Lee, J. Yu, M. Son, and K. H. Kim, “Proteomic analysis of fungal host factors differentially expressed by Fusarium graminearum infected with Fusarium graminearum virus-DK21,” Virus Research, vol. 144, no. 1-2, pp. 96–106, 2009.
- A. U. Igamberdiev, K. Baron, N. Manac'h-Little, M. Stoimenova, and R. D. Hill, “The haemoglobin/nitric oxide cycle: involvement in flooding stress and effects on hormone signalling,” Annals of Botany, vol. 96, no. 4, pp. 557–564, 2005.
- R. Wang, K. Guegler, S. T. LaBrie, and N. M. Crawford, “Genomic analysis of a nutrient response in Arabidopsis reveals diverse expression patterns and novel metabolic and potential regulatory genes induced by nitrate,” Plant Cell, vol. 12, no. 8, pp. 1491–1509, 2000.
- Y. Ohwaki, M. Kawagishi-Kobayashi, K. Wakasa, S. Fujihara, and T. Yoneyama, “Induction of class-1 non-symbiotic hemoglobin genes by nitrate, nitrite and nitric oxide in cultured rice cells,” Plant and Cell Physiology, vol. 46, no. 2, pp. 324–331, 2005.
- D. Kim, M. Hong, Y. Lee, M. Lee, and Y. Seo, “Wheat truncated hemoglobin interacts with photosystem I PSK-I subunit and photosystem II subunit PsbS1,” Biologia Plantarum. In press.
- P. Bustos-Sanmamed, A. Tovar-Méndez, M. Crespi, S. Sato, S. Tabata, and M. Becana, “Regulation of nonsymbiotic and truncated hemoglobin genes of Lotus japonicus in plant organs and in response to nitric oxide and hormones,” New Phytologist, vol. 189, no. 3, pp. 765–776, 2011.
- Y. He, Y. Hua, W. Liu, H. Hu, R. F. Keep, and G. Xi, “Effects of cerebral ischemia on neuronal hemoglobin,” Journal of Cerebral Blood Flow and Metabolism, vol. 29, no. 3, pp. 596–605, 2009.
- C. L. Grek, D. A. Newton, D. D. Spyropoulos, and J. E. Baatz, “Hypoxia up-regulates expression of hemoglobin in alveolar epithelial cells,” American Journal of Respiratory Cell and Molecular Biology, vol. 44, no. 4, pp. 439–447, 2011.
- Y. Sun, K. Jin, X. O. Mao, Y. Zhu, and D. A. Greenberg, “Neuroglobin is up-regulated by and protects neurons from hypoxic-ischemic injury,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 26, pp. 15306–15311, 2001.
- N. Hümmler, C. Schneider, A. Giessl et al., “Acute hypoxia modifies regulation of neuroglobin in the neonatal mouse brain,” Experimental Neurology, vol. 236, no. 1, pp. 112–121, 2012.
- N. Liu, Z. Yu, S. Xiang et al., “Transcriptional regulation mechanisms of hypoxia-induced neuroglobin gene expression,” Biochemical Journal, vol. 443, no. 1, pp. 153–164, 2012.
- B. Haines, M. Demaria, X. Mao et al., “Hypoxia-inducible factor-1 and neuroglobin expression,” vol. 514, no. 2, pp. 137–140, 2012.
- A. Ilari, A. Bonamore, A. Farina, K. A. Johnson, and A. Boffi, “The X-ray structure of ferric Escherichia coli flavohemoglobin reveals an unexpected geometry of the distal heme pocket,” The Journal of Biological Chemistry, vol. 277, no. 26, pp. 23725–23732, 2002.
- M. Mukai, C. E. Mills, R. K. Poole, and S. R. Yeh, “Flavohemoglobin, a globin with a peroxidase-like catalytic site,” The Journal of Biological Chemistry, vol. 276, no. 10, pp. 7272–7277, 2001.
- A. M. Gardner, L. A. Martin, P. R. Gardner, Y. Dou, and J. S. Olson, “Steady-state and transient kinetics of Escherichia coli nitric-oxide dioxygenase (flavohemoglobin). The B10 tyrosine hydroxyl is essential for dioxygen binding and catalysis,” The Journal of Biological Chemistry, vol. 275, no. 17, pp. 12581–12589, 2000.
- Y. Dou, D. H. Maillett, R. F. Eich, and J. S. Olson, “Myoglobin as a model system for designing heme protein based blood substitutes,” Biophysical Chemistry, vol. 98, no. 1-2, pp. 127–148, 2002.
- M. A. Martí, A. Crespo, L. Capece et al., “Dioxygen affinity in heme proteins investigated by computer simulation,” Journal of Inorganic Biochemistry, vol. 100, no. 4, pp. 761–770, 2006.
- P. R. Gardner, “Assay and characterization of the NO dioxygenase activity of flavohemoglobins,” Methods in Enzymology, vol. 436, pp. 217–237, 2008.
- R. Daigle, J. A. Rousseau, M. Guertin, and P. Lagüe, “Theoretical investigations of nitric oxide channeling in Mycobacterium tuberculosis truncated hemoglobin N,” Biophysical Journal, vol. 97, no. 11, pp. 2967–2977, 2009.
- A. Bidon-Chanal, M. A. Martí, A. Crespo et al., “Ligand-induced dynamical regulation of NO conversion in Mycobacterium tuberculosis truncated hemoglobin-N,” Proteins, vol. 64, no. 2, pp. 457–464, 2006.
- A. Crespo, M. A. Martí, S. G. Kalko et al., “Theoretical study of the truncated hemoglobin HbN: exploring the molecular basis of the NO detoxification mechanism,” Journal of the American Chemical Society, vol. 127, no. 12, pp. 4433–4444, 2005.
- A. Bidon-Chanal, M. A. Martí, D. A. Estrin, and F. J. Luque, “Dynamical regulation of ligand migration by a gate-opening molecular switch in truncated hemoglobin-N from Mycobacterium tuberculosis,” Journal of the American Chemical Society, vol. 129, no. 21, pp. 6782–6788, 2007.
- P. Y. Savard, R. Daigle, S. Morin et al., “Structure and dynamics of Mycobacterium tuberculosis truncated hemoglobin N: insights from NMR spectroscopy and molecular dynamics simulations,” Biochemistry, vol. 50, no. 51, pp. 11121–11130, 2011.
- Y. Ouellet, M. Milani, M. Couture, M. Bolognesi, and M. Guertin, “Ligand interactions in the distal heme pocket of Mycobacterium tuberculosis truncated hemoglobin N: roles of TyrB10 and GlnE11 residues,” Biochemistry, vol. 45, no. 29, pp. 8770–8781, 2006.
- S. Mishra and M. Meuwly, “Nitric oxide dynamics in truncated hemoglobin: docking sites, migration pathways, and vibrational spectroscopy from molecular dynamics simulations,” Biophysical Journal, vol. 96, no. 6, pp. 2105–2118, 2009.
- F. Spyrakis, S. Faggiano, S. Abbruzzetti et al., “Histidine E7 dynamics modulates ligand exchange between distal pocket and solvent in AHb1 from Arabidopsis thaliana,” Journal of Physical Chemistry B, vol. 115, no. 14, pp. 4138–4146, 2011.
- J. J. Weiss, “Nature of the iron-oxygen bond in oxyhæmoglobin,” Nature, vol. 202, no. 4927, pp. 83–84, 1964.
- J. B. Wittenberg, B. A. Wittenberg, J. Peisach, and W. E. Blumberg, “On the state of the iron and the nature of the ligand in oxyhemoglobin,” Proceedings of the National Academy of Sciences of the United States of America, vol. 67, no. 4, pp. 1846–1853, 1970.
- R. E. Huie and S. Padmaja, “The reaction of NO with superoxide,” Free Radical Research Communications, vol. 18, no. 4, pp. 195–199, 1993.
- H. P. Misra and I. Fridovich, “The generation of superoxide radical during the autoxidation of hemoglobin,” The Journal of Biological Chemistry, vol. 247, no. 21, pp. 6960–6962, 1972.
- F. B. Jensen, “Comparative analysis of autoxidation of haemoglobin,” Journal of Experimental Biology, vol. 204, no. 11, pp. 2029–2033, 2001.
- X. Zhao, K. Vyas, B. D. Nguyen et al., “A double mutant of sperm whale myoglobin mimics the structure and function of elephant myoglobin,” The Journal of Biological Chemistry, vol. 270, no. 35, pp. 20763–20774, 1995.
- A. Fago, C. Hundahl, S. Dewilde, K. Gilany, L. Moens, and R. E. Weber, “Allosteric regulation and temperature dependence of oxygen binding in human neuroglobin and cytoglobin: molecular mechanisms and physiological significance,” The Journal of Biological Chemistry, vol. 279, no. 43, pp. 44417–44426, 2004.
- A. Fago, C. Hundahl, H. Malte, and R. E. Weber, “Functional properties of neuroglobin and cytoglobin. Insights into the ancestral physiological roles of globins,” IUBMB Life, vol. 56, no. 11-12, pp. 689–696, 2004.
- S. Goldstein, G. Merenyi, and A. Samuni, “Kinetics and mechanism of *NO2 reacting with various oxidation states of myoglobin,” Journal of the American Chemical Society, vol. 126, no. 48, pp. 15694–15701, 2004.
- E. T. Yukl, S. de Vries, and P. Moënne-Loccoz, “The millisecond intermediate in the reaction of nitric oxide with oxymyoglobin is an iron(III)-nitrato complex, not a peroxynitrite,” Journal of the American Chemical Society, vol. 131, no. 21, pp. 7234–7235, 2009.
- S. Herold, M. Exner, and T. Nauser, “Kinetic and mechanistic studies of the NO∙-mediated oxidation of oxymyoglobin and oxyhemoglobin,” Biochemistry, vol. 40, no. 11, pp. 3385–3395, 2001.
- J. S. Olson, E. W. Foley, C. Rogge, A. L. Tsai, M. P. Doyle, and D. D. Lemon, “NO scavenging and the hypertensive effect of hemoglobin-based blood substitutes,” Free Radical Biology and Medicine, vol. 36, no. 6, pp. 685–697, 2004.
- M. S. Navati and J. M. Friedman, “The use of glassy matrices to identify intermediates in the nitric oxide dioxygenase reaction of hemoglobins and myoglobins,” Biophysical Journal, vol. 96, no. 3, pp. 558a–559a, 2009.
- T. S. Kurtikyan and P. C. Ford, “Hexacoordinate oxy-globin models Fe(Por)(NH3)(O2) react with NO to form only the nitrato analogs Fe(Por)(NH3)-ONO2, even at ~100 K,” Chemical Communications, vol. 46, no. 45, pp. 8570–8572, 2010.
- T. S. Kurtikyan, S. R. Eksuzyan, V. A. Hayrapetyan, G. G. Martirosyan, G. S. Hovhannisyan, and J. A. Goodwin, “Nitric oxide dioxygenation reaction by oxy-coboglobin models: in situ low-temperature FTIR characterization of coordinated peroxynitrite,” Journal of the American Chemical Society, vol. 134, no. 33, pp. 13861–13870, 2012.
- M. N. Hughes and H. G. Nicklin, “The chemistry of pernitrites. Part I. Kinetics of decomposition of pernitrous acid,” Journal of the Chemical Society A, pp. 450–452, 1968.
- W. G. Keith and R. E. Powell, “Kinetics of decomposition of peroxynitrous acid,” Journal of the Chemical Society A, p. 90, 1969.
- M. Anbar and H. Taube, “Interaction of nitrous acid with hydrogen peroxide and with water,” Journal of the American Chemical Society, vol. 76, no. 24, pp. 6243–6247, 1954.
- J. H. M. Tsai, J. G. Harrison, J. C. Martin et al., “Role of conformation of peroxynitrite anion (ONOO−) in its stability and toxicity,” Journal of the American Chemical Society, vol. 116, no. 9, pp. 4115–4116, 1994.
- S. Herold, T. Matsui, and Y. Watanabe, “Peroxynitrite isomerization catalyzed by His64 myoglobin mutants,” Journal of the American Chemical Society, vol. 123, no. 17, pp. 4085–4086, 2001.
- S. Herold, K. Shivashankar, and M. Mehl, “Myoglobin scavenges peroxynitrite without being significantly nitrated,” Biochemistry, vol. 41, no. 45, pp. 13460–13472, 2002.
- J. L. Bourassa, E. P. Ives, A. L. Marqueling, R. Shimanovich, and J. T. Groves, “Myoglobin catalyzes its own nitration,” Journal of the American Chemical Society, vol. 123, no. 21, pp. 5142–5143, 2001.
- J. Su and J. T. Groves, “Mechanisms of peroxynitrite interactions with heme proteins,” Inorganic Chemistry, vol. 49, no. 14, pp. 6317–6329, 2010.
- J. Lee, J. A. Hunt, and J. T. Groves, “Mechanism of iron porphyrin reactions with peroxynitrite,” Journal of the American Chemical Society, vol. 120, no. 30, pp. 7493–7501, 1998.
- R. Silaghi-Dumitrescu, “A density functional study of heme-peroxynitrite adducts,” Journal of Molecular Structure: THEOCHEM, vol. 722, no. 1–3, pp. 233–237, 2005.
- J. Su and J. T. Groves, “Direct detection of the oxygen rebound intermediates, ferryl Mb and NO2, in the reaction of metmyoglobin with peroxynitrite,” Journal of the American Chemical Society, vol. 131, no. 36, pp. 12979–12988, 2009.
- P. K. Witting, A. G. Mauk, D. J. Douglas, and R. Stocker, “Reaction of human myoglobin and peroxynitrite: characterizing biomarkers for myoglobin-derived oxidative stress,” Biochemical and Biophysical Research Communications, vol. 286, no. 2, pp. 352–356, 2001.
- N. Romero, R. Radi, E. Linares et al., “Reaction of human hemoglobin with peroxynitrite. Isomerization to nitrate and secondary formation of protein radicals,” The Journal of Biological Chemistry, vol. 278, no. 45, pp. 44049–44057, 2003.
- A. I. Alayash, B. A. B. Ryan, and R. E. Cashon, “Peroxynitrite-mediated heme oxidation and protein modification of native and chemically modified hemoglobins,” Archives of Biochemistry and Biophysics, vol. 349, no. 1, pp. 65–73, 1998.
- M. Minetti, G. Scorza, and D. Pietraforte, “Peroxynitrite induces long-lived tyrosyl radical(s) in oxyhemoglobin of red blood cells through a reaction involving CO2 and a ferryl species,” Biochemistry, vol. 38, no. 7, pp. 2078–2087, 1999.
- M. Minetti, D. Pietraforte, V. Carbone, A. M. Salzano, G. Scorza, and G. Marino, “Scavenging of peroxynitrite by oxyhemoglobin and identification of modified globin residues,” Biochemistry, vol. 39, no. 22, pp. 6689–6697, 2000.
- B. S. Jursic, L. Klasinc, S. Pecur, and W. A. Pryor, “On the mechanism of HOONO to HONO2 conversion,” Nitric Oxide, vol. 1, no. 6, pp. 494–501, 1997.
- D. S. Bohle and B. Hansert, “O-atom scrambling in the aqueous isomerization of pernitrous acid,” Nitric Oxide, vol. 1, no. 6, pp. 502–506, 1997.
- W. H. Koppenol, “The chemistry of peroxynitrite, a biological toxin,” Quimica Nova, vol. 21, no. 3, pp. 326–331, 1998.
- H. Taube, “The production of atomic iodine in the reaction of peroxides with iodide ion,” Journal of the American Chemical Society, vol. 64, no. 1, pp. 161–165, 1942.
- W. Bray, “Beiträge zur Kenntnis der Halogensauerstoffverbindung I. und II,” Zeitschrift für Physikalische Chemie, vol. 54, pp. 463–497, 1906.
- A. A. Noyes and W. O. Scott, “Beitrag zur Kenntnis der Gesetze der Geschwindigkeit von polymolekularen Reaktion,” Zeitschrift für Physikalische Chemie, vol. 18, pp. 118–132, 1895.
- J. Brode, “Die Oxydation des Jodions zu Hypojodit als Zwischenstufe einiger Reacktion,” Zeitschrift für Physikalische Chemie, vol. 49, pp. 208–216, 1904.
- M. A. Martí, A. Bidon-Chanal, A. Crespo et al., “Mechanism of product release in NO detoxification from Mycobacterium tuberculosis truncated hemoglobin N,” Journal of the American Chemical Society, vol. 130, no. 5, pp. 1688–1693, 2008.
- A. Lama, S. Pawaria, A. Bidon-Chanal et al., “Role of pre-A motif in nitric oxide scavenging by truncated hemoglobin, HbN, of Mycobacterium tuberculosis,” The Journal of Biological Chemistry, vol. 284, no. 21, pp. 14457–14468, 2009.
- B. A. Haines, D. A. Davis, A. Zykovich et al., “Comparative protein interactomics of neuroglobin and myoglobin,” Journal of Neurochemistry, vol. 123, no. 1, pp. 192–198, 2012.
- E. El Hammi, C. Houee-Levin, J. Rezac et al., “New insights into the mechanism of electron transfer within flavohemoglobins: tunnelling pathways, packing density, thermodynamic and kinetic analyses,” Physical Chemistry Chemical Physics, vol. 14, no. 40, pp. 13872–13880, 2012.
- A. M. Gardner, S. F. Sanders, and P. R. Gardner, “The flavohemoglobin F7 lysine ammonium group is essential for electron-transfer gating and nitric-oxide dioxygenase function,” submitted.
- A. Hausladen, A. Gow, and J. S. Stamler, “Flavohemoglobin denitrosylase catalyzes the reaction of a nitroxyl equivalent with molecular oxygen,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 18, pp. 10108–10112, 2001.
- A. Hausladen and J. S. Stamler, “Is the flavohemoglobin a nitric oxide dioxygenase?” Free Radical Biology and Medicine, vol. 53, no. 5, pp. 1209–1210, 2012.
- A. Hausladen, A. J. Gow, and J. S. Stamler, “Nitrosative stress: metabolic pathway involving the flavohemoglobin,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 24, pp. 14100–14105, 1998.
- M. Shepherd, P. V. Bernhardt, and R. K. Poole, “Globin-mediated nitric oxide detoxification in the foodborne pathogenic bacterium Campylobacter jejuni proceeds via a dioxygenase or denitrosylase mechanism,” Nitric Oxide, vol. 25, no. 2, pp. 229–233, 2011.
- L. S. Nobre, V. L. Gonçalves, and L. M. Saraiva, “Flavohemoglobin of Staphylococcus aureus,” Methods in Enzymology, vol. 436, pp. 203–216, 2008.
- M. T. Forrester and M. W. Foster, “Response to, ‘is the flavohemoglobin a nitric oxide dioxygenase’,” Free Radical Biology and Medicine, vol. 53, pp. 1211–1212, 2012.
- C. E. Immoos, J. Chou, M. Bayachou, E. Blair, J. Greaves, and P. J. Farmer, “Electrocatalytic reductions of nitrite, nitric oxide, and nitrous oxide by thermophilic cytochrome P450 CYP119 in film-modified electrodes and an analytical comparison of its catalytic activities with myoglobin,” Journal of the American Chemical Society, vol. 126, no. 15, pp. 4934–4942, 2004.
- S. Herold and G. Röck, “Mechanistic studies of the oxygen-mediated oxidation of nitrosylhemoglobin,” Biochemistry, vol. 44, no. 16, pp. 6223–6231, 2005.
- A. M. Gardner and P. R. Gardner, “Flavohemoglobin detoxifies nitric oxide in aerobic, but not anaerobic, Escherichia coli: evidence for a novel inducible anaerobic nitric oxide-scavenging activity,” The Journal of Biological Chemistry, vol. 277, no. 10, pp. 8166–8171, 2002.
- D. J. Kliebenstein, R. A. Monde, and R. L. Last, “Superoxide dismutase in Arabidopsis: an eclectic enzyme family with disparate regulation and protein localization,” Plant Physiology, vol. 118, no. 2, pp. 637–650, 1998.
- M. Couture, H. Chamberland, B. St-Pierre, J. Lafontaine, and M. Guertin, “Nuclear genes encoding chloroplast hemoglobins in the unicellular green alga Chlamydomonas eugametos,” Molecular and General Genetics, vol. 243, no. 2, pp. 185–197, 1994.
- R. Pathania, N. K. Navani, G. Rajamohan, and K. L. Dikshit, “Mycobacterium tuberculosis hemoglobin HbO associates with membranes and stimulates cellular respiration of recombinant Escherichia coli,” The Journal of Biological Chemistry, vol. 277, no. 18, pp. 15293–15302, 2002.
- C. Liu, Y. He, and Z. Chang, “Truncated hemoglobin O of Mycobacterium tuberculosis: the oligomeric state change and the interaction with membrane components,” Biochemical and Biophysical Research Communications, vol. 316, no. 4, pp. 1163–1172, 2004.
- Ramandeep, K. W. Hwang, M. Raje et al., “Vitreoscilla hemoglobin: intracellular localization and binding to membranes,” The Journal of Biological Chemistry, vol. 276, no. 27, pp. 24781–24789, 2001.
- A. Di Giulio and A. Bonamore, “Globin interactions with lipids and membranes,” Methods in Enzymology, vol. 436, pp. 239–253, 2008.
- B. Ertas, L. Kiger, M. Blank, M. C. Marden, and T. Burmester, “A membrane-bound hemoglobin from gills of the green shore crab Carcinus maenas,” The Journal of Biological Chemistry, vol. 286, no. 5, pp. 3185–3193, 2011.
- N. Cassanova, K. M. O'Brien, B. T. Stahl, T. McClure, and R. O. Poyton, “Yeast flavohemoglobin, a nitric oxide oxidoreductase, is located in both the cytosol and the mitochondrial matrix: effects of respiration, anoxia, and the mitochondrial genome on its intracellular level and distribution,” The Journal of Biological Chemistry, vol. 280, no. 9, pp. 7645–7653, 2005.
- E. J. H. Ross, L. Shearman, M. Mathiesen et al., “Nonsymbiotic hemoglobins in rice are synthesized during germination and in differentiating cell types,” Protoplasma, vol. 218, no. 3-4, pp. 125–133, 2001.
- B. J. Reeder, D. A. Svistunenko, and M. T. Wilson, “Lipid binding to cytoglobin leads to a change in haem co-ordination: a role for cytoglobin in lipid signalling of oxidative stress,” Biochemical Journal, vol. 434, no. 3, pp. 483–492, 2011.
- T. Jayaraman, J. Tejero, B. B. Chen et al., “14-3-3 binding and phosphorylation of neuroglobin during hypoxia modulate six-to-five heme pocket coordination and rate of nitrite reduction to nitric oxide,” The Journal of Biological Chemistry, vol. 286, no. 49, pp. 42679–42689, 2011.
- M. Tiso, J. Tejero, S. Basu et al., “Human neuroglobin functions as a redox-regulated nitrite reductase,” The Journal of Biological Chemistry, vol. 286, no. 20, pp. 18277–18289, 2011.
- D. Hamdane, L. Kiger, S. Dewilde et al., “The redox state of the cell regulates the ligand binding affinity of human neuroglobin and cytoglobin,” The Journal of Biological Chemistry, vol. 278, no. 51, pp. 51713–51721, 2003.
- D. Maiti, D. H. Lee, A. A. N. Sarjeant et al., “Reaction of a copper-dioxygen complex with nitrogen monoxide (∙NO) leads to a copper(II)-peroxynitrite species,” Journal of the American Chemical Society, vol. 130, no. 21, pp. 6700–6701, 2008.
- B. R. Li, J. L. R. Anderson, C. G. Mowat, C. S. Miles, G. A. Reid, and S. K. Chapman, “Rhodobacter sphaeroides haem protein: a novel cytochrome with nitric oxide dioxygenase activity,” Biochemical Society Transactions, vol. 36, no. 5, pp. 992–995, 2008.
- C. N. Hall and J. Garthwaite, “Inactivation of nitric oxide by rat cerebellar slices,” Journal of Physiology, vol. 577, no. 2, pp. 549–567, 2006.
- C. N. Hall, R. G. Keynes, and J. Garthwaite, “Cytochrome P450 oxidoreductase participates in nitric oxide consumption by rat brain,” Biochemical Journal, vol. 419, no. 2, pp. 411–418, 2009.
- U. N. Westfelt, G. Benthin, S. Lundin, O. Stenqvist, and Å. Wennmalm, “Conversion of inhaled nitric oxide to nitrate in man,” British Journal of Pharmacology, vol. 114, no. 8, pp. 1621–1624, 1995.
- C. K. Hallstrom, A. M. Gardner, and P. R. Gardner, “Nitric oxide metabolism in mammalian cells: substrate and inhibitor profiles of a NADPH-cytochrome P450 oxidoreductase-coupled microsomal nitric oxide dioxygenase,” Free Radical Biology and Medicine, vol. 37, no. 2, pp. 216–228, 2004.
- K. Schmidt and B. Mayer, “Consumption of nitric oxide by endothelial cells: evidence for the involvement of a NAD(P)H-, flavin- and heme-dependent dioxygenase reaction,” FEBS Letters, vol. 577, no. 1-2, pp. 199–204, 2004.
- M. A. Robinson, J. E. Baumgardner, V. P. Good, and C. M. Otto, “Physiological and hypoxic O2 tensions rapidly regulate NO production by stimulated macrophages,” American Journal of Physiology, vol. 294, no. 4, pp. C1079–C1087, 2008.
- X. Liu, C. Cheng, N. Zorko, S. Cronin, Y. R. Chen, and J. L. Zweier, “Biphasic modulation of vascular nitric oxide catabolism by oxygen,” American Journal of Physiology, vol. 287, no. 6, pp. H2421–H2426, 2004.
- X. Liu, P. Srinivasan, E. Collard et al., “Oxygen regulates the effective diffusion distance of nitric oxide in the aortic wall,” Free Radical Biology and Medicine, vol. 48, no. 4, pp. 554–559, 2010.
- M. Palacios-Callender, V. Hollis, M. Mitchison, N. Frakich, D. Unitt, and S. Moncada, “Cytochrome c oxidase regulates endogenous nitric oxide availability in respiring cells: a possible explanation for hypoxic vasodilation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 47, pp. 18508–18513, 2007.
- Y. R. Chen, C. L. Chen, A. Yeh, X. Liu, and J. L. Zweier, “Direct and indirect roles of cytochrome b in the mediation of superoxide generation and NO catabolism by mitochondrial succinate-cytochrome c reductase,” The Journal of Biological Chemistry, vol. 281, no. 19, pp. 13159–13168, 2006.
- A. U. Igamberdiev, N. V. Bykova, W. Ens, and R. D. Hill, “Dihydrolipoamide dehydrogenase from porcine heart catalyzes NADH-dependent scavenging of nitric oxide,” FEBS Letters, vol. 568, no. 1—3, pp. 146–150, 2004.
- R. Gaupp, N. Ledala, and G. A. Somerville, “Staphylococcal response to oxidative stress,” Frontiers in Cellular and Infection Microbiology, vol. 2, article 33, 2012.
- S. Herold and K. Shivashankar, “Metmyoglobin and methemoglobin catalyze the isomerization of peroxynitrite to nitrate,” Biochemistry, vol. 42, no. 47, pp. 14036–14046, 2003.
- M. T. Gladwin, “Hemoglobin as a nitrite reductase regulating red cell-dependent hypoxic vasodilation,” American Journal of Respiratory Cell and Molecular Biology, vol. 32, no. 5, pp. 363–366, 2005.
- Z. Huang, S. Shiva, D. B. Kim-Shapiro et al., “Enzymatic function of hemoglobin as a nitrite reductase that produces NO under allosteric control,” Journal of Clinical Investigation, vol. 115, no. 8, pp. 2099–2107, 2005.
- S. Shiva, Z. Huang, R. Grubina et al., “Deoxymyoglobin is a nitrite reductase that generates nitric oxide and regulates mitochondrial respiration,” Circulation Research, vol. 100, no. 5, pp. 654–661, 2007.
- T. Rassaf, U. Flögel, C. Drexhage, U. Hendgen-Cotta, M. Kelm, and J. Schrader, “Nitrite reductase function of deoxymyoglobin: oxygen sensor and regulator of cardiac energetics and function,” Circulation Research, vol. 100, no. 12, pp. 1749–1754, 2007.
- M. G. Petersen, S. Dewilde, and A. Fago, “Reactions of ferrous neuroglobin and cytoglobin with nitrite under anaerobic conditions,” Journal of Inorganic Biochemistry, vol. 102, no. 9, pp. 1777–1782, 2008.
- H. Li, C. Hemann, T. M. Abdelghany, M. A. El-Mahdy, and J. L. Zweier, “Characterization of the mechanism and magnitude of cytoglobin-mediated nitrite reduction and nitric oxide generation under anaerobic conditions,” The Journal of Biological Chemistry, vol. 287, no. 43, pp. 36623–36633, 2012.
- R. Sturms, A. A. Dispirito, and M. S. Hargrove, “Plant and cyanobacterial hemoglobins reduce nitrite to nitric oxide under anoxic conditions,” Biochemistry, vol. 50, no. 19, pp. 3873–3878, 2011.
- M. Tiso, J. Tejero, C. Kenney, S. Frizzell, and M. T. Gladwin, “Nitrite reductase activity of nonsymbiotic hemoglobins from Arabidopsis thalania,” Biochemistry, vol. 51, no. 26, pp. 5285–5292, 2012.
- A. Sakamoto, S. H. Sakurao, K. Fukunaga et al., “Three distinct Arabidopsis hemoglobins exhibit peroxidase-like activity and differentially mediate nitrite-dependent protein nitration,” FEBS Letters, vol. 572, no. 1–3, pp. 27–32, 2004.
- S. Nicolis, E. Monzani, C. Ciaccio, P. Ascenzi, L. Moens, and L. Casella, “Reactivity and endogenous modification by nitrite and hydrogen peroxide: does human neuroglobin act only as a scavenger?” Biochemical Journal, vol. 407, no. 1, pp. 89–99, 2007.
- M. Otsuka, S. A. Marks, D. E. Winnica, A. A. Amoscato, L. L. Pearce, and J. Peterson, “Covalent modifications of hemoglobin by nitrite anion: formation kinetics and properties of nitrihemoglobin,” Chemical Research in Toxicology, vol. 23, no. 11, pp. 1786–1795, 2010.
- K. J. Gupta, A. U. Igamberdiev, G. Manjunatha et al., “The emerging roles of nitric oxide (NO) in plant mitochondria,” Plant Science, vol. 181, no. 5, pp. 520–526, 2011.
- R. Sturms, A. A. DiSpirito, D. B. Fulton, and M. S. Hargrove, “Hydroxylamine reduction to ammonium by plant and cyanobacterial hemoglobins,” Biochemistry, vol. 50, no. 50, pp. 10829–10835, 2011.
- A. Bonamore, P. Gentili, A. Ilari, M. E. Schininà, and A. Boffi, “Escherichia coli flavohemoglobin is an efficient alkylhydroperoxide reductase,” The Journal of Biological Chemistry, vol. 278, no. 25, pp. 22272–22277, 2003.
- G. Wu, H. Corker, Y. Orii, and R. K. Poole, “Escherichia coli Hmp, an “oxygen-binding flavohaemoprotein”, produces superoxide anion and self-destructs,” Archives of Microbiology, vol. 182, no. 2-3, pp. 193–203, 2004.
- N. Kawada, D. B. Kristensen, K. Asahina et al., “Characterization of a stellate cell activation-associated Protein (STAP) with peroxidase activity found in rat hepatic stellate cells,” The Journal of Biological Chemistry, vol. 276, no. 27, pp. 25318–25323, 2001.
- E. Fordel, L. Thijs, W. Martinet, D. Schrijvers, L. Moens, and S. Dewilde, “Anoxia or oxygen and glucose deprivation in SH-SY5Y cells: a step closer to the unraveling of neuroglobin and cytoglobin functions,” Gene, vol. 398, no. 1-2, pp. 114–122, 2007.
- F. Trandafir, D. Hoogewijs, F. Altieri et al., “Neuroglobin and cytoglobin as potential enzyme or substrate,” Gene, vol. 398, no. 1-2, pp. 103–113, 2007.
- F. E. McRonald, J. M. Risk, and N. J. Hodges, “Protection from intracellular oxidative stress by cytoglobin in normal and cancerous oesophageal cells,” PLoS ONE, vol. 7, no. 2, Article ID e30587, 2012.
- E. Fordel, L. Thijs, L. Moens, and S. Dewilde, “Neuroglobin and cytoglobin expression in mice: evidence for a correlation with reactive oxygen species scavenging,” FEBS Journal, vol. 274, no. 5, pp. 1312–1317, 2007.
- K. G. Paul, “Peroxidases: past and present,” Journal of Oral Pathology, vol. 16, no. 8, pp. 409–411, 1987.
- Y. P. Chen, S. A. Woodin, D. E. Lincoln, and C. R. Lovell, “An unusual dehalogenating peroxidase from the marine terebellid polychaete Amphitrite ornata,” The Journal of Biological Chemistry, vol. 271, no. 9, pp. 4609–4612, 1996.
- H. Yanmin, P. D. Butcher, J. A. Mangan, M. A. Rajandream, and A. R. M. Coates, “Regulation of hmp gene transcription in Mycobacterium tuberculosis: effects of oxygen limitation and nitrosative and oxidative stress,” Journal of Bacteriology, vol. 181, no. 11, pp. 3486–3493, 1999.
- K. B. Hota, S. K. Hota, R. B. Srivastava, and S. B. Singh, “Neuroglobin regulates hypoxic response of neuronal cells through Hif-1α and Nrf2-mediated mechanism,” Journal of Cerebral Blood Flow and Metabolism, vol. 32, no. 6, pp. 1046–1060, 2012.
- Y. Liu and P. R. Ortiz de Montellano, “Reaction intermediates and single turnover rate constants for the oxidation of heme by human heme oxygenase-1,” The Journal of Biological Chemistry, vol. 275, no. 8, pp. 5297–5307, 2000.
- L. R. Kump, “The rise of atmospheric oxygen,” Nature, vol. 451, no. 7176, pp. 277–278, 2008.
- T. A. K. Freitas, J. A. Saito, S. Hou, and M. Alam, “Globin-coupled sensors, protoglobins, and the last universal common ancestor,” Journal of Inorganic Biochemistry, vol. 99, no. 1, pp. 23–33, 2005.
- X. Wan, J. R. Tuckerman, J. A. Saito et al., “Globins synthesize the second messenger bis-(3′-5′)-cyclic diguanosine monophosphate in bacteria,” Journal of Molecular Biology, vol. 388, no. 2, pp. 262–270, 2009.
- K. Wakasugi, T. Nakano, and I. Morishima, “Oxidized human neuroglobin acts as a heterotrimeric Gα protein guanine nucleotide dissociation inhibitor,” The Journal of Biological Chemistry, vol. 278, no. 38, pp. 36505–36512, 2003.
- K. Wakasugi and I. Morishima, “Identification of residues in human neuroglobin crucial for guanine nucleotide dissociation inhibitor activity,” Biochemistry, vol. 44, no. 8, pp. 2943–2948, 2005.
- L. Thijs, E. Vinck, A. Bolli et al., “Characterization of a globin-coupled oxygen sensor with a gene-regulating function,” The Journal of Biological Chemistry, vol. 282, no. 52, pp. 37325–37340, 2007.
- J. MacMicking, Q. W. Xie, and C. Nathan, “Nitric oxide and macrophage function,” Annual Review of Immunology, vol. 15, pp. 323–350, 1997.
- M. U. Shiloh and C. F. Nathan, “Reactive nitrogen intermediates and the pathogenesis of Salmonella and Mycobacteria,” Current Opinion in Microbiology, vol. 3, no. 1, pp. 35–42, 2000.
- C. T. Privalle, Methods for the Synthesis of a Modified Hemoglobin Solution, APEX Bioscience, US. European Patent Office, 2010.
- P. R. Gardner, Nitric Oxide Dioxygenase Inhibitors, Cincinnati Children's Hospital Medical Center, US. United States Patent Application Publication, 2008.
- G. Bauer, Method for Inducing Tumor Apoptosis by Increasing Nitric Oxide Levels, Universitatsklinik Freiburg, DE. United States Patent Application Publication, 2009.
- R. A. Helmick, A. E. Fletcher, A. M. Gardner et al., “Imidazole antibiotics inhibit the nitric oxide dioxygenase function of microbial flavohemoglobin,” Antimicrobial Agents and Chemotherapy, vol. 49, no. 5, pp. 1837–1843, 2005.
- E. El Hammi, E. Warkentin, U. Demmer et al., “Structure of Ralstonia eutropha flavohemoglobin in complex with three antibiotic azole compounds,” Biochemistry, vol. 50, no. 7, pp. 1255–1264, 2011.
- L. S. Nobre, S. Todorovic, A. F. N. Tavares et al., “Binding of azole antibiotics to Staphylococcus aureus flavohemoglobin increases intracellular oxidative stress,” Journal of Bacteriology, vol. 192, no. 6, pp. 1527–1533, 2010.
- A. Basra, M. Edgerton, G. J. Lee et al., Plants Containing Heterologous Flavohemoglobin Gene and Methods of Use Thereof, Monsanto Company, US. United States Patent Application Publication, 2012.
- H. Kahraman, E. Aytan, and A. G. Kurt, “Production of methionine g-lyase in recombinant Citrobacter freundii bearing the hemoglobin gene,” BMB Reports, vol. 44, pp. 590–594, 2011.
- X. Wang, Y. Sun, X. Shen et al., “Intracellular expression of Vitreoscilla hemoglobin improves production of Yarrowia lipolytica lipase LIP2 in a recombinant Pichia pastoris,” Enzyme and Microbial Technology, vol. 50, no. 1, pp. 22–28, 2012.
- T. Sanny, M. Arnaldos, S. A. Kunkel, K. R. Pagilla, and B. C. Stark, “Engineering of ethanolic E. coli with the Vitreoscilla hemoglobin gene enhances ethanol production from both glucose and xylose,” Applied Microbiology and Biotechnology, vol. 88, no. 5, pp. 1103–1112, 2010.
- M. Xu, Z. Rao, H. Xu et al., “Enhanced production of L-arginine by expression of Vitreoscilla hemoglobin using a novel expression system in Corynebacterium crenatum,” Applied Biochemistry and Biotechnology, vol. 163, no. 6, pp. 707–719, 2011.
- H. Zhu, S. Sun, and S. Zhang, “Enhanced production of total flavones and exopolysaccharides via Vitreoscilla hemoglobin biosynthesis in Phellinus igniarius,” Bioresource Technology, vol. 102, no. 2, pp. 1747–1751, 2011.
- X. C. Wu, Y. M. Chen, D. LiY et al., “Constitutive expression of Vitreoscilla haemoglobin in Sphingomonas elodea to improve gellan gum production,” Journal of Applied Microbiology, vol. 110, no. 2, pp. 422–430, 2011.
- T. E. Pablos, E. M. Mora, S. Le Borgne, O. T. Ramírez, G. Gosset, and A. R. Lara, “Vitreoscilla hemoglobin expression in engineered Escherichia coli: improved performance in high cell-density batch cultivations,” Biotechnology Journal, vol. 6, no. 8, pp. 993–1002, 2011.
- J. Shen, H. Zheng, X. Zhi et al., “Improvement of amorpha-4,11-diene production by a yeast-conform variant of Vitreoscilla hemoglobin,” Zeitschrift für Naturforschung C, vol. 67, no. 3-4, pp. 195–207, 2012.
- Y. Luo, X. Kou, X. Ding et al., “Promotion of spinosad biosynthesis by chromosomal integration of the Vitreoscilla hemoglobin gene in Saccharopolyspora spinosa,” Science China Life Sciences, vol. 55, no. 2, pp. 172–180, 2012.
- J. J. Stewart and K. J. Coyne, Novel Nitrate Reductase Fusion Proteins and Uses Thereof, University of Delaware, US. United States Patent Application Publication, 2012.
- M. T. Forrester, C. E. Eyler, and J. N. Rich, “Bacterial flavohemoglobin: a molecular tool to probe mammalian nitric oxide biology,” Biotechniques, vol. 50, no. 1, pp. 41–45, 2011.
- C. Seregélyes, B. Barna, J. Hennig et al., “Phytoglobins can interfere with nitric oxide functions during plant growth and pathogenic responses: a transgenic approach,” Plant Science, vol. 165, no. 3, pp. 541–550, 2003.
- T. E. Mishina, C. Lamb, and J. Zeier, “Expression of a nitric oxide degrading enzyme induces a senescence programme in Arabidopsis,” Plant, Cell and Environment, vol. 30, no. 1, pp. 39–52, 2007.
- F. L. Hünefeld, Der Chemismus in der thierischen Organisation, F. A. Brockhaus, Leipzig, Germany, 1840.